introvivo reduces the amount of the virus that causes hepatitis c infection . incivo is used for the treatment of adults , adolescents and children from the age of 18 years with either peginterferon alfa , ribavirin or telaprevir . it belongs to a group of medicines called ns3 - 4a protease inhibitors . the nns3 - foura enzyme is essential for the hepatitis c virus to reproduce itself . it works by blocking the activity of two proteins that are involved in the production of the nnnn nnf protein . this is called protease inhibitor . if you
do not take incivo - if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking incivo if : - you are taking peginterferon alfa or ribavirin . your doctor may need to adjust your dose of incivo and / or their contraindications ( e . g . pregnancy precautions ) before starting incivo . - you have been previously treated with a medicine that increases the amount of protein produced in the body ( called alpha - 1 - adrenoreceptor antagonists
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will prescribe the appropriate dose regimen for you . the recommended dose regimen is 3 mg , 6 mg , 2 mg , 8 mg and 6 mg . you should take both hepatitis c virus infection and human immunodeficiency virus infection with efavirenz . if you take more incivo than you should if you accidentally take too many tablets , or if someone else accidentally takes your tablets , contact your doctor , pharmacist or nurse immediately . if possible , show them the package leaflets for these
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you get an itchy skin rash . if the rash gets worse , stop using incivo and seek medical help immediately . other symptoms of the rash may include : - a severe skin reaction . contact your doctor or the nearest hospital immediately if your rash does not go away . - swelling of lymph glands . - a wide - spread rash with peeling skin . - fever and flu - like symptoms . - painful skin blisters . these may be blisters in the mouth , eyes , and / or genitals . if your
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the bottle after exp . this medicine does not require any special storage conditions . incivo tablets should be kept in the bottle tightly closed in order to protect from moisture .
what incivo contains the active substance in incivo is telaprevir . each tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose ( e460 ), silica colloidalanhydrous , sodium lauryl sulphate , croscarmellose sodium , sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , talc , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what incivo looks like and contents of the pack film - coated , yellow caplet - shaped tablets are
the active substance of zinbryta is daclizumab beta , a monoclonal antibody ( a type of protein that recognises and attaches to a specific target substance in the body ). what it is used for your doctor or nurse knows how to use it and why it has been prescribed for you by your doctor , pharmacist or nurse . how zinryta works in multiple sclerosis , therapy is two ms treatment followed by other treatments . inflammation destroys the protective sheath around the nerves in the central nervous system ( the brain and spinal cord ). this loss of myelin ( demyelination )
do not take zinbryta : - if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine ( listed in section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : - you have liver problems . your doctor may want to monitor you more closely while you are being treated with this medicine . you have any other autoimmune disorders . tell your doctor if you are taking , have recently taken or might take any other medicines . this includes herbal supplements . you should not take any medicines , including supplements obtained without a prescription
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of zinbryta is 150 mg once a day . your doctor will ask you to have a blood test to check how well your liver is working . if you have the impression that the effect is too strong or too weak , talk to your doctor , pharmacist or nurse . the usual dose is one or two tablets a day , with or without food . this blood test may be repeated every two weeks . if your doctor wants to change your dose , your
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with zinbryta : tell your doctor straight away if you notice any of the following serious side effects : liver problems : very common ( may affect more than 1 in 10 people ): unexplained nausea ( feeling sick ) vomiting ( being sick ) stomach pain increased tiredness loss of appetite ( anorexia ) changes in your skin or whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon ( might affect up to 1 in 100 people ): severe inflammation of the liver that may lead to death
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled syringe in its original package in order to protect from light . once a new syringe / pen has been removed from the refrigerator and has reached room temperature ( not above 30 ) it must either be used within 30 days or disposed of . if you are not sure , talk to your pharmacist or nurse before using z
what zinbryta contains - the active substance is daclizumab beta . each pre - filled syringe contains 150 micrograms ( 23 . 5 mg ) of dacluzumabbeta . 1 ml of solution for injection contains 150 milligrams ( 24 . 5mg ) of the active ingredient ( 25 . 2 mg ). - the other ingredients are sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( e433 ) and water for injections ( see section 2 for further information on the use , handling and disposal of medicines used to treat cancer ). what zzinb
what wilzin is wilzin belongs to a group of medicines called metabolism products . wilson ' s disease is due to a rare inherited defect in copper excretion from the liver to the eyes and brain . this defect leads to liver damage and neurological disorders . how wilzin works wilzin attaches to copper in the intestine and its further accumulation in the body . this is thought to play an important role in controlling the growth and spread of the disease . what wilzin looks like and contents of the pack this medicine is a white to off - white powder . it is a clear and colourless solution . it works by attaching to copper
do not use wilzin - if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilzin ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using wilzin wilzin is used for initial therapy in adults with signs and symptoms of wilson ' s disease . you are currently being treated with another anti - copper agent called penicillamine . wilzin should be used for the initial treatment in adults who are being treated in combination with other anti - copper agents such as penicillinamine . your doctor will monitor your symptoms closely during the treatment
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the different dose regimens are listed below . the recommended dose is 25 mg / 50 mg twice a day . the usual starting dose is 1 mg wilzin 50 mg once a day for 2 weeks . your doctor will tell you how many tablets of wilzin 25 mg to take . the dose may be increased or decreased depending on how you respond to the medicine . the daily dose is one 25 mg capsule per day for 1 week . the doctor may tell you to take two 50 mg capsules per day .
like all medicines , wilzin can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) not known ( frequency cannot be estimated from the available data ) 1 , 000 micrograms / ml ( 0 . 5 %) common : may affect up to 1 in 10 users ( 1 . 10 %) very rare ( affects less than 1 patient in 10 , 000 ) if any of the above applies to you ( or you are not sure ), talk to
keep out of the reach and sight of children . do not store above 25 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains - the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg zinc acetate dihydrate ). each 50 mg hard capsule also contains 25mg of zinc , equivalent to 167 . 84 mg ( 3 . 0 micrograms of zinc ethyl per 0 . 5 ml of solution ). - the other ingredients are magnesium stearate . - the capsule shell contains gelatin , titanium dioxide ( e171 ) and brilliant blue fcf ( e132 ). what wilzin looks like and contents of the pack wilzin 25 mg hard capsules are white to off - white ,
biktarvy contains the active substance bictegravir , an antiretroviral medicine ( also known as an integrase strand transfer inhibitor ). the other active substances are emtricitabine , an antiviral medicine known as a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir alafenamide , an antipirritiral medicine called a nucleotide reverse transcriptase inhibitors ( trti ). biktarv is used for the treatment of human immunodeficiency virus 1 ( hiv ) in adults . hiv is a type of infection that
do not take biktarvy if : you are allergic to bictegravir , emtricitabine , tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). you are taking the following medicines : - rifampicin used to treat some bacterial infections such as tuberculosis - st . john ' s wort ( hypericum perforatum ) a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor , pharmacist or nurse before taking bikarvy : if you have or have ever had liver problems .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of biktarvy is : antacids to prevent stomach ulcers , heartburn and acid reflux , aluminium and magnesium hydroxide mineral supplements , vitamins , magnesium and iron ( see section 2 " important information about some of these medicines "). your doctor will tell you how many tablets to take and how often to take them . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . use in children and adolescents bik
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects : inflammation or infection in patients with advanced hiv infection ( opportunistic infections ( infections caused by a weak immune system ). symptoms of inflammation or previous infections may occur during hiv treatment . these symptoms may be due to an improvement in the body ' s immune response , which is needed to fight infections . there are no obvious symptoms of autoimmune disorders , in which the immune system attacks other parts of the body tissue . medicines given to suppress the body may increase the chance of getting
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the seal after exp . this medicine does not require any special temperature storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the seal tightly closed in order to protect from light .
what biktarvy contains - the active substances are bictegravir , emtricitabine and tenofovir alafenamide . - each biktravir sodium equivalent tablet contains 50 mg of the active substance in each tablet . - bic tegravira 200 mg : each tablet contains 200 mg of both in one tablet and in the other tablet ( tablet core microcrystalline cellulose , croscarmellose sodium and magnesium stearate ). - film - coating polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , talc , iron
novondorm is an oral antidiabetic medicine containing repaglinide , which helps your pancreas make better use of insulin when your blood sugar is high ( glucose ). type 2 diabetes is a disease in which a person cannot make enough insulin to control the sugar in their blood or where their body does not make enough of the insulin it produces . novonorm helps control the level of sugar in your blood during treatment with diet and exercise and weight reduction . it can also be used alone or in combination with metformin ( another medicine for diabetes ). your doctor will tell you how long you should continue to take no
do not take novonorm : - if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too low ( diabetic ketoacidosis ). warnings and precautions talk to your doctor , pharmacist or nurse before taking novonor . if your doctor has told you that you have a severe liver disease . if you take gemfibrozil ( a medicine used to lower increased fat levels in the blood ) 47 if you think you may have liver problems , tell your doctor before taking
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . you can take novonorm with or without food . the usual starting dose is 30 mg twice a day for 4 weeks . your doctor may increase your dose to 30 mg every 16 weeks depending on how you respond to the medicine . your blood sugar may increase if you take a hypo . if you have any further questions on the use of this medicine , ask your doctor , pharm
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia is the most common side effect of novonorm ( may affect up to 1 in 10 people ). if you have a hypo in section 2 , talk to your doctor or pharmacist straight away . if you experience symptoms such as swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating , anaphylactic reaction ( see section 4 ). other side effects may include : very common ( affects more than 1 user in 10 ): stomach pain diarrhoea rare ( affects 1 to 1 users in 1 , 000
what novonorm contains - the active substance is repaglinide . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , poloxamer , iron oxide yellow ( e172 ) ( 1 mg ) and iron oxide red ( 2 mg ) ( see end of section 2 for further information on some of the important ingredients ). what noonorm looks like and contents of the pack no vonorm tablets are white to off -
pumarix is a vaccine used in adults ( aged 18 years and older ) to prevent pandemic flu ( influenza ). it is a type of influenza that happens at intervals not known ( cannot be estimated from the available data ). it spreads rapidly around the world . the signs of influenza are similar to those of influenza in adults and children 10 years of age and older . pandemic influenza is different from ordinary flu . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce its own protection against the disease . none of the ingredients in the vaccine can cause flu . as with all
do not use pumarix if you have had a sudden life - threatening allergic reaction to any of the ingredients of this vaccine ( listed in section 6 ) or to any ingredient of the vaccine ( e . g . chicken protein , ovalbumin , formaldehyde and sodium deoxycholate ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if any of these apply to you , stop using the vaccine and seek medical treatment immediately . if you experience signs of such allergic reaction , please contact your doctor . warnings and precautions talk to your doctor , pharmacist
pumarix is recommended for use in adults 18 years of age and older . pumarix contains a similar h5n1 as03 to those of the other ingredients in this vaccine ( listed in section 6 ). use in children and adolescents ( from the age of 18 years onwards ) the recommended dose is one vaccine ( 0 . 5 ml ) per kg body weight , given as an injection into a muscle ( usually in the upper arm ). if you have any further questions on the use of this vaccine , ask your doctor or pharmacist .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may lead to dangerously low blood pressure , shock and emergency treatment . tell your doctor straight away if you notice any of the following side effects : very common ( may affect more than 1 in 10 people pain at the site of the injection headache feeling tired aching muscles joint pain common ( likely to affect up to 1 in every 10 people ) redness or swelling where the injection was given fever sweating shivering diarrhoea feeling sick uncommon ( likely not to affect above 1 in 100 people ) bruising a hard lump or itching warmth
keep this vaccine out of the sight and reach of children . do not use this vaccine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vaccine in the sachet in order to protect from light . after preparation of the suspension , the vaccine should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 30 .
what pumarix contains - the active substance is split influenza virus ( 5 / 2005 , pr8 - ibcdc - rg2 ) in 0 . 5 ml . - the other ingredient is haemagglutinin , which is produced by recombinant dna technology . in the pandemic , the vaccine contains an ' adjuvant ' as03 . this adjuvanted contains squalene , dl - α - tocopherol , polysorbate 80 and adjuvants . the other ingredients of the vaccine are : sodium chloride , disodium hydrogen phosphate , potassium dihydrogen phosphate ,
somakit t is a radiopharmaceutical product containing an active substance called edotreotide . the powder contains a radioactive substance called gallium ( 68ga ) chloride . the active substance in somakit to be used for this procedure is a substance that dissolves in water . the solution is a concentrate of gallium , which is then excreted in a vein . it is then injected into your body areas as part of a medical imaging procedure called positron emission tomography ( ptom ) ( pet scan ). the purpose of this medical procedure is to obtain images of the abnormal cells and tumours in
do not take somakittoc - if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you experience any signs of allergic reaction ( see section 4 ). if you have kidney or liver problems . if you suffer from renal or hepatic disease . children and adolescents do not give this medicine to children under 18 years of age because of the risk of dehydration . the examination will be repeated every 28 days . other medical conditions that may affect your body ( e . g . cushing
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakittoc will only be handled and given to you by people who are trained and qualified to use it safely . they will keep you informed of their actions and their actions . the nuclear medicine doctor supervising the procedure will decide on the appropriate dose of the product to be used for you . the usual dose is one 100 mg or 200 mg megabecquerel tablet per kilogram body weight each day . the dose that you will receive will depend on your condition and the results of the procedure . radiolabelling ,
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects : allergic reactions ( hypersensitivity ) have been reported with somakit t . symptoms include warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may also include stinging at the injection site due to ionising radiation , cancer and hereditary abnormalities . reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials and radiolabelling . the following information is intended for the specialist only : keep this medicine out of the sight and reach of children . do not use somakittoc after the expiry date which is stated on the outer carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . after storage at room temperature ( up to 25 ) the product should be used
what somakit t contains - the active substance is edotreotide . one vial of powder contains 40 mg edotereotide ( as 10 - phenanthroline ). - the other ingredients are gentisic acid , mannitol , formic acid ( e421 ), sodium hydroxide , water for injections , sodium and radiolabelling . - the solution contains hydrochloric acid which is used to adjust the amount of radioactivity in the vial . radiopharmaceutical preparation is provided in a glass vial with black flip - off cap . each pack contains a white powder and a glass
afinitor is an anticancer medicine that contains the active substance erolimus . everolimus stops the growth and spread of cancer cells . afinitor inhibits the activity of hormone receptor - positive advanced breast cancer in postmenopausal women . it belongs to a group of medicines called non - steroidal aromatase inhibitors , which are used to keep the disease under control . it is used in combination with a medicine called exemestane ( a steroid aromatase inhibitor ) and hormonal anticancer therapy to treat advanced tumours ( neuroendocrine tumours in the stomach , bowels , lung and pancre
always take afinitor exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you if you need to change your dose of cancer treatment . if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before taking afinit if you : - are allergic to everolimus , sirolimus , temsurolimus or any of the other ingredients of this medicine ( listed in section 6 ). - think you might be allergic to any of these active substances . - are taking
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 10 mg tablet once a day . you should take afinitor at the same time each day . if you have liver problems , your doctor may prescribe a lower dose of Afinitor ( between 5 mg and 5 mg ) or a higher dose of 7 . 5 mg depending on certain side effects . your doctor will tell you how many tablets to take and how long you should continue treatment . do not take a double dose to make up for a forgotten tablet . continue taking af
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and tell your doctor straight away if you experience any of the following signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin , with a red rash or raised bumps . the following side effects have been reported with the combination of the two active substances of afinavitor : very common ( may affect more than 1 in 10 people ) - increased temperature - chills ( signs of infection ) - fever - coughing - difficulty breathing - wheezing - inflammation
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 25 . store in the original package in order to protect from moisture . once opened the blister , remove the tablets from the blister and dispose of them in accordance with local requirements . this medicine does not require any special temperature storage conditions . if you notice any visible sign of tampering , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect
what afinitor contains - the active substance is everolimus . - the other ingredients are tablet core : alanine ( e553b ) and aminotransferase ( e551b ). - the 2 . 5 mg tablets are white to slightly yellowish , oval , biconvex , and debossed with " gsi " on one side and " 5 " on the other side . - each tablet contains either 5 mg , 6 mg , 7 mg , 10 mg , 20 mg , 30 mg , 40 mg , 50 mg , 60 mg , 90 mg , 100 mg , 200 mg ,
what laventair ellipta is and what it is used for the active substance in this inhalation is umeclidinium bromide , vilanterol . this belongs to a group of medicines called bronchodilators ( bronchiolators ) which help to control the airways . what you need to know before you use this medicine , tell your doctor or pharmacist if you have or have ever had chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties . when you have copd , the muscles around your airways tighten . this
do not use laventair ellipta 31 if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine : if you have asthma . if you think any of these apply to you , tell your doctor or pharmacist as soon as possible . you may need to be treated with a different type of inhalation ( inhalation ) while you are being treated with this medicine . if your doctor thinks that you may have asthma , ask your doctor for advice .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . this medicine should be used every day for 24 hours . do not use more laventair ellipta than your doctor tells you to . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you experience any of the following symptoms stop taking laventair ellipta and contact your doctor immediately : uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) and redness rare side effects : may affect upto 1 in 1 , 000 people : swelling mainly of the face or mouth ( angioedema ), feeling very wheezy , coughing , difficulty in breathing , feeling weak or light headed , collapse or loss of consciousness . immediate breathing difficulties should be treated immediately . if immediate breathing
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose of 55 micrograms ( mbq ). each inhalation delivers a delivered delivered dose ( mpa . s ) of 36 microgram ( mba . s ). - the other ingredients ( excipients ) are lactose monohydrate ( see section 2 for further information on lactose '), magnesium stearate ( e470b ). what laventAir ellipta looks like and contents of the pack lavent air ellipta is an inhal
the active substance of tremfya is guselkumab , a monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the body ). this medicine belongs to a group of proteins called il - 23 and is used to treat psoriasis in adults . it is used in adult patients with moderate to severe " plaque psorgiasis " an inflammatory condition that affects the skin and nails . it can be used to improve the condition on the skin or to reduce symptoms such as scaling , shedding , flaking , itching , pain and burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have an active infection . you have active tuberculosis warnings , precautions , and precautions before you have a vaccine , please tell your doctor or pharmacist while you are being treated or shortly after you have been treated . you may have an infection or an infection with tuberculosis . tuberculosis is a type of tuberculosis that
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . tremfya 100 units / ml ( 1 pre - filled syringe ) solution for injection under the skin ( subcutaneous injection ) may be used for up to 4 weeks or up to 8 weeks . your doctor will decide how long you should be treated . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects : signs of serious allergic reaction such as difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , a red rash and raised bumps other side effects talk to your doctor , pharmacist or nurse before you are given tremfya . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . this medicine should not be used if you notice that the solution is cloudy or contains large particles , or if the liquid is discoloured . the product should be thrown away from the refrigerator immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of gusel kumab in 1 ml of solution . - the other ingredients are histidine , histidine monohydrochloride monohydrate , polysorbate 80 , sucrose and water for injections . what tremfa looks like and contents of the pack solution for injection in a vial is a clear , colourless to pale yellow solution . it is supplied in a carton pack containing one single - dose glass syringe and a multipack containing 2 ( 2 packs of 1 ) single
the active substance of trepulmix , treprostinil , belongs to a group of medicines called prostacyclins , a type of hormone that helps to control blood pressure by relaxing blood vessels and preventing them from clotting together . inoperable chronic thromboembolic pulmonary hypertension ( cteph ) persistent or recurrentcteph cannot be adequately controlled by surgical treatment or exercise capacity . symptoms of the disease can vary from patient to patient , but most of them are mild to moderate and generally go away within a few days . in adult patients , the most frequently reported symptom of chronic tachycardolic
do not take trepulmix if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a disease called " pulmonary veno - occlusive disease ". this is a disease that causes the blood vessels in the lungs to become swollen , leading to a higher pressure in the blood arteries between the heart and the lungs . if you suffer from severe liver disease . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if you : have a heart problem . have had a heart attack ( myocardial infar
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . trepulmix is given as a continuous subcutaneous infusion under the skin ( subcutaneously ) into a small tube ( cannula ) in the abdomen or thigh . your doctor will decide on the correct dose for you . the recommended dose is one tablet ( 1 mg ) twice a day . you will be given one tablet in the morning and one in the evening . the dose may be adjusted by your doctor using a portable pump . your treprostinil will be injected into the
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain due to the infusion site reaction . if you experience any of these , stop taking trepulmix and talk to your doctor straight away . swelling of feet , ankles , legs , fluid retention ( e . g . hot flush pain in arms and / or legs ) 36 uncommon : may affect up to 1 in 100 people : swollen eyelids ( eyelid oedema ), indigestions , vomiting , skinitches ( exanthema ), back
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the trepulmix vial in the outer carton in order to protect from light . after dilution , the product may be used for up to 30 days as continuous subcutaneous infusion in a single vial or a single reservoir ( syringe ) of undiluted turbulmix . if not used immediately , in - use storage times and conditions prior to use are the responsibility
what trepulmix contains - the active substance is treprostinil ( as sodium salt ). each vial of trepulemix contains 1 mg ( as 1 . 5 mg treprosticinil ) and sodium salt . each 10 ml vial contains 10 mg (as 10 mg of treprosteinil ). - the other ingredients are sodium salt ( see section 2 ). each 2 . 5 ml ampoule contains 2. 5 mg [ as 10 mg ' treprosterinil ] and water for injections . each 25 ml ampule contains 25 mg / 50 ml treprostail and
the active substance of thorinane is enoxaparin sodium . it is a low molecular weight heparin ( lmwh ). your doctor will tell you what you need to take to help you get the best results . the recommended dose in adults is 1 milligram per kilogram of body weight to prevent existing blood clots from forming ( see section 2 ). the other recommended dose is 2 milligrams per kg body weight per day . your doctor may prescribe a lower dose if you have any further questions on the use of this product , ask your doctor or pharmacist .
do not use thorinane : if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if you think you may be allergic to heparin or other low molecular weight heparins ( e . g . nadroparin , tinzaparin , dalteparin ). if you have ever had a reaction , including a severe drop in the number of your clotting cells ( platelets ). this reaction was called he
like other similar medicines ( medicines to prevent blood clotting ), thorinane is used to prevent bleeding . tell your doctor immediately if you experience any bleeding event that does not stop or shows signs of excessive bleeding such as exceptional weakness , tiredness , paleness , dizziness , headache or unexplained swelling . immediately stop taking your medicine and contact your doctor . if you have any of the following : - a severe allergic reaction ( difficulty breathing , swelling of the lips , mouth , throat or eyes ) - blockage of a blood vessel ( a blood clot ) - cramping pain , redness , warmth or swelling in the legs (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store below 25 . after dilution the solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 8 hours at 2ºc - 8ºc . this medicine is for single use only . the thorinane pre - filled syringes should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of
what thorinane contains - the active substance is enoxaparin sodium . each pre - filled syringe contains 100 micrograms ( 0 . 2 ml ). each vial of 2 , 000 microlitres contains 2 mg / ml ( 1 . 5 ml ) of enoxparin sodium and is for single use only . - the other ingredient is water for injections . one ml of solution is a clear , colourless type i neutral glass syringe barrel with fixed needle and needle shield with chlorobutyl rubber stopper and a blue polypropylene plunger rod . each carton contains 2 or 10 pre
sensend contains the active substances lidocaine and prilocaine . both belong to a group of medicines called local anaesthetics . senstend is used to prevent lifelong premature ejaculation in adult men . it works by attaching itself to the head of the penis , helping to prevent ejaculation .
do not use senstend - if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if you have a history of allergy or sensitivity to local anaesthetics ( see section 4 ). if you know that you are being treated with amide - type local anesthetics . if you suffer from a genetic disease or other condition that affects your red blood cells ( glucose and phosphate deficiency ) or anaemia ( methaemoglobinaemia ). medicine sensitivities
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose of senstend is 3 sprays ( 1 spray ) in the head of your penis every 3 hours for 24 hours . use in children and adolescents the recommended starting dose is 4 sprays per day . use the spray container at the same time each day . the pump technique is the same as the valve used for contact with eyes , nose , mouth and ears . after using the pump , apply 1 spray to the foreskin of your head of
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with this medicine : very common ( may affect more than 1 in 10 people ) inability to develop or maintain an erection in the penis feeling of burning in the area of the penis uncommon ( might affect up to 1 in 100 people ) headache local irritation of the throat ( irritation of any part of the skin redness ) failure to ejaculate during sexual intercourse abnormal orgasm tingling in or around the penis pain or discomfort in or near the penis itching in or close to the penis a high temperature other side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store below 25 for a maximum period of 12 months . keep the metal container in the outer carton in order to protect from light . after first opening , puncture and burn the container immediately after use , as instructed by your pharmacist . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 micrograms ( 0 . 5 milligrams ) lidocaine 50 microgram ( 1 . 0 milligram ) prilucaine 50 iu / ml solution for injection : each spray container contains 7 . 5 microlitres ( 2 . 5 million iu ) lidsocaine 25 microgram / ml ( 1 , 0 . 25 million iiu ) prlocaine 20 microlitre ( 1 ml ) each spraycontainer contains 5 or 12 sprays . - the
opdivo is a medicine used for the treatment of advanced melanoma ( a type of skin cancer ) in adults melanoma can be treated with complete resesection in adults ( treatment without surgery or adjuvant therapy ). advanced non - small cell lung cancer ( advanced renal cell carcinoma ) advanced kidney cancer in adults classical hodgkin lymphoma has been previously treated with an autologous stem - cell transplant or a transplant . advanced cancer of the head and neck in adults advanced urothelial carcinoma ( bladder and urinary tract cancer ) the active substance in opdivo , nivolumab , is
do not take opdivo - if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given opsdivo if : - you notice a change in the rhythm of the heartbeat or an abnormal heart rhythm . - you have problems with your lungs such as breathing difficulties , cough or inflammation of the lungs ( pneumonitis or interstitial lung disease ). - you get diarrhoea , watery , loose or soft stools , or any symptoms that could be a sign of inflammation of
always take opdivo exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to take the recommended dose for adults is one tablet ( 240 mg ) twice a day ( 2 tablets of 480 mg ) for 4 weeks . your doctor will prescribe the dose that is right for you . if you cannot take ipilimumab for the treatment of skin cancer , your doctor may prescribe a lower dose ( 1 tablet of nivolumab per kilogram of your body weight ), which will be given every 4 weeks , while you are being treated with opdiv
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . opdivo may be stored at room temperature ( up to 25 ) for up to 48 hours . the infusion solution should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains - the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nivlumab ( as 40 mg / ml ). each 4 ml vial contains 100 mg of 10 mg ( as 240 mg per ml ) solution for injection for 24 hours . - the other ingredients are : sodium citrate dihydrate , sodium chloride ( see section 2 for further information on sodium ). - the solvent is mannitol ( e421 ), pentetic acid , polysorbate 80 , sodium hydroxide , hydrochloric acid and water for injections .
clopidogrel tad contains the active substance dicagrel , which belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , anti platelet medicinalproducts reduce the chances of blood clots forming ( a process called thrombosis ). clopidigrel tetad is taken by adults to reduce the number of bloodclots ( thrombi ) that can form in hardened blood vessels ( arteries ), a process known as atherothrombinosis , which can lead
do not take clopidogrel tad : if you are more than 30 years of age . if you think you may be allergic , or if you have been told by your doctor that you have a medical condition that is currently causing bleeding ( e . g . a stomach ulcer or bleeding within the brain ). if you suffer from severe liver disease . if any of these apply to you ( or you are not sure ), talk to your doctor or pharmacist . warnings and precautions it is important that you take all of the following precautions : before you start taking the tablet , tell your doctor if you : - have a
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel tad per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may prescribe a lower or higher dose ( 300 mg of the tablet once a day ), or a lower dose , such as one 300 mg tablet
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
what clopidogrel tad contains - the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). - the other ingredients are : tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone , macrogol 6000 and hydrogenated castor oil ( see section 6 ). tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide [ e172 ] and talc . printing ink : talc and macrog
tacforius contains the active substance tacrolimus , which is an immunosuppressant . after your organ transplant ( liver and kidney ) your body ' s immune system will try to reject the new organ . tacforius is used to prevent rejection of the transplanted organ by your liver , kidney and heart after any previous treatment after your transplantation .
do not take tacforius if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to sirolimus , any macrolide , antibiotic ( e . g . erythromycin , clarithromycin or josamycin ), or any other medicine used to delay or increase the time between doses . warnings and precautions talk to your doctor , pharmacist or nurse before and during treatment with tacofius prolonged - release capsules ( see section " other medicines and tacfolimus "). tacf prolonged -
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed by a doctor who is experienced in the treatment of transplant patients . always take the same tacrolimus medicine as recommended by your doctor . if you have had a transplant , your doctor will prescribe you a different tacrolamus medicine . do not change the dose of this medicine without talking to your doctor first . you should continue taking this medicine until your doctor tells you the right medicine to treat the rejection of your transplanted organ . the recommended dose is based on your
like all medicines , this medicine can cause side effects , although not everybody gets them . infections stop taking tacforius and tell your doctor straight away if you notice any of the following serious or severe effects : allergic and anaphylactic reactions ( benign or malignant tumours ) have been reported in patients receiving ticforius treatment : pure red cell aplasia ( a very severe reduction in red blood cell counts ) agranulocytosis ( a severely lowered number of white blood cells ) haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ) febrile neutrop
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep all the prolonged - release hard capsules in the outer carton in order to protect from light . after first opening the aluminium wrapping , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment
what tacforius contains - the active substance is tacrolimus . each hard capsule contains 0 . 5 mg ( as monohydrate ). - the other ingredients are : each capsule contains 1 mg or 1 mg of tacrulimus ( asmonohydrate ). each capsule is packed in a sachet and can be divided into equal doses . - each capsule consists of 3 mg , 1 mg , and 3 mg capsules . each capsule also contains 4 mg , 5 mg , or 6 mg capsules of tacrolamus ( see section 2 ). - capsule content hypromellose 2910 , ethylcellulose , lact
the name of the medicine is clopidogrel zentiva . it is a member of a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . by reducing the amount of blood that is left in the body after a certain period of time , this clumping can stop the formation of blood clots ( thrombi ) which can form in hardened blood vessels ( arteries ), a process known as atherothrombosis , which can lead sometimes to the occurrence of athero
do not take clopidogrel zentiva - if you are allergic ( hypersensitive ) to clopilogrel or any of the other ingredients of this medicine ( listed in section 6 ). - have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - have severe liver disease . if any of these apply to you ( or you are not sure ), talk to your doctor or pharmacist . warnings and precautions you should tell your doctor straight away if you : - have had a problem with bleeding ( e . g . a history of internal bleeding ) or a stomach
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may prescribe a lower dose , such as 300 mg taken once a day . your doctor will decide how long you should continue to take cl
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special temperature storage conditions . clopidogrel zentiva is for single use only . aluminium blisters : do not store above 30 . store in the original package in order to protect from light . bottle : keep the bottle tightly closed . keep the cap on the bottle to protect the bottle from moisture . blister : after first opening of the bottle , the bottle may be kept at room temperature ( up to 30 ) for
what clopidogrel zentiva contains - the active substance is clopridogrel . each tablet contains 75 mg of clopidoogrel ( as hydrogen sulphate ). - the other ingredients ( excipients ) are ( see section 2 for important information about some of these ingredients ). - in the tablet core , the tablet contains lactose ' ( as hydroxypropylcellulose ), mannitol ( e421 ), hydrogenated castor oil , microcrystalline cellulose ( e460 ), macrogol 6000 ( e1521 ) and low - substituted hydrolysis propylcell
yttriga is a radioactive medicine that must not be used after the expiry date which is stated on the label and carton after exp . this medicine does not require any special storage conditions . it must be used immediately after dilution with another medicine . tiny radiation doses are used for the treatment of radiolabelled medicinal product . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user .
you must not be given yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : - you are pregnant , think you may be pregnant , or are planning to have a baby . - you have not been tested for the presence of radioactivity in your blood . - your doctor may decide to monitor you more closely while you are being treated . - this medicine is a radioactive medicine and is not to be used in combination with another medicinal product
your doctor will supervise the treatment . method of administration yttriga is for radiolabelling of medicinal products for specific diseases . your doctor will decide on the appropriate dose for you . the treatment will be supervised by a doctor experienced in the diagnosis and treatment of overdose . appropriate treatment is recommended .
like all medicines , yttriga can cause side effects , although not everybody gets them . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of the specialist in appropriate premises and under local regulations . storage of radioactive substances will be in accordance with national regulation on radioactive materials .
what yttriga contains - the active substance is chloride . 1 ml sterile solution contains 1 mg of hydrochloric acid ( equivalent to 3 mg / ml ). - the solvent is a clear , colourless type i glass vial with a flat bottom and a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . the active substance in ciambra , cisplatin , is another anti - cancer medicine . it is used for treatment of malignant pleural mesothelioma ( a form of cancer that affects the lining of the lung ) in adults who have not received prior chemotherapy . in this case , cimbra will be given to you by a doctor or nurse as an initial treatment . if you have lung cancer that has spread to other parts of your body , your doctor may decide to treat your disease with another type of treatment called initial chemotherapy . ciam
do not use ciambra : - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : - you are breast - feeding . your doctor will discuss this with you during treatment . - you have recently received or might receive a vaccine against yellow fever . if any of these apply to you ( or you are not sure ), tell your doctor or pharmacist before being given this type of medicine ( see section 4 ). - you don ' t have
the recommended dose of ciambra is 500 micrograms for every square metre of your body ' s surface area . this means that your height and weight are measured in square meters ( m² ) of the body . your doctor will work out the right dose for you based on this body surface area and will adjust your dose depending on your response to treatment and on your blood cell counts . the infusion will last approximately 9 minutes . sodium chloride solution will be given to you by your doctor or nurse as an injection into your veins . cisplatin is given by infusion into one of your veins approximately 30 minutes before the infusion of
like all medicines , this medicine can cause side effects , although not everybody gets them . 52 tell your doctor straight away if you experience fever or signs of infection ( with a temperature of 38ºc or greater ), sweating , or any other sign of infection . if you have less white blood cells than normal which could indicate infection ( sepsis ), which could be fatal and could be life - threatening . signs of death such as chest pain with a fast heart rate , pain , redness , swelling or sores in your mouth . allergic reaction such as skin rash , burning or prickling sensation or fever . skin reactions may be
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . this medicine does not require any special temperature storage conditions . the infusion solution of pemetrexed should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 8 and 15 to 25 . the reconstituted solution must be used within 24 hours or discarded . if you use more ciambra than
what ciambra contains - the active substance is pemetrexed . each vial contains 100 mg / ml of powder for concentrate for solution for infusion . one vial of 100 micrograms of powder contains 100 milligrams of pemrexed ( as peyrexed disodium hemipentahydrate ). one ml of solution for injection contains 500 milligram ( mpa ). - the other ingredients are mannitol ( e421 ), hydrochloric acid ( for ph adjustment ), sodium hydroxide ( e524 ) and water for injections . see section 2 for further information . what c
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ) used to treat certain infections in your blood . immunogam is used in adults to prevent increased levels of human hepatitis b immunoglubulins , and in children , adolescents and infants ( 3 years of age and older ) of immunoglobin g ( igg ) in the blood plasma ofscreened children . your doctor will test your body for these antibodies before and during the treatment . if you are not sure , talk to your doctor , pharmacist or nurse before you are given Immunogam . the use of immunog
you must not be given immunogam : - if you have had an allergic reaction to human immunoglobulins or other blood products ( iga ) or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if you : - have an iga deficiency . - have ever had an allergy reaction to iga containing products . - are under 18 years of age or older . your doctor may want to monitor you more closely while you are being treated . - experience allergic reactions such as chills , headache , fever
immunogam is intended for vaccination of hepatitis b virus . the first vaccine dose will be given in combination with human hepatitis b immunoglobulin ( hbv ). administration prevention the recommended dose for hepatitis b is 500 micrograms per kilogram of body weight every 24 hours for up to 72 hours . the recommended recommended dose is : hepatitis b in haemodialysed patients of 500 mbq per kg body weight each 2 weeks . seroconversion following vaccination is recommended . immunogam must be administered at a temperature of 20 to 25 . the solution should be clear to slightly opalescent and
like all medicines , immunogam can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) not known ( frequency cannot be estimated from the available data ) 1 , 000 micrograms / ml ( 0 . 5 %) very rare ( affects less than 1 users in 10 , 000 ) very small number of cases have been reported . if any of the undesirable effects gets serious , or if clinical trials are inconclusive , please tell your doctor . immun
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the outer carton and on the label of the vial after exp . store in a refrigerator ( 2 - 8 ). do not freeze . the product should not be used if the solution is cloudy or contains deposits . medicines should not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin ( hbib ). - one vial contains 1 mg or 5 mg of human plasma protein , corresponding to a concentration of 96 micrograms / ml . - the other ingredients ( excipients ) are polysorbate 80 and water for injections in a glass vial , which is a clear to slightly opalescent , colourless to pale yellow liquid . each pack contains 1 vial .
remicade contains the active substance infliximab . infliximab is a monoclonal antibody a type of protein that recognises and attaches to a specific target in the body called ' tumour necrosis factor '. remicade belongs to a group of medicines called ' tnf blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis , psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ) and psoriasis in adults and children aged 6 years and older . these diseases are also known as crohn ' s
do not take remicade : - if you are allergic to infliximab or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic ( hypersensitive ) to tb if you have or have had another serious infection , such as pneumonia , sepsis or heart failure if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor , pharmacist or nurse before you are given remicades . it is important that you follow all the instructions given to you by your doctor or nurse so that you are fully protected from the effects of
what remicade is used for the treatment of rheumatoid arthritis the usual dose is 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), psoriasis , ulcerative colitis and crohn ' s diseases the usual starting dose is 5 mg for each kg of weight . your doctor will decide how many treatments you need and how often you need to receive them . if you have the impression that the effect is too strong or too weak , talk to your doctor or pharmacist . the recommended dose of remic
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . tell your doctor straight away if you notice any of the following side effects during your treatment with remicade : - signs of an allergic reaction such as swelling of your face , lips , mouth or throat , which may cause difficulty in swallowing or breathing , skin rash , hives and swelling of the hands , feet or ankles . these reactions are usually mild and disappear within a few days . if you get any of these reactions , contact your doctor immediately .
remicade will be stored by the health professionals at the hospital or clinic . keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . store in a refrigerator ( 2 8 ). store in the original package in order to protect from light . if remicade is not used immediately , in - use storage times and conditions prior to infusion are the responsibility of the user and would normally not be longer than 3 hours at 2 to 8 , unless dilution has taken place in controlled and validated a
what remicade contains - the active substance is infliximab . each vial contains 100 mg of inflixamab . after reconstitution , each ml of solution contains 10 mg ( 1 . 5 milligrams ) of influximab ( as mesilate ). - the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate , dibasicodium phosphate and water for injections ( see end of section 2 for further information about some of the ingredients ). what remiganade looks like and contents of the pack remicades is supplied as a glass vial
rasagiline mylan is used to treat parkinson ' s disease in adults . it is used in combination with levodopa ( another medicine used in the treatment of parkinson's disease ). in parkinson ', s disease , there is a loss of cells that produce dopamine in the brain . dopamine is an important part of the brain ' s natural response to stimuli , such as movement control . by increasing the amount of dopamine that reaches the brain , it helps to maintain a balance between actions and emotions .
do not take rasagiline mylan - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). if you have severe liver problems . warnings and precautions talk to your doctor , pharmacist or nurse before taking the following medicines : - rasaline mylan ( monoamine oxidase ( mao ) inhibitors , used in the treatment of depression and parkinson ' s disease ) - medicinal or natural products containing st . john ' s wort ( pethidine ) - a strong pain killer ( see section 14 ' taking other medicines '). during ras
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet ( 1 mg ) taken by mouth once a day . take rasagiline mylan at the same time each day . swallow the tablet whole with a glass of water . do not chew , crush or split the tablet . you can take the tablet with or without food . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with rasagiline mylan and placebo ( frequency not known ): very common abnormal movements ( dyskinesia ) headache common abdominal pain uncommon rare ( may affect up to 1 in 1 , 000 people ) fall allergy fever flu ( influenza ) feeling of being unwell neck pain chest pain ( angina pectoris ) low blood pressure with symptoms such as light headedness ( orthostatic hypotension ) decreased appetite constipation dry mouth nausea vomiting flatulence abnormal results of blood ( leucopen
what rasagiline mylan contains - the active substance is rasagailine . each tablet contains a single dose ( 1 mg / ml ). - the other ingredients are : tablet core : microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize starch ( maize starch ), talc , stearic acid ( see section 2 " important information about some of the ingredients of this medicine "), and tablet coating : shellac ( e1203 ), red , white , and off - white ( approximately 11 . 5 mm x 6 mm ), biconvex tablets ( approximately
do not use hulio if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe infection such as tuberculosis . symptoms of infections may include fever , wounds , feeling tired , dental problems . if you suffer from moderate or severe heart failure or have a serious heart condition . allergic reaction . allergic reactions may include symptoms such as chest tightness , wheezing , dizziness , swelling and a rash . if any of these reactions occur , tell your doctor immediately . infections if your child has an infection , such as localised infection or leg ul
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . polyarticular juvenile idiopathic arthritis in children and adolescents from 2 to 17 years of age weighing 10 kg or more the usual dose is 30 mg once a day . hulio may be given as 20 mg twice a day ( see section 2 ) for children and teenagers from 2 - 17 years old weighing 30 kg or less . your doctor may decide to increase your dose to a maximum of 40 mg once daily . enthesitis in adults with arthritis in adults from 6 to 17 months of
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may require urgent medical treatment . tell your doctor straight away if you notice any of the following serious side effects ( seen in section 4 of this leaflet ) after the last hulio injection : allergic reaction , including heart failure , severe rash , hives swollen face , hands or feet , trouble breathing or swallowing , pale complexion , dizziness , persistent fever , bruising or bleeding . signs and symptoms of infection include fever , feeling sick , wounds , dental problems , burning on urination
what hulio contains - the active substance is adalimumab . - the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections ( see end of section 2 under ' important information about some of the ingredients '). what hulaio looks like and contents of the pack haulio 40 mg is a sterile solution for injection in a vial containing a single dose of 40 mg ( 1 ml ) in the morning . the solution is clear to slightly opalescent and has a rubber stopper . hul
the active substance of yellox is bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammatory drugs ( nsaids ), which reduce inflammation . yellox has been prescribed for the treatment of eye inflammation following cataract surgery in adults .
do not use yellox if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). if you have asthma , skin allergy or intense inflammation in your nose . warnings and precautions talk to your doctor , pharmacist or nurse before using yellox . you may need other nsaids such as acetylsalicylic acid , ibuprofen , ketoprofen and diclofenac . this medicine should not be used in combination with topical steroids such as cortisone , as it may increase the risk of unwanted side effects . bleeding problems if you
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of yellox is one drop in each eye ( s ) twice a day . use in children and adolescents your doctor will tell you how many drops you need to use in the first 2 weeks after your cataract surgery . method of administration yellox is for oral use . wash your hands after using the eye drops . remove the bottle cap from the bottle . hold the bottle , pointing down , between your thumb and fingers . tilt your head back . pull down
what yellox contains - the active substance is bromfenac . each ml of solution contains a single - use product called sodium sesquihydrate ( equivalent to 33 mg / ml ). - the other ingredients of the solution are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , tyloxapol , povidone ( k30 ), disodium edetate and sodium hydroxide to maintain acidity levels . what yellox looks like and contents of the pack yellox is a clear yellow liquid ( solution ) supplied in a glass vial
dzuveo contains the active substance sufentanil . it belongs to a group of strong painkillers called opioids . it is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo : if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious lung or breathing problem . warnings and precautions talk to your doctor , pharmacist or nurse before taking dzuvoo if : you have any condition that affects your breathing ( e . g . asthma , wheezing or shortness of breath ). your doctor may want to monitor you more closely , or adjust your dose , if necessary , if you think any of these apply to you . you have had a head injury or brain tumour
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the single - dose administration device should be used in combination with this medicine . dzuveo can be taken with or without strong painkillers such as sufentanil 30 mg twice a day . the sublingual tablet must be swallowed whole with a glass of water . do not crush or chew the tablet . the tablet must not be swallowed with the disposable single -dose applicator . the applicator should be inserted into the tongue . if the tablets dissolve in the tongue , pain relief should
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects : - severe breathing problems - slow and shallow breathing . stop taking dzuveo and see a doctor immediately . very common side effects ( may affect more than 1 in 10 people ): - nausea , feeling sick , vomiting , being sick and feeling hot . common side side effects that may affect up to 1 in every 10 people : - inability or difficulty sleeping , feeling anxious or confused , dizziness , headache , drowsiness , feeling sleepy , increased heart
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light and oxygen . this medicine does not require any special temperature storage conditions . dzuveo must not be used if you notice any visible sign of deterioration . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg of this medicine ( as citrate ). - the other ingredients are mannitol ( e421 ), dicalcium phosphate , hypromellose ( e464 ), croscarmellose sodium , indigo carmine ( e132 ), stearic acid and magnesium stearate . - the tablet is white to off - white with round edges . - each tablet is approximately 3 mm long and has a single - dose applicator ( labelled [ sublingual tablet ]). the applicator contains one suf
elleada is a cancer medicine that contains the active substance apalutamide . it is used to treat adult men with prostate cancer that has spread to other parts of the body and has not responded to surgical treatments . it also helps to control the level of testosterone in the blood when it is involved in the growth and spread of prostate cancer . erleada can be used alone or in combination with androgens to treat the cancer . if androgens are not removed from prostate cancer cells , the medicine may not work as well as it should .
do not take erleada if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant or are planning to become pregnant ( see section " pregnancy , breast - feeding and contraception section "). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . this medicine is not recommended for use in children and adolescents under the age of 18 years . take special care with this medicine if : you have ever had seizures . you are taking any medicines used to prevent blood clots ( e . g . warfarin
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg twice a day . your doctor may increase your dose to 60 mg once a day depending on how you respond to erleada . this medicine should be taken by mouth at the same time each day . you should swallow the tablets whole with a glass of water . do not chew or crush the tablets . you can take erleade with or without food . taking other medicines please tell your doctor , pharmacist or nurse if you take , have recently taken or might take any
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and see a doctor straight away if you notice any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling and ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may be accompanied by fever and flu - like symptoms . toxic epidermal necrolysis is a group of serious side effects . the most common side effects are fits ( seizure ). uncommon ( may affect up to 1 in
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of appalutamide ( as mesilate ). - the other ingredients are : tablet core : colloidal anhydrous silica , croscarmellose sodium , hypromellose acetate succinate , magnesium stearate . tablet coating : microcrystalline cellulose ( e460 ) and silica ( e470b ). film - coating : iron oxide black , iron oxide yellow , macrogol , polyvinyl alcohol , talc , and titanium dioxide ( e171 ). what
this medicine is a radiopharmaceutical product . axumin contains the active ingredient fluciclovine . it is used to perform a scan ( a pet scan ) in adult men who have previously had treatment for prostate cancer . other tests may be performed to check prostate specific antigen ( psa ), the type of protein that is present at the site of the cancer . an axumin pet scan may also be performed if the cancer has spread to other parts of the body . the scan will be recorded on the patient ' s patient alert card . your doctor or nurse will record the name of the patient who requested the scan .
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using axumin if you have kidney problems . you should follow a low sodium diet . axumin is given once a day for the duration of the axumin scan ( see section 4 " axumin contains sodium "). during the scan , you will be given your usual medicines for the latest 60 minutes . if you miss a dose of axumin , make another one as soon as possible and then go back to
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be handled and given to you by people who are trained and qualified to use it safely . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the nuclear medicine doctor supervising the procedure will decide on the quantity of axumin to be used . the usual dose is 370 megabecquerel per kilogram of body weight . do not shake axumin vigorously during the procedure axumin is injected into a vein by a flush of sodium chloride
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , the following side effects were reported : very common ( may affect more than 1 in 100 people ): when using the medicine , side effects associated with axumin may be uncommon ( frequency not known ( cannot be estimated from the available data ) in patients treated with at least 1 dose of 100 mg : pain , rash , altered taste in the mouth , altered sense of smell . when using this radiopharmaceutical , ionising radiation may increase the risk of cancer and hereditary abnormalities . reporting of side effects if you get any side effects
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials .
what axumin contains - the active substance is fluciclovine . axumin 1600 mg : each vial contains 1600 mg ( 3200 mg ). - the other ingredients ( excipients ) are : powder for concentrate for solution for injection ( see section 2 " axumin with sodium citrate and concentrated hydrochloric acid and sodium hydroxide "). solvent for solvent for inhalation ( e . g ., water for injections ). see also section 2 for further information . what axumin looks like and contents of the pack - the 1600 mg powder is a white to off - white powder in a glass vial
azopt contains brinzolamide which belongs to a group of medicines called carbonic anhydrase inhibitors . it works by reducing pressure within the eye . azopt eye drops help to reduce high pressure in the eye , which can lead to an illness called glaucoma . if the pressure in your eye is too high , it can damage your sight .
do not take azopt if you have severe kidney problems if you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to medicines containing sulphonamides ( medicines used to treat diabetes or infections ) or to diuretics ( water tablets ). warnings and precautions talk to your doctor , pharmacist or nurse before taking azopt . the same allergy may be associated with too much acidity in your blood ( hyperchloraemic acidosis ). if any of these apply to you , tell your doctor or pharmacist before you take az
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . azopt should only be used in the eyes . the recommended dose is 1 drop in the affected eye each day . do not use azopt in both eyes at the same time each day ( see section 1 , 2 , 3 ). keep the azopt bottle tightly closed in order to protect from moisture . wash your hands before using the cap . remove the cap and snap collar from the bottle . hold the bottle tightly with both hands . tilt your head back . pull down your eyelid with a clean finger
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects on the eye : blurred vision , eye irritation , eye pain , eye discharge , itchy eye , dry eye , abnormal eye sensation , redness of the eye . other side effects include : bad taste . uncommon side effects - effects affecting the entire eye : sensitivity to light , inflammation , infection of the conjunctiva , eye swelling , eyelid itching , swelling , deposits in eye , glare , burning sensation ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions to protect from infections . a pack containing a single bottle should not be used .
what azopt contains - the active substance is brinzolamide . each vial contains 10 mg of brinzi . - the other ingredients are benzalkonium chloride , carbomer 974p , edetate disodium , mannitol , purified water , sodium chloride , tyloxapol , hydrochloric acid and sodium hydroxide ( for acidity levels and ph levels ). what azopt looks like and contents of the pack azopt is a milky liquid ( a suspension ) supplied in a 5 ml plastic ( droptainer ) bottle with a screw cap . a pack containing three
the active substance of forxiga is dapagliflozin . it belongs to a group of medicines called medicines that are taken by mouth to treat diabetes . it helps control the level of sugar in your blood . it is used in adults and adolescents ( aged 18 years and older ) to help control diabetes . type 1 diabetes is a type of diabetes that develops when your body does not produce enough insulin or the insulin that your body makes does not work as well as it should . in some people , this can lead to diabetes . if you are overweight or obese , you may be more likely to have type 2 diabetes .
do not take forxiga if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). if you experience feeling sick or being sick ( stomach pain ), excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath or a sweet or metallic taste in your mouth , a different odour to your urine or sweat , rapid weight loss . tell your doctor straight away if you have one of the above symptoms . " diabetic ketoacidosis " is a complication of diabetes caused by increased levels of " ketone
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of forxiga for type 2 diabetes is between 10 mg and 5 mg once a day . if you have a liver problem , your doctor may prescribe a lower dose . your doctor will tell you how many tablets to take . how much to take your doctor can tell you if you need to take a different type of medicine . for example , for your type 1 diabetes can be taken with or without food . it may take up to 5 weeks before you start taking this medicine swallow the tablets
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : angioedema ( very rare : may affect up to 1 in 10 , 000 people ): signs may include swelling of the face , tongue or throat which may cause difficulties swallowing , hives and breathing problems . diabetic ketoacidosis ( rare ): if you have type 1 diabetes , your doctor may increase the amount of ketone bodies in your urine or blood . if you feel sick or are sick with stomach pain , excessive thirst , fast and deep breathing ,
what forxiga contains - the active substance is dapagliflozin . eachforxiga 5 mg film - coated tablet ( tablet ) contains a single tablet called ' pldf '. - the other ingredients ( excipients ) are : tablet core : microcrystalline cellulose , lactose ( see section 2 ' for important information about lactose '), crospovidone , silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol ( e1203 ), titanium dioxide ( e171 ), macrogol 3350 , yellow iron oxide ( e172 ). what forx
mifamurtide is a medicine that blocks the activity of certain bacteria in the immune system . mepact is used to treat adult patients with osteosarcoma ( bone cancer that has spread between 2 and 30 years ) after surgery to remove the tumour . it is used when chemotherapy has stopped the growth of cancer cells and cancer has come back .
do not take mepact if : you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). you are taking medicines containing ciclosporin and other calcineurin inhibitors ( non - steroidal - anti - inflammatory drugs ) ( nsaids ). you have problems with your heart or blood vessels such as blood clots ( thrombosis ), bleeding ( haemorrhage ) or inflammation of the veins ( vasculitis ). warnings and precautions talk to your doctor , pharmacist or nurse before starting treatment . some of these effects may be
treatment mepact will be given to you by a doctor or nurse . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will tell you how many tablets to take and how often you should take them . the usual starting dose of a medicine for adults is 2 mg of mifamurtide every 12 hours . your doctor may increase your dose to 24 mg every 24 hours depending on your mepact treatments and on your chemotherapy schedule . if you have any further questions on the use of this medicine , ask your doctor
like all medicines , mepact can cause side effects , although not everybody gets them . tell your doctor immediately if you experience chills , fever or fatigue after you have been given mypact . these may be transient . if you are given paracetamol to reduce the risk of fever , your doctor may reduce the dose or stop treatment . during treatment you may experience stomach problems ( such as nausea , vomiting and loss of appetite ). if this happens , you should stop chemotherapy and contact a doctor immediately . continuing fever and chills may occur up to 8 weeks after your last dose of the medicine . talk to your doctor
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial in outer carton after exp . store in a refrigerator ( 2 8 ). store in the original package in order to protect from light . reconstituted suspension : sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection may be stored at room temperature ( up to 30 ) for up to 6 months . this medicine must not be used if you notice any visible sign of deterioration .
what mepact contains - the active substance is mifamurtide . each ml of concentrate contains 4 mg ( 0 . 08 mg ) of mifamanurtide ( as monosodium salt ). - the other ingredients are : 1 - palmitoyl - 2 - ol - sn - glycero - 3 - phosphocholine ( see section 2 under ' important information about some of the ingredients ') 2 - dileoyl , 2 - nicolyl , 3 -ospho - l - sorbito - esters ( eosinophils ) 3 - sodium salt ( see
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . mirvaso is used on the skin ( face ) to reduce redness associated with rosacea ( redness of the face ) in adults , adolescents and children aged 6 years and older . the most commonly reported forms of rosinacea are redness on the face and on the other side of the body . if you are a woman of childbearing potential , your doctor may decide to reduce your dose , temporarily or permanently , or permanently remove your child ' s child - bearing potential ( see section 2 ). ro
do not take mirvaso - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 and section 2 " possible side effects "). warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine . the medicine should not be injected under the skin . certain medicines used to treat depression and parkinson ' s disease ( monoamine oxidase ( mao ) inhibitors such as selegiline , moclobemide , tricyclic antidepressants ( such as imipramine ), tetracyclic antidepressant such as maprotiline
always use this medicine exactly as described in this leaflet or as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso should be injected under the skin ( usually on the face ). this medicine should not be injected into any part of your body . if your body surfaces , such as your eyes , mouth , nose or vagina , your doctor may decide to change the dose or discontinue the treatment . use a small amount of gel ( a pea - sized amount ) to control your symptoms . the maximum daily dose of 1gram ( 5 pea sized amounts ) should be
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects ( may affect up to 1 in 10 people ): severe skin irritation , inflammation , skin rash , skin pain , discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . not known ( frequency cannot be estimated from the available data ): common side effects : worsening of rosacea . the treatment should be stopped immediately and symptoms ( see section 2 " warnings and precautions "). contact allergy allergic reaction ( rash ) rare angioedema ( a serious allergic reaction with swelling mainly of the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and tube and pump after exp . store in the original package in order to protect from moisture .
what mirvaso contains - the active substance is brimonidine . each millilitre of gel contains 3 . 3 mg ( 5 mg ) of bimonidine titrate . - the other ingredients are : carbomer , methylparahydroxybenzoate , phenoxyethanol , glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see section 2 under " important information " for further information ). - the excipients of the gel are : ethyl ( e321 ) and methyl ( e322 ) aspartate ( e507 ) and prop
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the immune system , the body ' s natural defences ). it is used to help defend the body from infection and cancer by preventing it from multiplying and multiplying . in mvasi , the target protein is called human vascular endothelial growth factor ( vegf ), which is found in lymph vessels all over the body . it is made specifically for use in patients whose vesicles have been damaged by the vesicle . the ve
do not use this medicine if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , hypersensitive , to chinese hamster ovary ( cho ) cell products . if you or your child are pregnant . warnings and precautions talk to your doctor , pharmacist or nurse before using mvasi . if any of these apply to you ( or you are not sure ), tell your doctor or pharmacist as soon as possible . children and adolescents do not give this medicine to children under 6 years of age
dose and frequency of administration your doctor will work out the dose of mvasi you will receive based on your body weight and the type of cancer you have . the recommended dose is 5 mg , 7 . 5 mg or 10 mg per kg of body weight . the dose may be increased or decreased depending on your general condition and on the size of your tumour growing . duration of treatment your doctor may decide to increase or decrease your dose of this medicine depending on how well you tolerate it . if you have not been treated before , your doctor might decide to reduce the dose you receive , or temporarily stop your treatment with mvas
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in theouter carton in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8 unless dilution has taken place in a sterile environment . chemical and physical in -
what mvasi contains - the active substance is bevacizumab . each ml of concentrate contains 25 mg of bevocizumumab in 1 . 4 ml or 16 . 5 ml of solution . each 4 ml vial contains 100 mg ( 2 . 4 mg ) / ml of the solution . - the other ingredients are aspartame , sodium phosphate , polysorbate 20 and water for injections ( see section 2 under " important information about some of the ingredients "). see section 4 under " other ingredients " for further information on some of these ingredients . see section 3 under " mvas
tecartus is a gene therapy medicine that is used to treat mantle cell lymphoma in adults . it is used in combination with other medicines to treat refractory mantle cell lipoma ( mcl ). tecartus consists of your own white blood cells called autologous anti - cd19 - transfduced cd3 + cells . mantlecell lymphoma is a cancer that affects the immune system ( the body ' s natural defences ) that affects b - lymphocytes ( a type of white blood cell ). mcl is thought to be caused by the lack of a sufficient number of these b cells in your blood . the
do not use tecartus if you are allergic to peanut or soya or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if you : - have had tests to check the number of white blood cells in your blood ( lymphodepleting chemotherapy ) ( see section 3 ) - have a problem with the number or number of red and yellow blood cells ( autologous use ) tests and checks of your lungs , heart , kidney , blood pressure
tecartus is made from your own white blood cells . your cells will be given to you by a doctor or nurse through a catheter placed in your vein ( a procedure call leukapheresis ). your doctor will decide how much tecartus you need and how often you need to receive it . the doctor will work out the right dose based on your condition and the type of medicine you are taking . the dose will be calculated by your doctor using your blood and will be injected into your vein over a period of 3 to 6 hours . the number of days you will be treated will depend on how well your white
like all medicines , this medicine can cause side effects , although not everybody gets them . if any of your side effects gets serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or pharmacist . you may need urgent medical attention . the following side effects have been reported during the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure with symptoms such as dizziness , lightheadedness , fluid in the lungs . all symptoms could be signs of a condition called cytokine release syndrome ( loss of consciousness , decreased level
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . infusion bag contains liquid nitrogen ( equivalent to 150 mg ). this medicine contains genetically modified human blood cells and human - derived material . the product is stable for 36 hours .
what tecartus contains - the active substance is autologous anti - cd19 - transduced cd3+ cells in a specific single infusion bag . each vial contains a dispersion of anti -cd19 car t cells equivalent to 68 x 2 cd3 + cells per ml . - the other ingredients are : 106 anti , sodium chloride and human albumin ( see section 2 " important information about some of the ingredients ") for solution for infusion in an infusion bag contained in a metal cassette . a single infusion bag contains 68 vials of cell dispersion . not all pack sizes may be marketed .
januvia contains the active substance sitagliptin and belongs to a group of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) which are used to control blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high for your condition . januvia can be used alone or in combination with certain other medicines ( insulin , metformin , sulphonylure
do not take januvia : if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). if you have inflammation of the pancreas ( pancreatitis ). warnings and precautions talk to your doctor , pharmacist or nurse before taking januuvia ( see section 4 ). blistering of the skin may be a sign of bullous pemphigoid ( a type of diabetes characterised by high blood sugar , rapid weight loss , nausea and vomiting ). your doctor may want to monitor you more closely for signs of present kidney problems . an allergic reaction to j
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 100 mg film - coated tablet 63 mg taken by mouth once daily . if you have kidney problems , your doctor may increase your dose to 25 mg or 50 mg once daily depending on how you respond to this medicine . your doctor will tell you how many tablets of this medicine to take . this medicine may be taken with certain other medicines that lower blood sugar . diet and exercise januvia is for oral use . swallow the tablet whole with a glass of water . you can take
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects : severe and persistent pain in the abdomen ( stomach area ), which may reach through to your back , nausea and vomiting . these may be signs of an inflamed pancreas ( pancreatitis ). if you have a serious allergic reaction ( frequency not known ): rash , hives , blisters on the skin , peeling skin , swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or swallowing stop taking this
what januvia contains - the active substance is sitagliptin . one tablet of each film - coated tablet ( tablet ) contains the following excipients : tablet core : sitaglptin phosphate monohydrate , equivalent to 25 mg sitaglioptin . tablet coating : microcrystalline cellulose , calcium hydrogen phosphate , croscarmellose sodium , magnesium stearate , sodium stearyl fumarate . the tablet film - coating : poly ( vinyl alcohol ), macrogol 3350 , talc , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide . what
xultophy is used to lower blood glucose in adults with type 2 diabetes mellitus . diabetes is a condition in which your body does not produce enough insulin to control the level of sugar in your blood . the insulin that helps control blood sugar is called insulin degludec . it is a long - acting basal insulin . it helps control your blood sugar levels when you are taking liraglutide ( a type of glp - 1 ) or insulin during meals . xultophy can be used alone or in combination with oral medicines . if you are already taking any of the following oral medicines for diabetes xult
do not take xultophy - if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). - if 39 you are taking a sulfonylurea such as glimepiride or glibenclamide . if you have any further questions on the use of this product , ask your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist , or diabetes nurse before taking this medicine if : you have type 1 diabetes mellitus ( also known as ' ketoacidosis '). your doctor may
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet once a day . you may need to take xultophy for as long as you are blind or have poor eyesight . your doctor will work out your blood sugar level and will tell you how many tablets to take each day . the usual starting dose is two tablets ( 1 tablet of insulin degludec 0 . 088 mg ) and one tablet of liraglutide ( 0 . 988 mg ). the maximum daily dose
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : low blood sugar ( very common : may affect more than 1 in 10 people ) if your blood sugar level gets low you may pass out or become unconscious . this could be a sign of serious hypoglycaemia ( which may lead to brain damage ). if you have low blood sugars , tell your sugar level straight away . if you are not sure what to do , talk to your doctor , pharmacist or nurse before taking xultophy . signs of low blood
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . after first opening : store in a refrigerator ( 2 8 ). do not freeze . store in the original package in order to protect from light . after opening : chemical and physical in - use stability has been demonstrated for 8 hours at room temperature ( up to 8 ). from a microbiological point of view , xultophy should be used immediately . however , if not used immediately , the product should be
what xultophy contains - the active substances are insulin degludec and liraglutide . each ml of solution contains 100 units ( 0 . 5 ml ). - the other ingredients ( excipients ) are glycerol , phenol , zinc acetate , hydrochloric acid , sodium hydroxide ( for ph adjustment ) and water for injections . see section 2 for further information about some of the ingredients . - the solvent ( s ) is sodium . pack sizes of 1 , 3 and 5 vials . a multipack containing 10 vials with 2 ml solution for injection and 5 ml solution
giotrif is a medicine that contains the active substance afatinib . it blocks the activity of two proteins called egfr [ epidermal growth factor receptor - 1 ] ( egfr1 ] and her2 [ erbb2 ] ( erbb3 ]). these proteins are involved in the growth of cancer cells . this medicine stops these proteins from working properly and stops them from multiplying and growing . this helps to stop cancer cells from growing and dividing . your doctor has prescribed this medicine for the treatment of cancer of the lung ( non - small cell lung cancer ). your doctor will decide on the best treatment for you
do not take giotrif if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ). if you have low body weight ( less than 50 kg ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you : have kidney problems . this medicine can cause side effects such as lung inflammation ( interstitial lung disease ). have liver problems . your doctor may need to change the results of some liver tests while you are being treated with this medicine . have a severe liver disease . have eye problems . have severe dry eyes . have inflammation of the
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . your doctor will tell you how many tablets of this medicine to take . giotrif can be taken with or without food . swallow the tablet whole with a glass of water . do not chew or crush the tablet . this medicine is for oral use . if you take more this medicine than you should if you accidentally take too many tablets , talk to a doctor or go to a hospital straight away . if possible , take the tablet with food
like all medicines , giotrif can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects during treatment : diarrhoea common ( may affect up to 1 in 10 people ) diarrhoeas ( see section 2 under ' warnings and precautions '): severe diarrhoehoea with or without fluid loss very common ( might affect more than 1 in10 people ) low blood potassium if you have worsening kidney function if you experience any of these , talk to your doctor or pharmacist immediately . your doctor may decide to discontinue appropriate antidiarrhoeal treatment
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of afinib . - the other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate . tablet coating : hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 , and water for injections ( see end of section 2 for further information on the use of this product ). what giotrarif looks like and contents of the pack
orkambi contains the active substance lumacaftor . it is a medicine used for long - term treatment of cystic fibrosis ( cf ) in adults , adolescents and children aged 6 years and older with a mutation called f508del mutation . this mutation affects the function of a protein called cyst fibrosis transmembrane conductance regulator ( cftr ), which is involved in the normal functioning of the lungs . the mutation causes the body to produce more of an abnormal cfr protein than it does when it is stored in the cells of the body . this is thought to be caused by the lack of
do not take orkambi : - if you are allergic to lumacaftor or ivaceaftor , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given or kambi . if you think any of these apply to you , tell your doctor or pharmacist . if the f508del mutation is found in your blood , your doctor may need to lower or stop your dose , or stop you from being given orkyambi if you have liver or kidney disease , or if the dose of ork
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended starting dose is one 6 mg tablet once a day for up to 12 weeks . your doctor will tell you how many tablets to take . the recommended orkambi tablet should be taken 6 to 11 hours before a meal . the usual dose for adults , adolescents and children weighing at least 25 kg or more is one or two tablets twice a day ( one tablet in the morning and two tablets in the evening ). if you have moderate or severe problems with liver function , your
like all medicines , this medicine can cause side effects , although not everybody gets them . some of the side effects may be serious and need immediate medical attention . stop taking orkambi and ivacaftor and see a doctor straight away if you notice any of the following serious side effects while you are being treated with this medicine : - raised levels of liver enzymes in the blood - liver injury - pre - existing severe liver disease - the worsening of liver function other side effects include : uncommon ( may affect up to 1 in 100 people ): - pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your
what orkambi contains - the active substance is lumacaftor . - each tablet contains either : - one or two tablets of ivocaftor ( 100 mg / 125 mg ) or - one tablet of lumacftor ( 125 mg / 150 mg ) ivacafto ( 125mg / 200 mg ). - one , two or three tablets of orkyambi ( 200 mg / 100 mg ) and one , four or five tablets of either ( 250 mg / 200mg ) or ( 300 mg / 1000 mg ) lumiacaftor and / or one , three or five tablet of ivac
the active substance of lynparza is olaparib , a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ). it works by preventing mutations ( changes ) in a gene called brca ( breast cancer gene ). in some types of cancer , parp inhibitors cause death of cancer cells by interfering with the activity of an enzyme needed to repair dna . the active substance in this medicine is called parp , which is used to treat ovarian cancer ( brca - mutated ovarian cancer ). it is used when the cancer has responded to previous
you must not be given lynparza - if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . children and adolescents do not give this medicine to children below the age of 6 years . use in children under 2 years of age is not recommended . if you have any further questions on the use of this product , ask your doctor or pharmacist . driving and using machines do not drive or use any tools or machines until you have established your ability to drive and use machines
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of lynparza is one 100 mg capsule twice a day . your doctor may increase your dose to 150 mg once a day depending on how you respond to the medicine . the doses of Lynparza capsules and tablets should be taken at the same time each day . if you take more tablets than you should if you accidentally take too many tablets , or if someone else accidentally takes a capsule , contact a doctor or the nearest hospital straight away . if possible , take the tablet with you .
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , pale skin , fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( might affect up to 1 in 100 people ): allergic reactions such as hives , difficulty breathing or swallowing , dizziness . signs and symptoms of hypersensitivity reactions are listed below . other side effects very common : may affect less than 1in 10 people : feeling sick ( nausea ) being sick ( vomiting )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep any lynparza capsules in the outer carton in order to protect from light . after first opening of the bottle , the bottle may be kept at room temperature ( up to 30 ) for a maximum period of 3 days . discard any capsules that are left in the bottle after this period . the capsules should be used within this period of time .
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg of olaparateib . - the other ingredients are lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( e172 ), and sunset yellow fcf ( e110 ) ( see section 2 under ' what you need to know before you take this medicine '). - the printing ink is a white , opaque , hard capsule imprinted with the company logo and the company abbreviation " olap
this medicine contains the active substance naloxone , which is used to treat opioid addiction in adults , adolescents and children aged 14 years and older . it is used in combination with heroin , methadone , fentanyl , oxycodone , buprenorphine and morphine . nyxoid is also used as a nasal spray for the emergency treatment of opioid overdose in adults . opioid overdose can occur in up to 14 people . overdose may cause breathing problems and severe sleepiness . if you experience an opioid overdose , stop taking opioids and seek emergency medical care immediately .
do not use nyxoid - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . you may need emergency medical care or emergency services if you have an opioid overdose . it is important that you tell your doctor straight away if you notice the signs and symptoms of an overdose . this nasal spray is for oral use . use within 2 to 3 hours after using a new nasal spray . do not use this medicine if : you are physically dependent on opioids ( e . g . heroin
always use nyxoid nasal spray exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . do not use more than the recommended dose . if you have symptoms such as : shoulders , ears , breastbone , sternum , ear , fingernail , clear the mouth and nose of any blockers , and breath on the cheek . overdose may occur if your response to touch or sounds is slow uneven breathing , breathing , snoring , gasping , gulping , blue or purple fingernails or lips , or if you notice any signs of an overdose .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : nyxoid may cause acute withdrawal symptoms associated with opioid drugs . symptoms may include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps , shivering , trembling changes in behaviour , including violent behaviour , nervousness , anxiety , excitement , restlessness , irritability unpleasant or uncomfortable mood increased skin sensitivity difficulty in sleeping . this is uncommon ( may affect up to 1 in 100 people ). these symptoms may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . one dose of each nasal spray contains 1 . 8 mg of nalxone ( as hydrochloride dihydrate ). - the other ingredients ( excipients ) are trisodium citrate diydrate , sodium chloride , hydrochloric acid , sodium hydroxide and purified water . - the concentration is 0 . 1 mg / ml in a pre - filled nasal spray . a single dose container is also available for use . not all pack sizes may be marketed .
what ovaleap is this medicine contains the active substance follitropin alfa , which is a gonadotropin ( a type of hormone that is produced naturally in the body ). fsh is involved in the growth and development of the sac ( follicles ) in the ovaries and in the production of sperm ( a immature egg cell ). it is used for treatment with a medicine called " clomifene citrate " which is used in assisted reproductive technology procedures ( procedures where a woman is able to become pregnant ) and in adult women who are unable to produce eggs and who are not able to take a medicine
do not use ovaleap if you are allergic to follitropin alfa , a type of follicle stimulating hormone , or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour in your hypothalamus or pituitary gland , which is located in the brain , large ovaries ( sacs of fluids in the ovaries ), ovarian cysts , unexplained vaginal bleeding , cancer in your ovaries , womb or breasts , any condition that makes normal pregnancy impossible , ovarian failure ( early menopause ), fibroid tumours of the womb , malformed reproductive organs or test
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how ovaleap is given this medicine is given as an injection into the tissue just under the skin ( subcutaneous injection ). if you have irregular periods , your doctor may give you this medicine for the first 7 days of your menstrual cycle . your doctor will tell you how many days of the cycle you need to use the medicine . this medicine can be given as either 75 mg or 150 mg of this medicine every 7 days ( corresponding to 14 days ). the usual starting dose is 37 . 5 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with ovaleap : serious side effects in women allergic reactions such as skin rash and raised itchy areas of skin . severe allergic reactions may include weakness , drop in blood pressure , difficulty breathing and swelling of the face . 37 common ( may affect up to 1 in 10 , 000 people ): if you experience this type of reaction , stop taking ovalesap injection and contact your doctor immediately . serious sideeffects in women lower stomach ache , nausea and vomiting are the symptoms of ovarian hyper - stimulation syndrome ( oh
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 to 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . after first opening , this medicine may be stored for a maximum of 3 days at room temperature ( up to 25 ). once this medicine has been removed from the refrigerator , it must either be used within 3 days or disposed of . if the cartridge is not used within 28 days it must be stored in the original carton
what ovaleap contains - the active substance is follitropin alfa . one ml of solution for injection ( injection ) contains 300 micrograms ( 0 . 5 ml ) of solution . one vial ( 300 microlitres ) ( 22 ml ) contains 25 microgofin ( 1 . 5 milligrams ). - one and a half vials ( 450 microlitre ) ( 33 ml ) contain 33 microgafin ( 2 . 75 milligram ). - two vials of the solution ( 850 microgram ) contain 600 microgram of solution ( 44 microgf ) of follit
voriconazole accord is an antifungal medicine that works by killing or stopping the growth of the fungi that cause infections . it is used in adults and children from the age of 2 years to treat invasive aspergillosis ( a type of fungal infection ) in adults , adolescents and children of all ages ( including those born without a doctor ' s prescription ) to treat candida sp . infections in non - neutropenic patients who have abnormally low white blood cells count due to the presence of the fungus fluconazole ( another antibacterial medicine to treat serious fungal infections caused by sced
do not take voriconazole accord : - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : - you are taking any other medicines , including herbal medicines . in particular , tell your doctor or pharmacist if you have any questions about the medicines you may be taking , or if they are not included in the package leaflet of the medicines listed in this leaflet . if any of these apply to you ( or you are not sure ), consult your doctor before taking
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will work out your dose based on your weight and the type of infection you have . the usual starting dose is 40 mg once a day . this will be given as 40 mg twice a day for 24 hours . the dose may be increased to 400 mg once daily for 12 hours and then increased to 200 mg once every 12 hours . if you take more voriconazole accord than you should if you accidentally take too many tablets , or if someone else accidentally takes your tablets , contact your
like all medicines , this medicine can cause side effects , although not everybody gets them . if you notice any side effects not listed in this leaflet , please tell your doctor or pharmacist . serious side effects of voriconazole accord include rash , jaundice , changes in blood tests of liver function and pancreatitis . other side effects include : very common ( may affect more than 1 in 10 people ): visual impairment ( change in vision , blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision , night blindness , swinging vision , seeing sparks , visual
what voriconazole accord contains - the active substance is voricazole . each 50 mg film - coated tablet ( tablet ) contains either 50 mg ( as perforated tablet ) or 200 mg ( in tablet form ). - the other ingredients are : tablet core : lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate . tablet coating : hypromellose ( e464 ), titanium dioxide ( e171 ), lactosemonohydrate and triacetin . what the film - coating looks like and contents of the pack vor
mvabea is a vaccine used to protect against ebola virus disease in the future . it is given to adults , adolescents and children from 1 year of age and older who are at high risk of getting ebola virus . a 2 - dose course of vaccinations will be given to protect you against the following types of ebolairus disease : the zaire ebolavirus and filovirus . this vaccine does not contain any of the active substances in the vaccine ( listed in section 6 ). if you are not sure , talk to your doctor , pharmacist or nurse before you are given this vaccine . if you
follow carefully all instructions given to you by your doctor , pharmacist or nurse while you are being given the vaccine . if you have ever had a severe allergic reaction to any of the ingredients of mvabea ( see section 6 . what you need to know before you are given this vaccine ) or to an antibiotic called ' gentamicin '. if any of these apply to you ( or you are not sure ), talk to your doctor or nurse before you receive the vaccine , as the vaccine may not fully protect all persons who are vaccinated . if this applies to you , tell your doctor straight away . warnings and precautions talk to
your doctor , nurse or pharmacist will give you the vaccine by injection into a muscle ( intramuscular injection ), usually in the upper arm or thigh or into a blood vessel . the recommended dose of vaccination is one zabdeno vaccine 8 weeks later . if you are given more mvabea vaccine than you should the second vaccine should be given at the same time as the first vaccine . primary vaccination first vaccination with zab deno red cap vial ( 0 . 5 ml ) the second vaccination with m vabea yellow cap vials ( 1 . 8 ml ) will be given after the first vaccination
like all medicines , this vaccine can cause side effects , although not everybody gets them . tell your doctor or nurse straight away if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): pain , warmth and swelling where the injection is given very tired muscle ache joint pain common : may affect up to 1 in every 10 people : feeling sick ( vomiting ) itching the injection may not last long enough for you to feel better . generalised itching the other side effects are listed below . very common in children and adolescents ( aged 1 to 17 years ): pain at the site of the injection
what mvabea contains - the active substance is zaire ebolavirus 29 . - the other ingredients are tai forest ebolavirus nucleoprotein marburg ( 0 . 7 %) and 108 micrograms of chickenembryo fibroblast cells . - this vaccine contains trace residues of gentamicin , sodium chloride , trometamol , water for injections , hydrochloric acid ( for ph adjustment ) and is supplied as a suspension in a single - dose glass vial with a rubber stopper and yellow cap . each pack contains 20 vials .
ondronat contains the active substance ibandronic acid , which belongs to a group of medicines called bisphosphonates . it is used to treat breast cancer that has spread to your bones ( called ' bone ametastases '). it helps to prevent your bones from breaking ( fractures ) and other bone problems that may need surgery or radiotherapy bondronat can be used if you have a raised calcium level in your blood due to a tumour that has been lost from your bones or if your bones are weaker .
do not take bondronat if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ). if you have low levels of calcium in your blood . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you : - have a side effect called osteonecrosis of the jaw ( onj ). onj is a serious form of bone damage in the jaw . your doctor may need to adjust your dose or stop your treatment with bondronatin . - have cancer or related conditions . onj may be life - threatening . stopping treatment with
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will determine the type of cancer you have and will give you an infusion into your vein . you will have regular blood tests while you are being treated with bondronat . the dose of this medicine depends on your illness . if you have breast cancer that has spread to your bones , the usual dose is 3 mg per kg body weight given every 3 - 4 weeks as an infusion in your vein over a period of 15 minutes with a raised calcium level in your blood . the recommended dose is 1
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ): persistent eye pain or inflammation new pain or weakness or discomfort in your thigh , hip or groin . unusual fracture of the thigh bone . very rare ( might affect more than 1 in 10 , 000 persons ): pain or sore in your mouth or jaw . severe jaw problems ( necrosis ( dead bone tissue ) in the jaw bone . ear pain or discharge from the ear .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . this medicine does not require any special storage conditions . after dilution the infusion solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2ºc - 8ºc unless dilution has taken place in controlled and validated aseptic conditions . your healthcare professional will ensure that this medicine is used correctly and
what bondronat contains - the active substance is ibandronic acid . each vial of 2 ml contains a concentrate for solution for infusion ( equivalent to 2 mg ibondronic acid ). - the other ingredients are sodium monohydrate , sodium chloride , acetic acid , sodium acetate , water and water for injections . what bondsronat looks like and contents of the pack 1 vial with a bromobutyl rubber stopper .
zeposia is a medicine that belongs to a group of medicines that affect the number of white blood cells ( lymphocytes ) in the body . it is used to treat adult patients with relapsing remitting multiple sclerosis ( rrms ), a type of active disease that affects the nerves of the brain and spinal cord . symptoms include numbness , difficulty in walking , and problems with vision and balance . relapses remitting ms is due to attacks on the nerve cells . the symptoms usually disappear within a few days or for periods of time . some problems may be life - threatening and may require medical attention . zep
do not take zeposia if you are allergic to zanimod or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severely weakened immune system ( e . g . a heart attack , angina , stroke , mini - stroke or transient ischemic attack ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given tia if : you have severe heart failure within the last 6 months you have irregular or abnormal heartbeats ( arrhythmia ) your heart is not working properly after treatment you have or have had severe infection such as hepatitis ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will work out your dose of zeposia based on your heart rate . you will be given a ' treatment initiation pack ' for the first 4 weeks . the recommended dose is 0 . 23 mg ozanimod once a day . this will be taken as 1 capsule in the morning and 4 capsules in the evening . after 4 weeks , your doctor may increase your dose to a ' maintenance pack ' with orange capsules , containing 0 . 92 mg ozanimod .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or pharmacist straight away if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): slow heart rate urinary tract infection raised blood pressure ( seen uncommonly in up to 1 in 100 people ): allergic reaction . the signs may include a rash . other side effects include : side effects that may occur with zeposia are listed below : common : may affect up to one in every 10 people : infections of the nose or nostrils , nasal cavity , mouth ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store below 25 . store in the original package in order to protect from moisture . this medicine does not require any special temperature storage conditions . if you notice any damage or signs of tampering to the pack , tell your pharmacist .
what zeposia contains - the active substance is ozanimod . each capsule contains 0 . 23 mg of zepanimod ( as hydrochloride ). - the other ingredients are microcrystalline cellulose , silica , colloidal anhydrous , croscarmellose sodium , magnesium stearate . - capsule shell : 0 . 22 mg of gelatin , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), black iron oxide [ e172 ] ( 0 . 46 mg / ml ) and red iron oxide black ( nm ). capsule shell - 0 . 03 mg : capsule contents : gelatin
the active substances of temybric ellipta are fluticasone furoate , umeclidinium bromide , and vilanterol . fluticasmone feuroate belongs to a group of medicines called corticosteroids . steroids are substances produced by the body that are then used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties . in copd the muscles around the airways tighten , making breathing difficult . this medicine helps relax these muscles in the lungs , reducing the swelling and irritation of the small air passages
do not use temybric ellipta : - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before you are given this medicine . if you think any of these apply to you , or if you have any questions at all , ask your doctor or pharmacist . use in children and adolescents this medicine should not be used in children or adolescents under the age of 18 years . the safety and efficacy of temy
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should take this medicine for 24 hours at the same time each day . if you have the impression that the effect of temybric ellipta is too strong or too weak , talk to your doctor , pharmacist or nurse before taking this medicine . if this applies to you , do not take the next dose until 24 hours after your last dose . do not stop taking the medicine unless your doctor tells you to . how to use temy
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing ( wheezing ) does not improve after taking this medicine , tell your doctor straight away . pneumonia ( infection of the lung caused by copd ) the most common side effect of temybric ellipta is symptoms of a lung infection such as fever , chills , increased mucus production , change in mucus colour , increased cough and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) are sore , raised patches in the mouth or throat caused by a fungal infection (
what temybric ellipta contains - the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each inhalation provides 92 micrograms of the two active substances . - each delivered dose ( the dose that leaves the mouthpiece ) is delivered as a single dose ( as a two - dose inhalation ) in the morning and evening . - the other ingredients ( excipients ) are lactose monohydrate ( see section 2 for further information on lactose '), magnesium stearate ( e470b ) and water for injections . what
zinforo is an antibiotic medicine that contains the active substance ceftaroline fosamil . it belongs to a group of medicines called 'cephalosporin antibiotics '. zinforo helps to prevent infections of the skin and the tissues around the skin . it is used to treat an infection of the lungs ( called ' pneumonia ') that has spread to other parts of the body . your doctor will tell you how long you should continue to take it . you should not stop taking it unless your doctor tells you to do so . you must talk to your doctor if you have any further questions on the use of
do not take zinforo : if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to othercephalosporin antibiotics . if you have had previous severe allergic reactions to other antibiotics ( e . g . penicillin or carbapenem ). warnings and precautions talk to your doctor or pharmacist before taking zin foro if : you have kidney problems . you have seizures ( convulsions ). you have ever had any non - severe allergic reaction to any other antibiotics such as penic
always use zinforo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is 600 mg once a day for 12 weeks . your doctor may increase your dose to 600 mg every 8 weeks depending on how you respond to some infections . the recommended dose is 8 to 12 mg twice a day . it is given as a drip into a vein ( intravenously ) over a period of 5 to 60 minutes . if you have the impression that the effect of the medicine is too strong or too weak , talk to your doctor . the dose may be increased or decreased
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , or swallowing or breathing problems . these could be signs of a severe allergic reaction ( anaphylaxis ). diarrhoea , stool , blood or mucus . your doctor may decide to stop treatment with zinforo or tell you to stop taking medicines that slow bowel movement ( see section 1 ). a blood test called a ' coombs test '
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 30 . store in the original package in order to protect from moisture . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains - the active substance is ceftaroline fosamil . - the other ingredients are arginine and water for injections ( see section 2 ). what zzinforo looks like and contents of the pack zincforo is a pale yellowish to light yellow powder for concentrate for solution for infusion in a vial . it is available in packs containing 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neurological pain : pregabalin fizer is used to relieve long lasting pain caused by damage to the nerves . it is used in a variety of diseases , but is most commonly used in patients with peripheral neurological pain ( such as diabetes or shingles ). pain sensations may be described as burning , throbbing , shooting , stabbing , sharp , cramping , aching , tingling , numbness , pins and needles . in addition , peripheral
do not take pregabalin pfizer : - if you are allergic to pregaabalin or any of the other ingredients of this medicine ( listed in section 6 ). if you think any of these apply to you , tell your doctor or pharmacist straight away . warnings and precautions talk to your doctor , pharmacist or nurse before taking pregagalin psfizer . symptoms of an allergic reaction may occur . these symptoms include swelling of the face , lips , tongue , and throat and diffuse skin rash . the severity of these reactions may vary from person to person , but are generally mild to moderate . preg
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of pregabalin pfizer for peripheral and central neuropathic pain , epilepsy and generalised anxiety disorder is 150 mg or 600 mg once a day . your doctor will prescribe the dose that is right for you . you should swallow the capsule whole with a glass of water . do not chew , crush or split the capsule . you can take the capsule with or without food . you may also take the capsules in the morning and in the evening . if you weigh 59 kg or more
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): dizziness , drowsiness , headache . common : may affect up to 1 in every 10 people : increased appetite , feeling of elation , confusion , disorientation , decrease in sexual interest , irritability , disturbance in attention , clumsiness , memory impairment , loss of memory , tremor , difficulty with speaking , tingling feeling , numbness , sedation , lethargy , insomnia , fatigue , feeling abnormal , blurred vision , double vision , vertigo ,
what pregabalin pfizer contains - the active substance is preginabalin . each hard capsule contains 25 mg , 50 mg , 75 mg , 100 mg , 150 mg , 200 mg , 225 mg or 300 mg of preginibalin . - the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica , black ink , shellac , black iron oxide ( e172 ), propylene glycol ( e1521 ), potassium hydroxide ). - the 75 mg
xadago is a medicine that contains the active substance safinamide , which blocks the action of dopamine , a chemical in the brain that is involved in movement . it is used to treat parkinson ' s disease in adults . xadago can be used in adults who have the following conditions : sudden swings in their ability to move ( difficulties moving ) in response to the medicine . the medicine may be used alone or in combination with levodopa or other medicines used in the treatment of parkinson '. if you have any further questions on the use of this medicine , ask your doctor .
do not take xadago if : you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). you are taking the following medicines : monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , rasagiline ), moclobemide , phenelzine , isocarboxazid , and tranylcypromine ( for treatment of parkinson ' s disease or depression ). pethidine ( a strong pain killer ) has been shown to increase the chance of having a stroke within 7 days of starting xad
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of xadago is 50 mg once a day . the dose may be increased to 100 mg once daily by mouth . your doctor will prescribe the dose that is right for you . if you have moderately reduced liver function , your doctor may prescribe a lower dose of 50 mg per day . you should continue to take xadadago until your doctor tells you otherwise . if necessary , you should contact your doctor if you experience any of the following : raised blood pressure , anxiety , confusion ,
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis : very high blood pressure may lead to collapse ( neuroleptic malignant syndrome ): confusion , sweating , muscle rigidity ( hyperthermia ), increase level of enzyme creatine kinase in your blood ( serotonin syndrome ), confusion , hypertension , muscle stiffness , hallucinations ( hypotension ). the following side effects have been reported with the use of parkinson ' s disease in combination with safinamide and levodopa . other medicines and xadago tell your doctor or pharmacist if you are taking , have recently taken or might take
what xadago contains - the active substance is safinamide . each 50 mg or 100 mg film - coated tablet is made up of the following ingredients : - the other ingredients are : - tablet core : methansulfonate , microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablet coating : hypromellose , macrogol , titanium dioxide ( e171 ) - printing ink : iron oxide red ( e172 ) - coating : shellac ( e904 ), talc ( e553b ) what xad
zytiga is a medicine that contains the active substance abiraterone acetate . it is used to treat adult men with prostate cancer that has spread to other parts of the body . zytiga lowers testosterone ( androgen deprivation therapy ) in men . your doctor will test for this in order to determine if it is appropriate for you to have this type of prostate cancer . you should not have this kind of disease unless you have been previously treated with hormone therapy ( a treatment that lowers testosterone (( androgen depletion therapy ). you should also be given another medicine containing prednisone . prednisolone is used
do not take zytiga : if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant . warnings and precautions talk to your doctor , pharmacist or nurse before you are given ztiga . if you have severe liver damage or prostate cancer . this medicine should not be given at the same time as this medicine . if any of these apply to you , do not take this medicine and tell your doctor straight away . do not stop taking this medicine unless your doctor tells you to . liver problems such as high blood pressure
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 , 000 mg once a day . swallow the tablet whole with a glass of water . this medicine can be taken with or without food . do not chew , crush or split the tablet before swallowing . take zytiga at the same time each day . it is important that you continue taking this medicine until your doctor tells you otherwise . your doctor will tell you how long you should continue to take it . if you have the impression that the effect is too strong or too weak ,
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact your doctor immediately if you experience : - muscle weakness , muscle twitches , a pounding heart beat or palpitations . - level of potassium in your blood is low . your doctor will check your potassium regularly . other possible side effects include : very common ( may affect more than 1 in 10 people ): - fluid in your legs or feet . - low blood potassium ( seen in liver function test ). - high blood pressure . - urinary tract infection . - diarrhoea ( common , may affect up to 1
what zytiga contains - the active substance is abiraterone acetate . each tablet contains nominally 250 mg abirate . - the other ingredients are : tablet core : microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate . see section 2 for further information about some of the ingredients of this medicine ( see section 4 for important information on some of these ingredients ). what ztiga looks like and contents of the pack - zyt
hefiya contains the active substance adalimumab . it is a medicine used for the treatment of inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis , paediatric plaque psoriasis and paediatric crohn ' s disease . paediatric non - infectious uveitis . your doctor will determine the type of antibody ( monoclonal antibody ) that is most appropriate for treating the inflammatory diseases . the antibody is a type of protein called tumour necrosis factor ( tnfα ). hefiya works by blocking the activity of this protein . the inflammation in these
do not take hefiya - if your child is allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ) - if you have a severe infection , such as tuberculosis , sepsis ( blood poisoning ), or other opportunistic infections ( unusual infections caused by a weakened immune system ). symptoms of infections may include fever , wounds , feeling tired , dental problems , or moderate or severe heart failure . warnings and precautions talk to your child ' s doctor , pharmacist or nurse before taking this medicine . allergic reaction allergic reactions may include symptoms such as chest tightness , wheezing ,
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 40 mg tablet once a day . your doctor will tell you how many tablets to take . the dose may be increased or decreased depending on your response to the medicine . for polyarticular juvenile idiopathic arthritis age and body weight the usual starting dose is 2 tablets of 30 mg twice a day ( equivalent to 40 mg ) for 2 years of age and weighing 10 kg or more . thereafter , your doctor may increase your dose to 30 mg two days a week ( equivalent
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . tell your doctor straight away if you notice any of the following side effects ( see section 4 of this leaflet ): - after the last hefiya injection - allergic reaction - heart failure - severe rash , hives , swollen face , hands , feet - trouble breathing or swallowing - shortness of breath - swelling of the feet - signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , burning on urination , feeling weak
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . after first opening , the product may be stored at room temperature ( up to 25 ) for a single period of up to 14 days . once removed from the refrigerator for room temperature storage , you may take his / her solution back to your refrigerator and use it within 14 days or dispose of your pre -
what hefiya contains - the active substance is adalimumab . one ml of each pre - filled syringe contains 20 mg / 0 . 4 ml . - the other ingredients ( excipients ) are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid and sodium hydroxide and water for injections ( see end of section 2 ). what hefaya looks like and contents of the pack hafiya is a clear , colourless to slightly yellowish solution for injection in a clear type i glass syringe with a stainless steel
the active substance of ritemvia is rituximab , a type of protein known as a " monoclonal antibody ". it attaches to a specific type of white blood cell called " b - lymphocyte " ( b lymphocyte - colony stimulating factor ) and blocks its action . by attaching to b lymphocytes it blocks their action and allows them to multiply and divide into smaller pieces . this results in an increase in their size and number of cells . your doctor will test your body ' s immune system to make sure that it is working properly . this is called a " survival factor " and helps your body to
do not take ritemvia : - if you are allergic to rituximab , other proteins that are derived from the needles of yew trees or to any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection with a weak immune system . if you suffer from severe heart failure or severe uncontrolled heart disease . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you : - have a history of granulomatosis , polyangiitis , microscopic polyangiopiitis or pemphigus vulgaris . ritem
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . ritemvia will be given to you by a doctor or nurse who is experienced in the use of this treatment . your doctor will monitor you closely while you are being given this medicine and will treat any side effects that may occur during or after your treatment . for non - hodgkin ' s lymphoma your doctor may decide to give you ritvia together with other medicines ( pre - medication ) in order to reduce the risk of side effects . your treatment will be overseen by your doctor .
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion , fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of platelets
what ritemvia contains - the active substance is rituximab . each ml of solution contains 100 mg of ritudimab ( as besilate ). each vial of concentrate contains 10 mg / ml ( 23 . 5 mg / vial ). - the other ingredients are : powder : sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . this product is a clear , colourless solution for infusion in a glass vial . pack size of 2 vials . not all pack sizes may be marketed .
capecitabine teva belongs to a group of medicines called " cytostatic medicines ", which stop the growth and spread of cancer cells . the name of the active substance in this medicine is capecitabrine ( also called " tacrolimus ") which is derived from the needles of yew trees ( needles ) and is used to treat adult patients with certain types of colon , rectal , gastric , or breast cancers that have spread beyond the original tumour and have not responded to treatment with other medicines .
do not take capecitabine teva - if you are allergic to cape citabine or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may have an allergy to this medicine . if you have severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines , such as fluorouracil ) if you ( or your partner ) are pregnant , have low levels of white cells or platelets in the blood ( leucopenia , neutropenia , thrombocytopenia ), have severe liver or kidney problems , have problems with the enzyme
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . capecitabine should only be prescribed by a doctor who is experienced in the use of anticancer medicines . your doctor will prescribe you a dose and treatment regimen that is right for you . the dose and dose you will take is based on your body surface area ( height and weight ). the usual dose for adults is 1250 mg / m2 of body surface surface taken twice a day . this means that your body weight is 64 kg or greater . your height is 1 . 64 mbq /
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva and contact your doctor immediately if you get any of these symptoms : diarrhoea : if you have an increase of 4 or more bowel movements per day . if you vomit more than once in a 24 - hour period , or if you lose your appetite . stomatitis : pain , redness , swelling or sores in your mouth and / or throat . hand and foot skin - reaction : pain and swelling , including redness and tingling of hands and or feet fever with a temperature
what capecitabine teva contains - the active substance is capecabine . each film - coated tablet contains 150 milligrams ( 1 . 5 mg ) capecitabeine . - each tablet contains 500 milligram ( 5 . 0 mg ). - the other ingredients are : tablet core : lactose , microcrystalline cellulose , hypromellose , croscarmellose sodium , magnesium stearate , macrogol 400 , talc ( e553b ). tablet coating : hypromellaose , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), red iron oxide
silodosin recordati is a medicine that belongs to a group of medicines called alpha1a - adrenoreceptor blockers . it is used to control the activity of the prostate , bladder and urethra . it helps to maintain a smooth muscle in these tissues . it also helps to control your symptoms when you get up from a lying or sitting position and when you lie down or lie down for a short time after you have been up for a long time . your doctor will test your condition to see how well it is working and may adjust your dose or stop your treatment if it is not controlling your symptoms . silod
do not use silodosin recordati - if you are allergic to siliodosin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before you are given this medicine . during eye surgery , you may experience cloudiness of the lens ( cataract surgery ) in your eye . 26 if this happens , your doctor may decide to reduce the dose you receive or temporarily stop the treatment . your doctor will advise you on appropriate precautions , including the use of medicine and surgical techniques . if any of these apply to you , tell your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of silodosin recordati is 8 mg once a day . if you have kidney problems or moderate kidney problems , your doctor may prescribe a lower dose . take this dose at the same time each day . swallow the capsule whole with a glass of water . do not chew or crush the capsule . you can take the tablet with or without food . try to take it at any time of the day . it is important that you continue taking this medicine for as long
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin , hives ( the most common side effect of silodosin recordati ). dizziness . dizziness may be accompanied by occasionally fainting . if you feel weak or dizzy , tell your doctor straight away . the symptoms may include dizziness and faints . if any of the above apply to you ( or you are not sure ), talk to your doctor or pharmacist before taking silodnosin recordi . complications following
what silodosin recordati contains - the active substance is silodusin . each hard capsule contains 8 mg of siliodosin . - the other ingredients are : capsule content : mannitol ( e421 ), magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( e171 ). - printing ink : shellac ( e904 ), red ink ( e1521 ), white to off - white powder ( e1203 ), black ink ( i1521 ) and yellow iron oxide ( e172 ). not all the pack sizes may be marketed in your country . what silod
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angiotENSin ii is a substance produced in the body which causes your blood vessels to narrow . this results in an increase in your blood pressure ( i . e ., it increases the amount of blood in the blood each day , which makes it harder for your body to pump enough blood to the surface ). thus , you have an increased risk of developing a condition called essential hypertension ( high blood pressure ). this condition is called the ' essential ' condition because the blood vessels in several organs can become damaged , leading to heart
do not take kinzalmono if you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you ( or you are not sure ), talk to your doctor , pharmacist or nurse before taking this medicine . warnings and precautions 3 if you or your family are pregnant , think you may be pregnant , or are planning to have a baby . see section " pregnancy section for more information . if you have severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder ) or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . you should take kinzalmono at the same time each day . the tablets should be swallowed whole with a glass of water . do not chew or break the tablet . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious and need immediate medical attention : sepsis ( blood poisoning ), a severe infection with whole - body inflammatory response , rapid swelling of the skin and mucosa ( angioedema ). these side effects are rare ( may affect up to 1 in 1 , 000 people ). if any of the side effects gets serious , stop taking kinzalmono and contact your doctor immediately . common side effects ( affects more than 1 user in 10 ): low blood pressure ( hypotension ) and cardiovascular events . uncommon side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special temperature storage conditions . keep your medicine bottle tightly closed in order to protect from moisture . once your kinzalmono tablet has been removed from the blister , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmisantan . - the other ingredients are povidone , meglumine , sodium hydroxide , sorbitol ( e420 ) and magnesium stearate in the tablet core and in the film - coating ( see end of section 2 for further information about some of the ingredients of this medicine ). - the tablet can be divided into equal doses ( 20 mg / m2 ) and 50 mg / ml ( 100 mg / 0 . 25 mg / 1 . 5 mg ). what kinz
afstyla is a human clotting ( coagulation ) factor viii product produced by recombinant dna technology in the manufacturing process in the laboratory . the active substance is lonoctocog alfa , a type of protein that belongs to the group of proteins called cytokines ( granulocyte - colony stimulating factor erythromycin ). afstylfa is used for the treatment of bleeding episodes in patients with haemophilia a ( inborn factor v iii deficiency ) in adults , adolescents and children aged 2 years and above who are unable to clot . the safety and efficacy of afst
do not use afstyla - if you have ever had an allergic reaction to the active substance or any of the other ingredients ( listed in section 6 ). if you think you may be allergic to hamster proteins 46 warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if you are not sure , ask your doctor or pharmacist for advice . the dose and duration of your treatment diary should be recorded on the patient alert card you have been given by your doctor . you should not be given more than once a week . if any of these apply to you , tell your doctor straight
your treatment will be overseen by a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the dose of afstyla you receive will depend on the duration of treatment , the severity of your disease the site and the bleeding your clinical condition . reconstitution and administration general instructions the powder and the solvent ( liquid ) should be used in aseptic conditions . the solution should be clear , colourless to slightly opalescent and should be administered immediately after withdrawal . do not use the solution if
like all medicines , afstyla can cause side effects , although not everybody gets them . symptoms of allergic reactions allergic reactions may include the following symptoms : hives generalised urticaria ( itchy rash , tightness of the chest , difficulty in breathing , wheezing ), low blood pressure and dizziness ( anaphylaxis ). bleeding has been reported in patients treated with factor viii medicines with inhibitor antibodies ( see section 2 ' warnings and precautions '). common side effects ( may affect up to 1 in 10 people ) - in patients who have received previous treatment with factors viii ( more than 150 days of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the afstyla powder in the outer carton in order to protect from light . after reconstitution , the reconstituted product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 8 hours at 2 - 8 unless dilution has taken place in controlled and validated
what afstyla contains the active substance is lonoctocog alfa . each vial contains 250 iu / 2 . 5 ml of solution for injection and injections the solution contains 100 iu ( 0 . 5 %) loroctocag alfa in the form of pellets . after reconstitution and dilution and diluution , the product is stable for up to 2. 5 hours and is for single use only . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 8
what praxbind is and what it is used for the active substance in this medicine , idarucizumab , is a recombal agent . it dissociates from dabigatran ( pradaxa ), a blood thinner medicine used to prevent blood clot formation . when used in combination with a recombinant dabigatra , the effect is similar to that of a natural antiretroviral agent ( i . e ., a substance produced naturally in the body but which can also be removed by chemical and physical inactivity ). when used together with a reconstituted form of idar
do not take praxbind - if you are allergic to idarucizumab or any of the other ingredients of this medicine ( listed in section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : - you have a genetic disease called hereditary fructose intolerance ( hafr ). - you are taking the substance sorbitol . this medicine may cause serious adverse reactions . do not take this medicine with dabigatran . other medicines may increase the risk of blood clots ( see section " other medicines and praxbind ") dabigATran has been shown to
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 5 mg ( equivalent to 2 . 5 mg dabigatran ). you will be given this medicine once a day for 5 days . this medicine will be injected into a vein . your doctor will decide how many days you should receive this medicine . your treatment will be overseen by a doctor who is experienced in blood clot formation . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains - the active substance is idarucizumab . - the other ingredients are sodium acetate trihydrate , acetic acid , sorbitol ( e420 ), polysorbate 20 and water for injections . what Praxbind looks like and contents of the pack the clear , colourless to slightly opalescent and slightly yellow solution is supplied in a butyl rubber stopper and an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temomedac is used in the treatment of specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme ( gli ) when radiotherapy ( concomitant phase of treatment ) is contraindicated or inadequate . - in children and adolescents ( 3 years of age and older ) with malignant glioma , such as gliOBlastoma multipurpose or anaplastic astrocytoma ( maoi ). temomedic is used
do not take temomedac if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). if you have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction may include feeling itchy , breathlessness or wheezing , swelling of the face , lips , tongue or throat . if blood cells are severely reduced ( myelosuppression ) in your white blood cell count and platelet count . these blood cells help you in fighting infection and are important for proper blood clotting . your doctor will
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dose and duration of treatment your doctor will work out your dose of temomedac based on your height and weight . this is especially important if you have a recurrent tumour or have had chemotherapy treatment in the past . your doctor may also give you other medicines ( anti - emetics ) to reduce the amount of the medicine in your body . the dose you take will depend on your condition and whether you are being treated for nausea or vomiting . for newly - diagnosed glioblastoma multiforme
like all medicines , this medicine can cause side effects , although not everybody gets them . if you have a severe allergic ( hypersensitive ) reaction , e . g . hives , wheezing or other breathing difficulty , uncontrolled bleeding , seizures , convulsions , fever , chills and severe headache , stop temomedac treatment and tell your doctor straight away . there may be a reduction in certain kinds of blood cells , which may result in increased bruising or bleeding ( anaemia ), reduction in the number of red blood cells and fever and reduced resistance to infections . the reduction in blood cell counts may lead to anaemia (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . after first opening , the capsules should be used within 30 days . if you notice any change in the appearance of the capsules , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what temomedac contains - the active substance is temozolomide ( see section 2 under ' contents of the pack and other information '). each capsule contains either 5 mg or 5 mg of temozolsomide . - each capsule shell ( including printing ink ) contains either 20 mg , 20 mg or 20 mg temozlomide in each capsule . - the other ingredient ( s ) ( excipients ) ( e . g ., gelatin , lactose , colloidal anhydrous silica ) is sodium starch glycolate type a , tartaric acid , stearic acid ( see
cialis is a treatment for adult men with erectile dysfunction , a condition in which a man cannot get , keep or keep a hard , erect penis suitable for sexual activity . cialis helps to provide a hard erect penis in men when they are not able to have sex or are unwilling to engage in activities that would normally be pleasurable for a man such as driving a car or operating machinery ( such as a needle or a screw ) while they are at bedtime . the active substance tadalafil belongs to a group of medicines called phosphodiesterase type 5 inhibitors , which help to maintain erectile function
do not take cialis if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to organic nitrate or nitric oxide donors ( e . g . amyl nitrite ) or medicines (" nitrates ") used to treat angina pectoris (" chest pain "). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if any of these apply to you ( or you are not sure ), ask your doctor or pharmacist for advice before taking nitrate . if you have serious
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . cialis tablets are for oral use . swallow the tablets whole with a glass of water . the tablets can be taken with or without food . the recommended starting dose is 5 mg twice a day . your doctor may increase your dose to 2 . 5 mg once a day if necessary . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . use in children and adolescents do not give this medicine to children or adolescents under the age of 18 years .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with the medicine : allergic reactions including rashes ( frequency not known ) and chest pain have been reported in patients taking nitrates . the frequency is not known ( frequency cannot be estimated from the available data ). priapsim may cause a prolonged and possibly painful erection . stop taking cialis and get an erection straight away ( see section 4 " warnings and precautions "). contact your doctor immediately if you experience sudden loss of vision . this is of no frequency . other side effects very common ( may affect more than
what cialis contains - the active substance is tadalafil . each 2 . 5 mg film - coated tablet contains a single tablet ( tablet core ) containing a total of 2 . 75 mg of dal ( as mesilate ). - the other ingredients are : tablet core : lactose monohydrate ( see end of section 2 ), croscarmellose sodium , hydroxypropylcellulose ( e463 ), microcrystalline cellulose , sodium laurilsulfate , magnesium stearate . film - coating : cellulose and hypromellose , triacetin , titanium dioxide (
enyglid is an oral antidiabetic medicine containing repaglinide , which helps your pancreas make better use of insulin when your blood sugar is too high ( glucose ). type 2 diabetes is a disease in which your body does not make enough insulin to control the sugar in your blood or where your body is not able to use the insulin it produces effectively . eneyglid helps control the level of sugar in the blood after you have started treatment with diet and exercise and weight reduction . it is also used in combination with metformin to treat diabetes . your doctor will test for these changes . eny
do not take enyglid : if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too low . if you suffer from diabetic ketoacidosis ( see section 4 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have a severe liver disease . you are taking gemfibrozil ( a medicine used to lower increased fat levels ). you have liver problems . you have moderate liver 28 disease . see section 2
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . you can take enyglid with or without food . the usual starting dose is 30 mg twice a day for 4 weeks . your doctor may increase your dose to 30 mg every 16 weeks depending on your blood sugar . do not take a double dose to make up for a forgotten dose . if you have any further questions on the use of this medicine , ask your doctor , pharm
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia is the most common side effect of enyglid . it is very common ( may affect more than 1 in 10 people ) in patients treated with this medicine . in some cases , the following symptoms may occur : - swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating ( signs of anaphylactic reaction ). other side effects may include : - stomach pain , diarrhoea ( rare ) ( not known ( frequency cannot be estimated from the available data ) - acute coronary syndrome ( very rare )
what enyglid contains - the active substance is repaglinide . each vial contains 0 . 5 mg , 1 mg or 2 mg repagginide . - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate , anhydrous , croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , poloxamer , yellow iron oxide ( e172 ) ( see section 1 for further information on some of the ingredients ). tablet coating : orange , round and biconvex with beve
azacitidine mylan is an anti - cancer agent . it is given to you by your doctor or nurse . your doctor will tell you how many tablets of azacitine mylan to give to you . how much to give the doctor , nurse or pharmacist knows how to give you the medicine . the doctor will ask you to have a stem cell transplantation . adults with higher - risk myelodysplastic syndromes ( mds ) and chronic myelomonocytic leukaemia ( cmml ) acute myeloid leukemia ( aml ). aml is a group of diseases
do not take azacitidine mylan - if you are allergic to azapitidine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you have advanced liver cancer . if this applies to you , tell your doctor straight away . if you think any of these apply to you ( or you are not sure ), ask your doctor or pharmacist for advice . you may also be more likely to get decreased counts of platelets , red or white blood cells . your doctor may ask you to have blood tests before and
before starting azacitidine mylan you will be given another medicine to control nausea and vomiting . the recommended dose is one 75 mg tablet once a day . your doctor will tell you how many tablets of this medicine you need to take . the dose will depend on your height and weight . you will usually receive one half a tablet each day . if you have the impression that the effect is too strong or too weak , talk to your doctor or pharmacist . you may be given one tablet every day for 3 weeks during this " treatment cycle " ( cycle 4 to 6 ). this medicine is given under the skin ( subcut
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these could be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue . these may be signs or symptoms of kidney failure . a fever may be a sign of an infection . low levels of white blood cells . chest pain
keep this medicine out of the sight and reach of children . do not use azacitidine mylan after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vials in the outer carton in order to protect from light . after reconstitution , the reconstituted product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 1 hour at 2 to 8 . the azac
what azacitidine mylan contains - the active substance is azapitidine . one vial of powder contains 100 mg of azacinidine . after reconstitution , 4 ml of water for injections is sufficient for the reconstituted suspension to contain 25 mg / ml . - the other ingredient ( s ) ( excipients ) ( in the powder ) is mannitol ( e421 ) ( see section 4 ) ( e433 ) ( for further information on the use of this product in children and adolescents ) ( please refer to the package leaflet for information on this product ). what azac
duotrav eye drop solution contains a combination of two active substances , travoprost and timolol in one drop . travostrost is a prostaglandin analogue , which is used to measure pressure in the eye and to reduce the amount of fluid inside the eye that can be caused by pressure within the eye . duotraveye drops are used to reduce high pressure in an eye associated with an illness called glaucoma .
do not take duotrav if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). if you have respiratory problems such as asthma , severe chronic obstructive bronchitis , severe lung disease , wheeziness , difficulty in breathing , long - standing cough , breathing problems , severe hay fever , a slow heartbeat , heart failure ( a disorder of heart rhythm ), or if your eye becomes cloudy . if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before taking du
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop in each eye each day . do not use duotrav in your eyes unless your doctor tells you to . if you have any further questions on the use of this medicine , ask your doctor . how to use the following eye drops : 1 , 2 , 3 , 4 drop in a bottle . 1 . wash your hands . hold the bottle tightly closed with a clean finger , pointing down , between your thumb and fingers . tilt your head back .
like all medicines , this medicine can cause side effects , although not everybody gets them . stop using duotrav and see a doctor straight away if you notice any of the effects listed below . very common side effects ( may affect more than 1 in 10 people ) effects of the eye eye redness . this is a common side effect that may affect up to 1 in every 10 people . the effect may be increased if the eye surface inflammation is not treated . signs and symptoms may include eye pain , blurred vision , abnormal vision , dry eye , itchy eye and eye discomfort . tell your doctor as soon as possible if you have
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 30 . store in the original package in order to protect from light . once opened , duotrav may be used for up to 4 months to reduce the risk of infections .
what duotrav contains - the active substances are travoprost and timolol . each vial contains 40 mg ( 1 . 5 mg of the active substance ). - the other ingredients ( excipients ) are : - tablet core : timbolol maleate , polyquaternium - 1 , mannitol , propylene glycol , polyoxyethylene hydrogenated castor oil ( 40 mg / ml ). - solvent : boric acid , sodium chloride , sodium hydroxide , hydrochloric acid . - purified water ( see end of section 2 ). - printing ink : shellac , sodium
nplate ' s active ingredient is romiplostim . it is a protein that helps to control low platelet counts in the immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease in which your body ' s immune system does not produce enough platelets . platelets are important in the blood to prevent blood clots from forming . if you suffer from very lowplatelet counts , bruising or serious bleeding ( see section 1 , " warnings and precautions "). if you have spleen removed ( chronic itp ) you have previously received corticosteroids
do not take nplate if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before taking nplate : if you have a low blood platelet count ( thrombocytopenia ). your doctor may need to adjust your dose of nplate . if your platelet counts are too low , you may have a higher risk of blood clots . if you suffer from problems with blood clotting , such as liver problems .
always use nplate exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents ( from 1 to 17 years of age ) the recommended dose is one tablet of nplate per day . nplate should be injected under the skin ( subcutaneous ) at least 1 hour before you start using nplate . your doctor will check your platelet counts regularly . you will also have regular blood samples taken to measure the number of your platelets and the amount of platelet count in your blood . the doctor will also tell you how much nplate you need to take .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with itp : very common ( may affect more than 1 in 10 people ): headache , allergic reaction , upper respiratory tract infection ( common ) and respiratory tract disorders ( common ). common : dizziness , tingling , or numbness of the hands or feet ( paraesthesia ), migraine , redness or the skin ( flushing ), blood clot in a lung artery ( pulmonary embolism ), nausea , diarrhoea , abdominal pain , indigestion ( dyspepsia ), constipation ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . store in the original package in order to protect from light . after first opening : do not store above 30 .
what nplate contains - the active substance is romiplostim . nplate 125 mg powder for solution for injection : each vial contains 230 micrograms ( 23 . 5 mg ) of romplostim ( 25 . 2 mg ) in each ml . - the other ingredients are : tablet core : nplate 250 mg : each ml of solution contains 375 microgram ( 24 . 0 mg ) romiplustim . tablet coat : one vial of 0 . 25 ml solution contains 125 microgram( 24 . 5 μg ) of the other ingredient . - tablet coating : one ampoule of 1 ml solution
this medicine contains an active substance called glycopyrronium bromide which belongs to a group of medicines called bronchodilators . what tovanor breezhaler is used for this medicine is used to treat breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). copd causes the muscles around the airways to tighten , making breathing difficult . this medicine prevents this tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . your doctor has prescribed this medicine to help reduce the effects of copd on your everyday life .
do not use tovanor breezhaler : - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if you : - have kidney problems - have an eye problem called narrow - angle glaucoma - have difficulty passing urine . your doctor may decide to reduce your dose or stop treatment . if you think any of these apply to you , tell your doctor or pharmacist immediately . - have tightness of the chest , coughing , whe
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much tovanor breezhaler to inhale the recommended dose is one inhalation once a day . this medicine should be inhaled every 24 hours at a maximum of 75 inhalations per day . do not inhale this medicine if you feel that the effect of this medicine is too strong or too weak . if you use more this medicine than you should use an inhaler and capsules ( in blisters ) that contain the medicine ( inhalation powder ). the capsules
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each hard capsule contains 63 micrograms ( 0 . 5 milligrams ) glycopromroniumbromide and one inhalation dose of 50 microgram ( 1 . 0 milligram ) has been demonstrated . - the delivered dose of glycogen in the mouthpiece of the inhaler is 44 microgram per kilogram of body weight ( i . e ., one millilitre per kg body weight ). - the other ingredients in the inhalation powder are lactose monohydrate and magnesium st
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by stimulating the brain to produce dopamine and serotonin , which are involved in calming effects and relieving aggressive behaviour . adasuve is used to treat acute symptoms of mild - to - moderate agitation in adults with schizophrenia and bipolar disorder . these are diseases characterised by symptoms such as : ( schizophrenia ) hearing , mistaken beliefs , incoherent speech and behaviour , emotional flatness , depressed , guilty , anxious or tense . ( bipolar disorder ) feeling " high ", having excessive amounts of energy , needing much less sleep
do not take adasuve : - if you are allergic to loxapine or any of the other ingredients of adsasuve ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if you : - have lung problems like asthma , chronic obstructive pulmonary disease ( copd ), narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness and shortness of breath 25 - have had neuroleptic malignant syndrome ( nms ), which has been reported with symptoms of antipsychotic medicines . these symptoms include high
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 9 . 1 mg twice a day . your doctor may increase your dose every 2 weeks to 4 . 5 mg depending on your condition . adasuve should be taken by mouth once a day , at about the same time each day . you should swallow the tablet whole with a glass of water . do not chew or break the tablet as this may cause the device to break . if you have any of the following symptoms : extreme tiredness , sleepiness , trouble breathing , low blood
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : - any breathing symptoms such as wheezing , cough , shortness of breath , chest tightness , irritating your airways ( asthma or copd ). - light - headedness or fainting . these may be signs that your blood pressure is getting too high . - worsening agitation , confusion , fever and muscle stiffness . these could be signs of a severe condition called neuroleptic malignant syndrome . other side effects include : very common ( may affect more
keep this medicine out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and the blister after exp . this medicine does not require any special storage conditions . keep the blister in an open or torn pouch in order to protect from light and physical damage .
what adasuve contains - the active substance is loxapine . each single - dose inhaler contains 5 mg of loxepine . after dilution , each delivered dose delivers a delivered dose of 4 . 5 mg . - the other ingredients are lactose and water for injections ( see section 2 under ' adasve contains lactose ' and " other ingredients '). what adasuves looks like and contents of the pack adsasuve is a white to off - white plastic inhaler with " lh5 " debossed on one side . each inhaler is packed in a sealed foil pouch .
the active substance of azacitidine betapharm is called azapitidine . it is an anti - cancer agent , which belongs to a group of medicines called cytokines . the active substance in this medicine is called quinidine . what azcapitidinebetapharm looks like and contents of the pack white to off - white , oval shaped , biconvex tablets , debossed with " mds " on one side and plain on the other side . it can be used as a stem cell transplantation in adults with higher - risk myelodysplastic syndromes ( mds
you must not be given azacitidine betapharm - if you are allergic to azapitidine or any of the other ingredients of this medicine ( listed in section 6 ). if you have advanced liver cancer . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have decreased counts of platelets ( a type of red or white blood cells ) you have kidney disease you have liver disease you suffer from a heart condition you have heart attack you have lung disease your doctor will ask you to have blood test periodically during treatment . your doctor may decide to stop treatment with az
before starting azacitidine betapharm , you will be given another medicine to prevent nausea and vomiting . the recommended dose is one 75 mg tablet of this medicine per day . your doctor will work out your dose based on your height and weight . if you have the impression that the effect of the medicine is too strong or too weak , talk to your doctor or pharmacist . you will usually be given one tablet once a day for 3 weeks before starting this " treatment cycle " ( cycle 4 to 6 ). this medicine is injected under the skin ( subcutaneously ) on the skin of the thigh , tummy or upper
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue . these could be signs or symptoms of kidney failure . a fever may be a sign of an infection . low levels of white blood cells . chest pain
keep this medicine out of the sight and reach of children . do not use azacitidine betapharm after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . the reconstituted and diluted solution for injection is stable for up to 45 hours at room temperature ( 20 - 25 ). after reconstitution with water for injections , the suspension should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than
what azacitidine betapharm contains - the active substance in this powder vial is azapitidine . each vial contains 100 mg of azaitidine ( as besilate ). after reconstitution , 4 ml of water for injections is sufficient . the reconstituted suspension contains 25 mg / ml of azaccitidine . - the other ingredients are mannitol ( e421 ) ( see section 2 " important information about some of the ingredients ") and potassium ( e1203 ( e507 ) ( e903 ) ( for further information on some of these ingredients ). what az
the active substance of cerdelga is eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults . gaucher diseases type 1 is inherited condition in which a substance called glucosylceramide is not removed from the body . this substance is mainly produced by the spleen , liver and bones . if you have not been able to remove it from your affected organs , you may not be able to use this medicine . your doctor will tell you how long you should continue to take this medicine and how long it will take to work . the recommended dose is one tablet a day . cer
do not take cerdelga if : you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). you are taking medicines known as moderate cyp2d6 inhibitors ( e . g . quinidine , terbinafine , 31 ) or moderatecyp3a inhibitors such as erythromycin or itraconazole . these medicines are used to improve your body ' s ability to use its own blood . warnings and precautions talk to your doctor , pharmacist , or nurse before you are given the medicine ( see section " other medicines and cerdel
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one tablet twice a day with or without food . your doctor will tell you how many tablets to take . the amount of metaboliser to take depends on the type of food you are taking . the recommended daily dose for metaboliser is one 84 mg tablet once a day . swallow the tablet whole with a glass of water . if you take more cerdelga than you should if you accidentally take too many tablets , contact a doctor or the nearest hospital straight away .
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache dizziness change in taste ( dysgeusia ) palpitations ( throat irritation ) heartburn ( dyspepsia ) feeling sick ( nausea ) diarrhoea constipation abdominal pain stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux diseases ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dysphagia ) vomiting dry mouth gas ( flatulence ) dry skin h
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the sleeve after exp . store in the original package in order to protect from moisture .
what cerdelga contains - the active substance is eliglustat . each hard capsule contains 84 mg of this active substance . - the other ingredients are : capsule content : microcrystalline cellulose , lactose monohydrate ( see section 2 under ' important information about lactose '), hypromellose , glycerol dibehenate . capsule shell : gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), indigotine ( e132 ). printing ink : shellac , black iron oxide , propylene glycol and ammonia solution ( e1520 ). what cer
ziehira contains the active substance in zoledronic acid hospira . it belongs to a group of substances called bisphosphonates ( also known as polysorbate - 2b agonists ) and is used to reduce the amount of calcium in the blood in adult patients who are at risk of bone change . it is used in adults to prevent bone complications , e . g . fractures , from occurring in bone metastases ( spread of cancer from primary site to the bone ). it is also used in patients whose level of calcium is too low due to the presence of a tumour . tumours can accelerate the
follow carefully all instructions given to you by your doctor , pharmacist or nurse . your doctor will carry out blood tests before and during treatment with zoledronic acid hospira and regularly during treatment . if you are not sure if any of the above applies to you , talk to your doctor or pharmacist before you are given this medicine . warnings and precautions talk to the nuclear medicine doctor or nurse before being given the medicine if : you think you may be allergic ( hypersensitive ) to the active substance of zoledron acid or to another bisphosphonate ( the group of substances to which the medicine is made ), or
zoledronic acid hospira will be given to you by a doctor or nurse who is experienced in the use of bisphosphonates intravenously ( into a vein ) under the supervision of a doctor experienced in ' iv ' administration . in order to reduce the risk of dehydration , it is recommended that you drink at least one glass of water before each infusion . your doctor will tell you how many tablets you need to take . if you have a kidney problem , your doctor may decide to lower the dose or stop your dose . if your kidney problem has not resolved after your first infusion , you may be given zoledronic
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : common ( may affect up to 1 in 10 people ): severe kidney impairment ( may be seen in blood tests ) low level of calcium in the blood ( uncommon ) uncommon : jaw discharge , numbness , feeling of heaviness or loosening of a tooth ( osteonecrosis ). contact your doctor immediately if you experience such symptoms . your doctor may decide to reduce the dose or discontinue treatment . irregular heart rhythm ( atrial fibrillation
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly .
what zoledronic acid hospira contains - the active substance is zedronic acid . one vial of zoledic acid contains 4 mg zoledron acid . - the other ingredients are : monohydrate , mannitol , sodium citrate and water for injections . what zolingronic acid hospira looks like and contents of the pack zoledidronic acidic hospira is supplied as a liquid concentrate for solution for infusion (' sterile concentrate '). each pack contains either 4 vials or four vials . the concentrate is clear and colourless to pale yellow .
varuby contains the active substance rolapitant . it is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) during cancer treatment chemotherapy . when chemotherapy is given , nerve cells in the brain start growing out of control . this can lead to vomiting . if you feel sick ( vomit ) or are sick ( being sick ) after being given varuby , these nerve cells can help to control nausea and vomiting .
do not take varuby if : you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). you are taking an herbal medicine called st john ' s wort ( hypericum performatum ). you have depression or difficulty sleeping ( see section 2 under ' warnings and precautions '). you have been taking this medicine for 27 years . you have severe liver or kidney problems . you take certain medicines containing rifampicin ( used to treat tuberculosis and other infections ) such as carbamazepine ( used for epilepsy and nerve pain ) or phenobarbital ( used
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 180 mg tablet once a day for up to 90 days . swallow the tablet whole with a glass of water . you can take varuby with or without food . take the tablet at least 2 hours before or 2 hours after your chemotherapy cycle . your doctor may change your dose depending on how you respond to chemotherapy and whether you experience sickness . if you have sickness after taking this medicine , you may be given chemotherapy at the start of another chemotherapy cycle and may be feeling sick or
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with varuby : very common side effects ( may affect more than 1 in 1 , 000 people ) symptoms of an allergic reaction may include sudden shortness of breath , swelling of the lips or tongue , change in taste or swelling of skin or tissue , sudden rash , fever and faster heartbeats . tell your doctor immediately if you experience any of these symptoms . your doctor may decide to give you appropriate treatment . other side effects include : common : may affect up to 1 in 10 people headache constipation feeling
what varuby contains - the active substance is rolapitant 90 mg . - the other ingredients are lactose monohydrate ( see section 2 under ' important information about lactose '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . - film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . - solvent : blue ( 100 mg / ml ) solution for injection in vial . - printing ink : a
what enerzair breezhaler is and what it contains - the active substances are indacaterol and glycopyrronium - mometasone febrile acetyltransferase in the form of inhaled inhaled gas . - the other ingredients are : - an inhalation called bronchodilators which relax the muscles of the small airways in the lungs . this helps to open the airways wider and allows air to get in and out of the lungs more easily and allows the air to be breathed in more easily . - another ingredient in the inhalation product is mometsone
do not take enerzair breezhaler if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you have : - heart problems - an irregular or fast heartbeat - thyroid gland problems - diabetes - high blood sugar - seizures - severe kidney problems - severe liver problems - low level of potassium in your blood - an eye problem called angle
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one inhaler twice a day . the medicine should be inhaled once a day at about the same time each day . if you use more enerzair breezhaler than you should if your asthma is getting worse , or if your symptoms get worse , contact your doctor . how to use and how long to use it your doctor will tell you how long you should use the medicine . the inhaler and capsules should be swallowed whole with a glass of water
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious . stop using enerzair breezhaler and see a doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives . these may be signs of allergic reaction . other side effects other possible side effects are listed below . the following side effects have been reported with the active substance : oral thrush ( candidiasis ). if you get thrush ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from light . the capsules should be used within one month after first opening .
what enerzair breezhaler contains - the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ) and mometasone furoate . each capsule contains 150 micrograms of the active substance , and each delivered dose is 63 microgram ( 0 . 5 millilitres ) of the other ingredients . - the following doses are available : - one inhalation contains 50 microgram of ethyl ( 3 . 0 milligrams ) of indacate , and one injection contains 160 microgram( 0 . 4 millilitre ) of momet
clopidogrel acino pharma gmbh contains the active ingredient clopridogrel which belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures , which clump together during blood clotting . by reducing the amount of this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process known as thrombolybosis ). furthermore , clopidodogrel has been shown to reduce the number of bloodclots ( thrombi ) forming in hardened blood vessels ( arteries
do not take clopidogrel acino pharma gmbh if any of the above applies to you . if you are not sure , ask your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or nurse if you : - have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain - have severe liver disease . your doctor may want to monitor you more closely if you think any of these apply to you ( or you are in any doubt at all ). if you have any further questions on the use of this product , ask the pharmacist ,
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet once a day . your doctor may increase your dose to one tablet once daily depending on your condition and on the severity of bleeding . take the tablet at the same time each day . do not chew , crush or split the tablet . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) not known ( frequency cannot be estimated from the available data ): very common : may affect up to 1 in 10 people 1 , 000 cases of rare decrease of some blood cells ( liver problems ) yellowing of the skin and the whites of the eyes ( jaundice ) bleeding mainly under the skin ( red pinpoint
store in the original blister in order to protect from moisture and light . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special temperature storage conditions . for the treatment of children and adolescents , the hospital pharmacist is responsible for the correct storage of all medicines and should not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment
what clopidogrel acino pharma gmbh contains - the active substance is clopridogrel ( 75 mg ). - the other ingredients in the tablet core are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating ( e1203 ) tablet coat ( e464 ) printing ink ( e1521 ) ink ( type a ) shellac shellac ( e904 ) cellulose ( e463 ) titanium dioxide ( e171 ) coating : shellac type a 171 what cl
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults . it is used in combination with medicines called ' antiretroviral medicines '. the active substances in delstrigo are doravirine , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), lamivudine , which itself is not known ( cannot be estimated from the available data ) as well as an analogues of nrti . tenofovir disoproxil , which is also known as a radiopharmaceutical , is also used as a nucleos
do not take delstrigo : - if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 . warnings and precautions talk to your doctor , pharmacist , or nurse before taking the following medicines : carbamazepine ( e . g . oxcarbazepine , phenobarbital , phenytoin ( medicines to prevent seizure ) rifampicin and rifapentine ( medicines used to treat tuberculosis ) st . john ' s wort ( hypericum per
always take delstrigo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is a complete regimen of one tablet a day . a single tablet should not be used to treat hiv infection . your doctor will tell you how many tablets to take and how often to take them . the recommended starting dose is 1 tablet per day . if you take certain medicines ( e . g . doravirine or any of the other ingredients of this medicine swallow the tablet whole with a glass of water . you can take this medicine with or without
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and tell your doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): abnormal dreams difficulty in sleeping ( insomnia ) headache dizziness sleepiness cough nasal symptoms feeling sick ( nausea ) diarrhoea stomach pain vomiting wind ( flatulence ) hair loss rash muscle symptoms pain ( stiffness ) feeling tired fever blood tests showing increased levels in liver enzymes uncommon ( might affect up to 1 in 100 people ): nightmares , depression , anxiety , irritability , confusion , suicidal thoughts 45 trouble
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . this medicine does not require any special storage conditions . keep the bottle tightly closed in order to protect from moisture . after first opening of the bottle , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what delstrigo contains the active substance is doravirine . each tablet contains 300 mg of lamivudine ( equivalent to 245 mg ). the other ingredients are tenofovir disoproxil ( as fumarate ), croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fidarate . a coating material containing carnauba wax e903 . the printing ink contains : - the tablet core contains : tablet core : hyprom
spravato contains the active substance esketamine . it belongs to a group of medicines called anti - depressants . this medicine helps control your depression and relieves the symptoms of depression such as feeling sad , anxious , worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities and feeling of being slowed down . spravato can be used alone or in combination with another antidepressant ( see section 2 , " antidepressant medicines ").
do not take spravato if you are allergic to esketamine , ketamine or any of the other ingredients of this medicine ( listed in section 6 ). if you have an aneurysm ( a weak spot in a blood vessel wall that bulges out ) or bleeding in the brain . if you recently had a heart attack . within 6 weeks of taking this medicine , you may experience a temporary increase in blood pressure . this can lead to serious complications in these conditions . tell your doctor immediately if you think any of these apply to you . warnings and precautions talk to your doctor , pharmacist or nurse before taking sp
always use this medicine exactly as described in this leaflet or as your doctor has told you . check with your doctor or pharmacist if you are not sure . the spravato nasal spray is for oral use . the nasal spray device is for single use only . use in children and adolescents the recommended dose is 1 spray , 2 spray devices and 3 nasal spray devices . if you have more than one spray device , use it within 4 hours of your child ' s first dose . if your child has more than 4 hours after the first dose , use the second dose as soon as possible . do not change the dose of sp
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): feeling disconnected , feelings and things around you feeling dizzy headache change in sense of taste feeling sleepy decreased feeling or sensitivity of the mouth area spinning sensation ( vertigo ) vomiting nausea common : may affect up to 1 in every 10 people : feeling extremely happy ( euphoria ), feeling agitated , feeling anxious , eyes or ears , sense of touch are deceived or mimicked , irritable panic attacks , change in
what spravato contains - the active substance is esketamine . one ml of each nasal spray device contains esketam hydrochloride equivalent to 28 mg esketa . - the other ingredients ( excipients ) are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections ( see section 2 " important information about some of the ingredients "). whatspravato looks like and contents of the pack spravatos is presented as a nasal spray solution . this medicine is a clear , colourless solution supplied in a single - use nasal spray unit . sprav
zelboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat adult patients with melanoma that has spread to other parts of the body or cannot be removed by surgery . this type of cancer is caused by a change ( mutation ) in a gene responsible for the growth and spread of melanoma . by attaching itself to proteins that are involved in the growth of your cancer .
do not use zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash and fainting sensation . if any of these apply to you , tell your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or nurse before you are given zelberaf . allergic reactions if allergic reactions occur while you are being treated , or after you have been treated , your doctor may decide to temporarily or permanently stop your treatment with
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 4 mg tablet once a day for up to 8 weeks . if you take more than 4 tablets a day , you may experience side effects . your doctor may reduce your dose or stop your treatment completely . taking zelboraf if you experience vomiting , take it as soon as you remember . do not take a double dose to make up for a forgotten tablet . take the tablet at the same time each day . you can take it with or without food . swallow the tablet whole
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions ( swelling of the face , lips or tongue , difficulty breathing rash fainting sensation ) have been reported in patients treated for radiation treatment . tell your doctor immediately if you experience any of the following symptoms : skin rash , blistering , peeling , discoloration of the skin shortness of breath , a cough , fever or chills ( pneumonitis ) difficulty or pain when swallowing , chest pain , heartburn or acid reflux ( esophagitis ) if you notice any changes in your skin .
your doctor , pharmacist or nurse knows how to store zelboraf properly . these measures will help to protect the environment .
what zelboraf contains - the active substance is vemurafenib . one tablet of each film - coated tablet contains 240 milligrams ( mpa ). each tablet also contains a co - concipitate of valsartan . - the other ingredients are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , hydroxypropyl cellulose , magnesium stearate film - coating : iron oxide ( e172 ), macrogol 3350 , polyvinyl alcohol , talc and titanium dioxide ( e171 ). what
duoplavin contains the active substance clopidogrel , which is also known as acetylsalicylic acid ( aca ). aca belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , the blood vessels relax and blood can flow freely ( a process known as atherothrombosis ). by preventing blood clots from forming in hardened arteries , you can reduce the risk of atherostrombotic events ( such as stroke , heart attack , or death ).
do not take duoplavin if you are allergic to clopidogrel , acetylsalicylic acid ( arsa ) or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to other products called non - steroidal anti - inflammatory products . if you have painful and / or inflammatory conditions of muscles or joints ( for example , a medical condition called asthma , nasal discharge , runny nose , polyps ( a type of growth in the nose ) or if you currently have a risk of bleeding such as a stomach ulcer or bleeding within the brain .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . you can take duoplavin with or without food . you should take your medicine at the same time each day . do not take more than your doctor tells you to . if you have had a heart attack , your doctor may lower your dose or temporarily stop your dose . contact your doctor , pharmacist or your nearest hospital emergency department because of the increased risk of bleeding . take the tablet pack with you and this leaflet with you so that you can
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the whites of the eyes ( jaundice ), bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an allergic reaction
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 25 . store in the original package in order to protect from moisture . this medicine does not require any special temperature storage conditions . in the unlikely event of deterioration , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
duoplavin 75 mg film - coated tablets 46 the active substances are clopidogrel and acetylsalicylic acid ( arsa 75 mg ). each 75 mg tablet contains clopridogrel ( as hydrogen sulphate ). the other ingredients are : - tablet core : hydrochloric acid , mannitol ( e421 ), macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylcellulose , maize starch , hydrogenated castor oil ( see also section 2 under ' duoplin contains hydrolysis '), stearic acid and colloidal an
the active substance of simbrinza is brinzolamide . brimonidine tartrate is a substance produced in the body that binds to receptors in the blood called alpha - 2 adrenergic receptor agonists ( α - 2 agonists ). it is used to reduce pressure within the eye in adults and children aged 18 years and older who have been previously treated for eye conditions such as glaucoma , ocular hypertension and high pressure in the eyes .
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to sulphonamides ( a group of medicines used to treat diabetes and infections ), diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitors ( medicines used in the treatment of depression or parkinson ' s disease ). if any of these apply to you , tell your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or nurse before taking sim
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . simbrinza should only be used in the eyes . do not use in your eyes unless your doctor tells you to . wash your hands thoroughly after each use ( see section 1 , 2 , 3 , 4 , 5 , 6 ). remove the cap and snap collar from the bottle . hold the medicine between your fingers . tilt your head back . pull down the eyelid with a clean finger and squeeze until there is a ' pocket ' between the eyeball and the eye .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : if you have a reaction to the medicine ( frequency not known ): signs of an allergic reaction may include severe skin reactions , rash , redness or itching all over your body , eyes trouble breathing , chest pain , irregular heart beat , tell your doctor immediately extreme tiredness or dizziness . other side effects that have been reported with simbrinza in combination with other medicines called brinzolamide or brimonidine : common side effects ( may affect up to 1 in 10 people )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . if you use more simbrinza than you should if you accidentally take too many tablets , or if someone else accidentally takes your medicine , contact your pharmacist or the nearest hospital for advice straight away . you may require medical attention if you have any further questions on the use
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . each ml of suspension contains 10 micrograms ( 0 . 5 millilitres ) of the active substance , as measured in international units ( iu ). - each vial of suspension delivers 2 milligrams ( 1 . 3 milliliter ) of each millilitre of brginidine . - the other ingredients are benzalkonium chloride ( see section 2 under ' simbinza '), propylene glycol , carbomer 974p , boric acid , mannitol , sodium
what filgrastim ratiopharm is and what it is used for the treatment of adults , adolescents and children of all ages is a combination of two active substances , called a protein ( escherichia coli ) and a natural protein ( granulocyte - colony stimulating factor [ gsf ]) produced by biotechnology in the laboratory at the end of the manufacturing process ( i . e ., it stimulates the bone marrow to produce new blood cells ). more blood cells than normal can be made from white cells . white cells are important as they help your body fight infection . if you have any questions about how filgr
do not use filgrastim ratiopharm : - if you are allergic ( hypersensitive ) to the active substance or any of the other ingredients ( listed in section 6 ). if you think any of these apply to you , tell your doctor or pharmacist as soon as possible . warnings and precautions talk to your doctor , pharmacist or nurse before use . if you have ever had a cough , fever or difficulty breathing , as these may be signs of a pulmonary disorder . possible side effects of sickle cell disease 57 if you get left upper abdominal pain or pain at the tip of your shoulder ( as this may be
filgrastim ratiopharm will be given to you by a doctor or nurse who is experienced in the care of patients who are not able to take the medicine themselves . your doctor will explain to you how to prepare and give the medicine and how long you should be given it . the dose you will receive will depend on your condition and on how well you respond to the treatment . the usual starting dose of the first course of filgrasteim ratiotopharm is : - chemotherapy of 0 . 5 mg or 60 mg per kilogram body weight once every 30 days . your treatment will last approximately 14 days .
you must not be given filgrastim ratiopharm : if you have sickle cell disease 57 if you get left upper abdominal pain or pain at the tip of your shoulder . if you suffer from a spleen disorder . see section 4 . possible side effects . your doctor will carry out regular blood tests before you are given this medicine . the number of neutrophils ( a type of white blood cells ) in your blood will depend on how well you respond to treatment . children and adolescents this medicine is not recommended for use in children or adolescents under the age of 18 years because it has not been studied in this
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the outer carton and on the blister after exp . store in a refrigerator ( 2 to 8 ). do not freeze . keep the tablet in the original package in order to protect from light and moisture . keep away from the sight and reach of children and adolescents . don ' t open the blister if it is cloudy or there are particles in it . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these
what filgrastim ratiopharm contains - the active substance is filgrasterim . each ml of concentrate for solution for infusion contains 60 million international units ( iu ). - the other ingredients ( excipients ) are water for injections ( see section 2 ) and solvent for reconstituted solution for injection ( e . g . 60 million units [ iu ]). - the solvent for dilution ( solvent for injection ) is aminotransferase ( efg ). - each pre - filled syringe of 30 micrograms contains 30 milligrams ( i . e . filgr
what riluzole zentiva is and what it is used for the active substance in the treatment of amyotrophic lateral sclerosis ( amy ) is a type of motor neurone disease in which the nerve cells in the muscles atrophy , leading to weakness , muscle waste and paralysis . amy is due to the destruction of nerve cells . in motor neuroone disease , too much glutamate ( a chemical messenger ) in the brain and spinal cord is accumulated in the blood and can lead to problems such as lack of energy or too high of a concentration of glutamate , which may lead to paralysis . this condition also results in the destruction
do not take riluzole zentiva : - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you have : - any liver disease . - increased blood levels of some enzymes of the liver called transaminases . if you think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before you are given this medicine . - signs of any liver problems such as yellowing of your skin or the whites of your eyes (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet twice a day . the tablets should be taken by mouth once a day for 12 hours . if you take more riluzole zentiva than you should contact your doctor , pharmacist or your nearest hospital emergency department straight away if you forget to take a dose . do not take a double dose to make up for a forgotten dose . take the next tablet at the usual time . if it is almost time for your next dose , skip the missed dose and take your
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever ( increase in temperature ) during treatment with riluzole zentiva . this may be due to a decrease in the number of white blood cells . your doctor will take a blood sample to check for these changes . if you notice any of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick . these may be signs of liver disease ( hepatitis ). your doctor may do regular blood tests while you are taking r
what riluzole zentiva contains - the active substance is rilusole . - the other ingredients are : tablet core : anhydrous dibasic calcium phosphate , microcrystalline cellulose ( e460i ), an hydrous colloidal silica , magnesium stearate . tablet coating : croscarmellose sodium , hypromellose , macrogol 6000 , titanium dioxide ( e171 ). not all of the ingredients in the tablet core may be present in the film - coating , but if they are , they should be clear and colourless to pale yellow . what ril
emgality contains the active substance galcanezumab . it is a medicine that blocks the activity of a protein called calcitonin gene , which is involved in migraine . increased levels of cgrp in the blood can lead to an increased risk of migraine . emgality is used to treat migraine in adults , adolescents and children aged 4 years and older . migraines have been associated with an increase in the frequency and severity of migraine headache and improve your quality of life .
do not take emgality if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious cardiovascular disease warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you think any of these apply to you . serious cardiovascular diseases can be life - threatening and can be fatal in some cases ( see section 4 . possible side effects ). children and adolescents do not give this medicine to children under the age of 18 years because it is not known if it has been studied in this age group . other medicines and emg
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg / m2 body surface ( subcutaneous injection ). your doctor will decide on the correct dose based on your age and body weight . your doctor may decide to increase or decrease the dose depending on your condition and on how well you respond to the medicine . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may include rash and itching . serious allergic reactions ( rare , may affect up to 1 in 1 , 000 people ): difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , with a red rash and raised bumps . other side effects very common side effects ( may affect more than 1 in 10 people ): injection site pain injection site reactions including red skin , itching , bruising
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . after dilution , the product may be stored at room temperature ( up to 8 ) for a maximum period of 7 days . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 30 days at 2 8 , unless dilution has
what emgality contains - the active substance is galcanezumab . one ml of each pre - filled pen contains 120 mg ( 23 mg ) of galcanesumab in 1 ml of solution . - the other ingredients are l - histidine , l- histidine hydrochloride monohydrate , polysorbate 80 , sodium chloride and water for injections . what emgonality looks like and contents of the pack emegality is presented as a solution for injection in a clear glass syringe . the solution is colourless to slightly yellow . the syringe is provided in a pack of single -
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hepatic ) in which the blood vessels in the liver become damaged and clogged with blood clots . it has been given to you by your doctor or nurse in combination with medicines you have received prior to a stem cell transplantation . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have a history of blood clots ( tissue plasminogen activator warnings ) you are taking medicine to prevent bleeding ( for example , if you have heavy bleeding after a blood transfusion or surgery ) you have problems with blood circulation or a constant blood pressure ( see section 1 ) you take other medicines to prevent blood clotting ( e . g . acetylsalicy
the treatment with defitelio will be started by a doctor who is experienced in the treatment of stem cells transplantation . it will be given by infusion into one of your veins ( known as an ' intravenous infusion ') or drip . the duration of this treatment is 21 days . if your symptoms do not improve after this 21 day period , your doctor may decide to reduce your dose . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , defitelio can cause side effects , although not everybody gets them . if any of the side effects gets serious , or if you notice any of these side effects not listed in this leaflet , tell your doctor immediately . very common ( may affect more than 1 in 10 people ) low blood pressure ( common ) may affect up to 1 in every 10 people bleeding in general bleeding including the nose bleeding in the brain bleeding from the gut vomiting in the lungs bleeding in blood in the urine and in the mouth bleeding under the skin coagulopathy ( disturbance of blood clotting ) nausea vomiting diarrhoea
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the outer carton and on the vial label after exp . this medicine does not require any special storage conditions . the infusion storage will be in accordance with local requirements . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not normally be longer than 24 hours at 2 - 8 , unless dilution has taken place in controlled and validated aseptic conditions . if you have any further questions on the use of this product
what defitelio contains - the active substance is defibrotide . each ml of 2 . 5 ml solution contains 200 mg of defibrojectide . - the other ingredients are sodium citrate dihydrate , hydrochloric acid and sodium hydroxide ( for ph - adjustment ) and water for injections ( see section 2 " important information about some of the ingredients of this medicine "). - the solvent for solution for infusion is a 10 ml clear , colourless to pale yellow concentrate .
daklinza contains the active ingredient daclatasvir . hepatitis c is an infectious disease that affects the liver caused by the hepatitis c virus . this medicine is used to treat adults with hepatitis c . it is used when the body is not able to fight the virus in its own cells . it can also be used when other medicines have not worked well enough to control hepatitis c infection . your doctor will check whether the virus is in your blood and will tell you if you need to take other medicines . if you have any further questions on the use of this medicine , ask your doctor or pharmacist .
do not take daklinza : if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) if you have taken by mouth the following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital ( used to prevent epileptic seizures ) rifampicin , rifabutin and rifapentine ( antibiotics to treat tuberculosis ) dexamethasone ( a steroid used to treat allergic and inflammatory diseases ) medicines containing st . john ' s wort ( hypericum perforatum
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of daklinza is one 60 mg tablet once a day . do not chew , crush or chew the tablet as this may have an unpleasant taste . your doctor will tell you how many tablets to take . how to take some other medicines your doctor may tell you to take if you need to take a different dose . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . how long to continue taking dak
like all medicines , this medicine can cause side effects , although not everybody gets them . when daklinza is used in combination with sofosbuvir or ribavirin , the following side effects have been reported : very common ( may affect more than 1 in 10 people ): headache fatigue common : may affect up to 1 in every 10 people : difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles have also been reported in patients treated with either of the two active substances , when either of them was given alone , when both of them were given together with so
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains either 30 mg or 60 mg ( as dihydrochloride ). - the other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), macrogol 400 , indigo carmine aluminum lake ( e132 ) and yellow iron oxide ( e172 ) ( see section 51 for further information on some of the ingredients of d
proquad is a vaccine to protect against measles , mumps , rubella and chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce its own protection ( antibodies ) against the diseases that cause them . in adults , the protection against mumps and rubella is made up of two different types , called varicelluses . the antibodies help protect against diseases caused by these viruses . how proquad works proquad is given to adults , adolescents and children aged 9 years and older who have received national vaccination schedules containing measles
do not receive proquad if you are allergic to any varicella vaccine , measles , mumps , rubella vaccine or any of the other ingredients of this vaccine ( listed in section 6 ) if you have a blood disorder ( a type of cancer that affects the immune system ) if treatment with medications that suppress your immune system ( e . g . low - dose corticosteroid therapy , asthma or replacement therapy ) if your child has a weakened immune system due to a disease ( including aids ), congenital or hereditary immunodeficiency ( immune competence ), active untreated tuberculosis ( fever of 38 . 5 or low -
proquad is given as an injection into a muscle ( subcutaneously ) under the skin ( usually in the thigh or upper arm ). injections will be given into the muscle of the thigh area or into the upper arm . if you have a blood clotting disorder with low levels of platelets , the vaccine should not be given . if any of the above apply to you ( or you are not sure ), talk to your doctor , pharmacist or nurse before you are given proquad . injecting into the skin will reduce the risk of bleeding . proquad is injected into a blood vessel ( intravenously ). proquad can be given
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions ( hives ) these reactions may cause difficulty in breathing or swallowing . if you experience signs of an allergic reaction , contact your doctor immediately . other side effects that have been reported with proquad include : very common ( may affect more than 1 in 100 people ): seizures with a fever rare ( likely to affect up to 1 in 1 , 000 people ): bronchiolitis ( difficulty breathing , cough , unsteadiness with walking ) other possible side effects of proquad are listed below . very common : may affect less than
what proquad contains - the active substances are : measles virus1 , edmonston strain , 3 . 00 mg mumps virus1 ( jeryllynn™ level b ) strain , 4 . 30 mg rubella virus2 , strain 3 .00 mg varicella virus3 , and merck strain ( 3 . 99 mg mrc ). - the other ingredients are : powder sucrose , hydrolysed gelatin , urea , sodium chloride , sorbitol ( e420 ), monosodium glutamate , sodium phosphate , sodium bicarbonate , potassium phosphate , potassium chloride 199 and hanks ' salts ( mem ,
jylamvo is an anticancer medicine used to prevent unwanted reactions . it is an immunosuppressive agent . it acts on the body ' s own immune system ( the immune system ) and neutralizes its own inflammatory activity . it can be used in rheumatic and skin diseases such as active rheumatoid arthritis , polyarthritic forms of joints , severe juvenile idiopathic arthritis ( jia ) and in children 3 years of age and older . it may be used alone or in combination with non - steroidal anti - inflammatory drugs ( nsaids ) to treat inadequate o severe and disabling ps
do not use jylamvo if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe kidney impairment or a liver impairment . if you suffer from blood disorders ( e . g . bone marrow hypoplasia , leukopenia , thrombocytopenia , significant anaemia ). if 34 you have or have ever had a weakened immune system , a serious infection such as tuberculosis , hiv , ulcers in the stomach or intestines , an inflammation of the mucous membrane of the mouth or mouth ulcers . if
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . jylamvo can cause severe side effects , sometimes leading to even death . the treatment should be initiated under the supervision of a physician experienced in the care of patients with rheumatoid arthritis , severe juvenile idiopathic arthritis and severe psoriasis . if you have severe psoriatic arthritis , your doctor may decide to give you a lower dose , or to discontinue the treatment altogether . use in rheumatic and skin diseases such as jia , ps
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash and itching all over your whole body . other possible side effects include breathing problems , feeling of illness , dry , irritating cough , shortness of breath , difficulty or breathing , chest pain ( fever ), spitting or coughing blood , serious peeling or blistering of the skin unusual bleeding ( vomiting blood ), bruising nose bleeds nausea , vomiting , abdominal discomfort severe diarrhoea mouth ulcers , black or tarry
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the carton and on the vial label after exp . store below 25 . store in the original package in order to protect from light . the medicine should be used immediately after dilution . accidental spillage may occur within 3 hours . any unused medicine or waste material should be disposed of in accordance with local requirements for cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotexate . - the other ingredients are macrogol ( equivalent to 400 mg ), glycerol , orange flavour , sucralose , ethyl parahydroxybenzoate ( e218 ), sodium methyl parahydroxybenzene ( e219 ), citric acid , tri - sodium citrate , purified water for injections ( see section 2 " important information about some of the ingredients ") and sodium chloride ( e172 ) ( e433 ) ( see also section " jy
this medicine contains the active substance glycopyrronium bromide , which belongs to a group of medicines called bronchodilators . this medicine is used to treat breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd , the muscles around the airways tighten , making breathing difficult . using this medicine helps to stop this tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . your doctor has prescribed this medicine to help reduce the effects of copd on your everyday life .
do not use enurev breezhaler if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). if you suffer from kidney problems . if you have an eye problem called narrow - angle glaucoma ( difficulty passing urine ). if any of these apply to you ( or you are not sure ), talk to your doctor or pharmacist before using this medicine . tell your doctor immediately if you experience tightness of the chest , coughing , wheezing or breathlessness . these may be signs of bronchospasm ( difficulties in breathing
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose is one inhalation once a day . this medicine should be used within 24 hours of your last dose . your doctor may increase your dose to 75 inhalations per day depending on how you respond to this medicine . using this medicine in combination with an inhaler and capsules ( in blisters ), you can inhale the medicine using inhalation powder . the capsules should be swallowed whole with a glass of water . do not chew or break the capsules
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious ( may affect up to 1 in 100 people ) irregular heart beat high level of blood sugar ( hyperglycaemia ) typical symptoms are excessive thirst or hunger ( frequent urination ) rash , itching , hives , difficulty breathing or swallowing dizziness allergic reaction swelling mainly of the tongue , lips , face or throat ( angioedema ) if any of the side effects gets serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or pharmacist . the frequency of
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each hard capsule contains 63 million international units ( iu ). - the other ingredients in the inhalation powder are lactose monohydrate and magnesium stearate . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is 44 micrograms ( 23 . 5 milligrams ) per kilogram of body weight each day . - the excipients in the powder are glucose and water for injections ( see section 2 ). - in the solvent in the inhaled inhaler , the active
riximyo contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a specific target in a certain type of white blood cell called " b - lymphocyte ". by sticking to the target of the protein , riximyo slows down the rate of growth and decreases the duration of the treatment . your doctor will tell you what you need to know before you are given this medicine . if you are not sure , talk to your doctor , pharmacist or nurse . warnings and precautions you must tell your doctor or nurse before being given rix
do not use riximyo if you are allergic to rituximab , other proteins , or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection at the moment ( e . g ., a weak immune system ), severe heart failure , severe uncontrolled heart disease ( granulomatosis , polyangiitis , microscopic polyangaiitis or pemphigus vulgaris ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given any of these medicines : if you currently have or have previously had hepatitis b . if you
your treatment with riximyo will be overseen by a doctor who is experienced in the use of this treatment . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you experience any side effects , talk to your doctor , pharmacist or nurse before you are given this medicine . your doctor will decide how many treatments you need and will prescribe you other medicines ( premedication ) to help reduce the risk of side effects . the duration of your treatment with non - hodgkin ' s lymphoma your doctor may decide to give you rix
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion , fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of platelets
what riximyo contains - the active substance is rituximab . each vial of 10 ml contains 100 mg of ritudimab ( 10 mg / ml ). each ml of solution contains either 50 mg or 500 mg ( 300 mg ( 500 mg ) ritukimab in 10 ml ). - the other ingredients are sodium citrate , polysorbate 80 , sodium chloride , sodium hydroxide , hydrochloric acid ( see section 2 for further information on some of the ingredients of this medicine ). colourless to slightly yellowish solution for infusion . pack sizes of 2 , 3 ,
the active substance topotecan actavis is a medicine that contains the active substance tacrolimus . it is used to treat adults with the following conditions : - small cell lung cancer that has come back after chemotherapy - advanced cervical cancer that cannot be treated with surgery or radiotherapy . in this case topetecan actedavis treatment is given alone or in combination with medicines called cisplatin .
do not take topotecan actavis : - if you are allergic to topoteecan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . your doctor may check your blood cell counts if they are too low . if any of these apply to you ( or you are not sure ), tell your doctor . children and adolescents do not give this medicine to children under the age of 18 years because it is not known if this medicine is safe and effective in this age group . if you have any kidney problems , tell
always use topotecan actavis exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will determine the severity of the disease and will carry out blood tests before you start treatment . the recommended dose of treatment for adults small cell lung cancer is 1 . 5 mg per square metre of body surface area for the first 5 days of this treatment cycle . for cervical cancer , your doctor may prescribe a lower dose ( i . e . 0 . 75 mg / m2 of bodysurface area ) every 3 days . the doctor will also monitor your kidney function during this treatment
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects stop taking topotecan actavis and tell your doctor straight away if you notice any of the following serious effects : infections : very common ( may affect more than 1 in 10 people ): fever . your general condition may include local symptoms such as sore throat , burning sensation , severe stomach pain , fever , diarrhoea and bowel inflammation ( neutropenic colitis ). your doctor may need to reduce or stop your dose of the active substance in order to maintain your ability to fight infections . lung inflammation : very rare ( may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . the drug product solution should be used immediately after reconstitution and dilution chemical and physical in - use stability has been demonstrated for 24 hours at 25 micrograms / ml ( corresponding to 2 hours dilution ) and for 2 hours from 2 to 8 hours at refrigerated temperature ( 20 - 25 ) and at room temperature ( 25 - 25 ). if not used immediately
what topotecan actavis contains - the active substance is topofecan . each 1 ml ampoule contains 4 mg of topotan ( as hydrochloride ). after reconstitution with 1 ml of water for injection , 1 ml ( 0 . 5 %) of the solution is clear and colourless . - the other ingredients ( excipients ) are mannitol ( e421 ), tartaric acid , hydrochloric acid and sodium hydroxide ( see end of section 2 for further information on some of the ingredients in this medicine ). what topotecaan effectavis looks like and
the active substance in this medicine is rivastigmine hexal , which belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson ' s disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivaldigmine works by blocking two of the enzymes that break down some of these substances : acetylchloroline , and butyrylcholsterase . by blocking both of these enzymes , r
do not take rivastigmine hexal : - if you are allergic to rivetigmine or any of the other ingredients of this medicine ( listed in section 6 ). if you have had a previous skin reaction ( allergic contact dermatitis ). warnings and precautions talk to your doctor , pharmacist , or nurse before you are given the medicine . if you think any of these apply to you ( or you are not sure ), ask your doctor or pharmacist for advice before being given the product . you may also be more at risk of developing allergiccontact dermatitis ( see also section 4 ). if this applies to you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . your doctor may increase your dose depending on how you respond to treatment . the highest dose that should be taken is 6 . 0 mg per kilogram of body weight each day . you should continue taking this medicine until your doctor tells you otherwise . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking rivastigmine hexal and see a doctor straight away if you notice any of the following serious side effects : very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ) diarrhoea common : may affect up to 1 in every 10 people anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling or feeling confused decreased appetite nightmares uncommon : may effect up to one in every
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and on the blister after exp . store below 30 . store in the original package in order to protect from moisture .
what rivastigmine hexal contains 64 - the active substance is rivetigmine hydrogen tartrate . - the other ingredients are : capsule content : hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ), titanium dioxide ( e171 ) and shellac ( e1521 ). - each rivasta hexal 1 . 5 mg film - coated tablet is engraved with the code " ri1 " on one side and the number " 4 . 5 " on the other . -
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used to treat adult patients with kidney cancer , renal cell carcinoma or liver cancer who have previously been treated with a specific anticancer medicine containing sorafenib . cabometyx has been shown to increase the activity of proteins called receptor tyrosine kinases ( rtyks ), which are involved in the formation of new blood vessels . by binding to these proteins , the medicine can increase the number of high amounts in cancer cells that can be grown and given to you . if you have any questions about how cabomet
do not take cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking cabomety 45 if you : - have high blood pressure - have or have had an aneurysm ( enlargement or weakening of a blood vessel wall ) - have a tear in or around a blood valve wall - have diarrhoea - have recently had significant bleeding - had surgery within the last month - have had surgical procedures or dental surgery - have inflammatory bowel disease - have
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . this medicine is for oral use . swallow the tablet whole with a glass of water . you can take cabometyx with or without food . your doctor may increase your dose depending on your response to your treatment and on whether you experience serious side effects . duration of treatment your doctor will tell you how long you should continue to take cabometyx . the usual starting dose is 60 mg each day . if you take more cabometx than you should
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with cabometyx and other medicines used to treat your side effects : tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : symptoms include pain in the abdomen ( nausea and feeling sick ), vomiting , constipation and fever . these may be signs of a gastrointestinal perforation ( a hole in the stomach or intestine ). severe or uncontrollable bleeding . symptoms include vomiting blood , black stolls , bloody urine , headache , coughing up blood , swelling , pain in
what cabometyx contains - the active substances are cabozantinib ( s ) and malate . each tablet contains either 20 mg / m2 of the active substance in one tablet , or 20 mg of the other active substances in two tablets , each with a scoreline of 20 on one side and an interval of 30 on the other side . - cabostyx is available as two 40 mg / ms tablets , and as two 60 mg / s tablets , respectively . - the other ingredients in the tablet core are called " capsule content " ( see section 2 ), microcrystalline cellulose , lactose an
pemetrexed hospira is a medicine used in the treatment of cancer . it is given in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . pemetrexED hospira will be given to you on its own . your doctor will decide on the appropriate dose for you . if you are not sure , talk to your doctor , pharmacist or nurse before you are given the initial treatment . for patients with advanced stage of lung cancer pemet
do not use pemetrexed hospira : - if you are allergic ( hypersensitive ) to any of the active substances in this medicine ( listed in section 6 ) or to peanut or soya ( see section " pregnancy , breast - feeding and fertility "). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . children and adolescents do not give this medicine to children under 6 years of age because it has not been studied in this age group . your doctor will discuss this with you and will advise you on the best way to prevent or reduce the development of yellow fever during treatment with
always use pemetrexed hospira exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 500 mg based on your body ' s surface area . your height and weight are measured to work out the surface area of your body . your doctor will adjust this body surface area depending on your response to treatment and on your blood cell counts . if necessary , your doctor may also change the dose or frequency of administration . the doctor or hospital pharmacist will also check your vial and / or the amount of sodium chloride solution you receive before you are given pemet
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following : - fever or signs of infection ( with a temperature of 38ºc or greater ). - sweating . this may be a sign of infection . - you have less white blood cells than normal , which may increase your risk for infection ( sepsis ). this may lead to death . - chest pain with a fast heart rate . - pain , redness , swelling or sores in your mouth . - allergic reaction ( including skin rash , burning , prickling sensation and fever ).
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . this medicine does not require any special storage conditions . reconstituted and infusion solution : the product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2ºc - 8ºc unless dilution has taken place in controlled and validated aseptic conditions . in the case of parenteral
what pemetrexed hospira contains - the active substance is pemetreepentahydrate . one vial contains 100 milligrams ( millilitres ) of pemphrexed ( as pemetereed disodium hemipentahhydrate ). one ml ( 0 . 5 ml ) of solution for infusion contains 500 milligram ( milliliter ). one ampoule ( 1 . 000 iu ) of powder for concentrate for solution for injection contains 1 , 000 international units ( iu ). - the other ingredient ( s ) ( excipients ) ( e . g . p
the active substances of ganfort are bimatoprost and timolol . they work together to reduce pressure in the eye . bimAToprost belongs to a group of medicines called prostamides . it works by interfering with a prostaglandin analogue ( analogue ) that is used in the treatment of glaucoma .
do not use ganfort eye drops : if you are allergic to bimatoprost , timolol , beta - blockers or any of the other ingredients of this medicine ( listed in section 6 ) if you have respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease ( signs include wheeziness , difficulty in breathing , and long - standing cough ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you suffer from coronary heart disease ( symptoms include chest pain , tightness , breathlessness , choking ), heart failure , low blood pressure 44 if you experience disturbances
always use ganfort exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop in the eye once a day . treatment should be started at the same time each day . keep the bottle tightly closed in order to protect from moisture . do not put the bottle close to your neck . 5 . gently squeeze the bottle . 1 . wash your hands . tilt your head back . 2 . pull down your eyelid . this will open a small pocket . 3 . put your eye back in place after treatment . 4 . close the lid of your eye .
like all medicines , ganfort can cause side effects , although not everybody gets them . stop using the drops and see a doctor straight away if you notice any of the following serious side effects after using a single dose ( multi - dose or single - dose ). very common side effects ( may affect more than 1 in 10 people ) - the eye redness . - the following side effects have been reported since the launch of the product : very common ( affects less than 1 user in 10 ) - sensitivity to light , eye pain , sticky eyes , dry eyes , feeling of something in the eye , small breaks in the surface of
keep this medicine out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . if you notice that the solution is discoloured , it should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 4 hours at 2 to 8 , unless dilution has taken place in controlled and
what ganfort contains - the active substance is bimatoprost in 0 . 3 ml of solution . - the other ingredients are timolol 5 mg / ml ( corresponding to a nominal dose ) of 2 . 5 micrograms ( equivalent to 6 . 8 microgram ) of benzalkonium chloride ( a preservative ) - the ingredients are sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate , purified water , hydrochloric acid and sodium hydroxide - the colour of the solution is clear to slightly yellow and colourless to pale yellow . what
gefitinib mylan contains the active substance gefitinib . it works by inhibiting the activity of a protein called epidermal growth factor receptor ( egfr ). this protein is involved in the growth and spread of cancer cells and is present in large amounts in patients with advanced stage of non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan - if you are allergic to gefitoninib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before you take this medicine if you : - have or have had any other lung problems . some lung problems can be serious and need immediate medical attention . your doctor may want to monitor you more closely while you are you are taking this medicine . - have had problems with your liver . if you think any of these apply to you , tell your doctor or pharmacist before taking gef
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 250 mg antacids taken once a day on an empty stomach ( see section 2 , " gefitinib mylan contains lactose "). if you have trouble swallowing the tablets , you can take them with or without food . do not split , crush or split the tablets . if you take any other liquids , take them at least 20 minutes before or at the same time each day . you should swallow the tablets whole with a glass of water . if necessary , g
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives , nettle rash , difficulty breathing , serious breathlessness , sudden worsening breathlessness with a cough or fever . these may be signs of an inflammation of the lungs called ' interstitial lung disease ' ( i . e . uncommon , may affect up to 1 in 100 people ). gefitinib may cause severe skin reactions
what gefitinib mylan contains - each film - coated tablet contains 250 mg of gefinib . - the other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose ( e460 ), crospovidone ( type a ) ( type k30 ), sodium laurilsulfate , magnesium stearate . tablet coating : polyvinyl alcohol ( e1203 ), macrogol 4000 , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide red ( e 172 ). what gefitoninib melan looks like and contents of
the active substance of reblozyl is luspatercept . it is used to treat myelodysplastic syndromes ( mds ). mds is a group of many different blood and bone marrow disorders in which red blood cells become abnormal . signs and symptoms include a low red blood cell count ( anaemia ) which cannot be controlled with the use of red blood blood cell transfusions . your doctor or nurse will give this medicine to you in a hospital or clinic under the supervision of a doctor who is experienced in the treatment of mds . it can be given either alone or in combination with red blood
do not take reblozyl if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant or are planning to have a pregnancy , ask your doctor for advice before taking this medicine . if you have thalassaemia ( a condition where the spleen removed ) or have had a blood clot during hormone replacement therapy or after a previous blood clot . if any of these apply to you , tell your doctor . preventive measures should be taken by your doctor while taking medicines to prevent or reduce the risk of a blood clot .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will carry out blood tests before and during your treatment with reblozyl . the recommended dose is one injection under the skin ( subcutaneously ). the injections should be given in a maximum of 1 . 0 ml per kg of body weight . this dose will be adjusted by your doctor depending on your blood pressure . use in children and adolescents use in adults with myelodysplastic syndromes the maximum single dose ( 1 . 75 ml ) per kg body weight should not be
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects : difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , and blurred vision . these may be symptoms of a stroke . blood clots swelling in the area around the eyes , face , lips , mouth or tongue throat allergic reactions ( rashes ) 36 reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . store in a refrigerator ( 2 8 ). store in the original package in order to protect from light . after reconstitution , reblozyl may be stored at room temperature ( up to 8 ) for up to 24 hours at 2 8 . any unused medicinal product or waste material should be disposed of in accordance with local requirements .
what reblozyl contains - the active substance is luspatercept . each ml of solution contains either 25 mg or 75 mg ( 10 mg / ml ) luspaterscept . after reconstitution , each mlof solution contains 50 mg ( 25 mg ) of luspatecept . - the other ingredients are excipients , citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( to adjust ph adjustment ). see section 2 under " important information about some of the ingredients of the reconstituted solution ". what re
fotivda contains the active substance tivozanib . it is a protein kinase inhibitor . it works by inhibiting the activity of a protein called alpha or interleukin - 2 , which is involved in the development of your disease .
do not take fotivda if : you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). you are taking st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine : if you have high blood pressure . your doctor will check your blood pressure regularly while you are being treated with a medicine . if you think any of these apply to you , tell your doctor or pharmacist . before you start taking fot
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of fotivda is 1340 mg twice a day ( 21 mg and 7 mg ) taken as 1 capsule in the morning and 2 capsules in the evening ( 4 mg ). your doctor will tell you how many capsules to take each day . if you take too many capsules , contact your doctor as soon as possible . do not take more capsules than your doctor tells you to . you may experience unacceptable side effects . if severe side effects occur , stop taking fot
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure is a very common side effect ( may affect more than 1 in 10 people ). tell your doctor immediately if you experience any of the following symptoms : severe headaches , blurred vision , shortness of breath , changes in your mental state ( e . g . feeling anxious , confused or disorientated ). your doctor may want to monitor your blood pressure more closely while you are taking fotivda . you may need to stop taking this medicine for a short time , or stop taking it altogether . if your high blood
what fotivda contains - the active substance is tivozanib . each tablet contains 890 micrograms ( 10 milligrams ) of the other ingredients ( listed in section 6 ). - the other ingredient ( s ) are : capsule contents : gelatin , titanium dioxide ( e171 ), indigo carmine ( e132 ), yellow iron oxide ( e172 ) and propylene glycol ( for strong ammonia solution ). capsule shell : titanium dioxide , tartrazine aluminium lake ( e129 ) and shellac . printing ink : shellac , printing ink ( shellac ), printing ink of the ingredients ( s
stribild contains two active substances : elvitegravir ( an antiretroviral medicine known as an integrase inhibitor cobicistat , which is a booster ( pharmacokinetic enhancer ) of the activity of the immune system ( the body ' s natural defence system ) of each of the active substances in stribild . each of these active substances is given as an injection into a vein . the other active substances are : tenofovir disoproxil ( an antiviral medicine also known as a nucleotide reverse transcriptase inhibitor ). each of them is given in combination with strib
do not take stribild : - if you are allergic to elvitegravir , cobicistat , emtricitabine , tenofovir , ten ofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 of this leaflet ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . during treatment , your doctor may change the dose of any medicine that you take to increase the amount and frequency of tenofovexil . this will depend on your kidney function and whether you are taking any of these medicines
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents 12 to less than 18 years of age 35 the recommended dose is one tablet taken by mouth once a day . swallow the tablet whole with a glass of water . you can take your medicine with or without food . your doctor may change the dose or interrupt the treatment with medicines such as oral supplements , antacids or laxatives containing minerals ( e . g . magnesium , aluminium , calcium , iron , zinc ). see section 4 for further information . if you take more stribild
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether the unwanted effects of stribild are caused by the disease itself or by other factors . serious side effects tell your doctor immediately if you notice any of the following : lactic acidosis (
what stribild contains - the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each tablet contains 150 micrograms of the two active substances ( as mesilate ). - the other ingredients ( excipients ) in each tablet are : tablet core ( e460b ): elvitesgravira 150 mbqcqt tablet ( e464b ): cobicistsat 200 mmbqt tablets ( e463b ): Emtricitonabine 245 milligrams of tenof
zyprexa contains the active substance olanzapine . zyprexa belongs to a group of medicines called antipsychotics and is used to treat schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , a condition with symptoms of excitement or euphoria , have been reported in patients taking zyprixa . however , there has been no recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to o
do not take zyprexa if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include a rash , itching , a swollen face , swollen lips and shortness of breath . if you have eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). if any of these apply to you , tell your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or nurse before taking zyprixa : if you suffer from dementia . serious side effects can
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose of zyprexa tablets is one tablet a day . your doctor may increase your dose to between 5 and 20 mg once a day depending on your symptoms . swallow the tablet whole with a glass of water . do not chew or crush the tablet . you can take your tablets with or without food . it is important that you take the tablets at the same time each day to help you remember to take them . you should swallow the tablets whole with some water . if you take more z
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue . this may be a sign of blood clots in the veins . this side effect is likely to occur uncommonly ( affects 1 in 100 people ) in the legs . symptoms include swelling , pain , and redness in the leg which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if you notice any of these symptoms seek medical advice immediately . fever ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . zyprexa will be stored by the health professionals at the hospital or clinic . these measures will help to protect the environment .
what zyprexa contains - the active substance is olanzapine . one tablet contains 2 . 5 mg or 5 mg . - the other ingredients are : tablet core : tablet dimension : 7 . 5 mm , 10 mm , 15 mm , 20 mm . - tablet coating : tablet shell : lactose monohydrate , hyprolose , crospovidone , microcrystalline cellulose , magnesium stearate . - printing ink : hypromellose , titanium dioxide ( e171 ), carnauba wax , ink : shellac , macrogol , propylene glycol , polys
what prolia is prolia contains the active substance denosumab . it is a protein ( monoclonal antibody ) that attaches to a specific target in the body . attaching to another protein is thought to play an important role in preventing bone loss in adult patients with osteoporosis . treatment with prolia helps to make bone stronger . it helps to reduce the amount of oestrogen in the bone . this helps to prevent bones from becoming thin and fragile , especially in women after the menopause . if your body does not respond to treatment with glucocorticoids , it may not be able to
do not use prolia : if you have low calcium levels in the blood ( hypocalcaemia ) if you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using prolia if : you have a skin infection with symptoms such as a swollen , red area of skin on one side of your leg that feels hot and tender ( cellulitis ) you have symptoms of fever . these symptoms may be due to an allergy to latex . the needle in the pre - filled syringe contains a derivative of latex
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one pre - filled syringe of 60 ml given every 6 weeks as a single injection under the skin ( subcutaneous ) in the front of your thighs , abdomen or upper arm . you can inject prolia with or without stickers . your doctor will tell you if you need calcium and vitamin d supplements . if you have any further questions on the use of this product , ask your doctor . how to use prolia if you use more prolia than you
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking prolia and see a doctor straight away if you notice any of the following skin infections ( cellulitis ). these symptoms may be due to prolia : swollen , red area of skin , usually in the leg , which feels hot and tender , with or without symptoms such as fever . prolia may cause pain in the mouth and / or jaw , swelling or non - healing of sores in the jaw , discharge , numbness , feeling of heaviness or loosening of a tooth . these may be signs of bone damage in the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the label of your pre - filled syringe after exp . store in a refrigerator ( 2 8 ). do not freeze . you may remove prolia from the refrigerator and keep it at room temperature ( not above 25 ) for a single period of up to three months . after the injection , the product may be stored either below 25 or up to 30 days at 2 - 8 , but do not throw away any medicines via wastewater or household waste . ask your pharmacist how
what prolia contains - the active substance is denosumab . each vial contains 1 ml of solution for injection ( equivalent to 60 mg / ml ). - the other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prolia looks like and contents of the pack prolia is a clear , colourless to slightly yellow solution in a pre - filled syringe with a needle guard . not all pack sizes may be marketed .
aimirix is a vaccine for use in adults and adolescents from 1 to 15 years of age . it is used to treat two diseases : hepatitis a and hepatitis b infection . the hepatitis a virus is found in the liver , which is swollen and inflamed by the virus . the virus can also be found in faeces , serum or saliva . symptoms usually occur within 3 to 6 weeks of infection . if you feel sick , have a fever , aches and pains , feel very tired , dark urine , palefaeces or yellowish skin or eyes ( jaundice ). the severity and type of symptoms can vary
you must not be given ambirix - if you are allergic to the active substance or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath , and swelling of your face or tongue . if you have been previously vaccinated with any vaccine for hepatitis a or hepatitis b diseases you have a severe infection with a high temperature . the vaccine should be given at the same time as a minor infection such as a cold . warnings and precautions talk to your doctor , pharmacist or nurse before you or your caregiver are given Ambirix .
always use ambirix exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one injection ( injection into the muscle of the upper arm ). your doctor will tell you how many injections you need . the injection will usually be given into the thigh muscle . your doctor may give you a total of two injections . the injections should be given within 12 months of the first injection . the second injection may be given between 6 and 12 months after the first . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . other side effects reported in clinical trials with ambirix were : common ( may affect up to 1 in 10 people ): headache loss of appetite feeling tired irritable pain or redness where the injection
what ambirix contains 26 the active substance is hepatitis a virus . each 1 ml pre - filled syringe contains 720 micrograms of elisa units . the other ingredients are : hepatitis b surface antigen ( mrc ), human diploid , mrc , cells , aluminium hydroxide ( hydrated in 0 . 05 ml ), saccharomyces cerevisiae , aluminium phosphate ( 0 . 4 ml ), sodium chloride , and water for injections . what Ambirix looks like and contents of the pack suspension for injection is a white , slightly milky liquid , supplied in a glass vial containing 1 ml of
besero is a meningococcal group b vaccine . bexsero is given to adults , adolescents and children from 2 years of age with disease caused by the neisseria meningitidis group b bacteria . these bacteria help to prevent infections ( such as meningitis , inflammation of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine works by helping to prevent the disease from returning .
do not use bexsero - if you are allergic to the active substance or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are vaccinated . if you have a severe infection with a high temperature ( over 38 ). if this applies to you , vaccination should be postponed until you have recovered from a minor infection such as a cold . if any of these apply to you ( or you are not sure ), your doctor may postpone the vaccination until you return to your regular dosing schedule . tell your doctor if you suffer from haemoph
always use bexsero exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 5 mg injection into the muscle of the thigh or upper arm . the first two injections should be given at least 2 months apart . the interval between injections should not exceed 1 month . if you have the impression that the effect of the vaccine is too strong or too weak , talk to your doctor . your doctor may give you an additional injection ( booster ) at the end of the first injection ( see section 2 ). if you do not respond well enough to the second injection
like all vaccines , this vaccine can cause side effects , although not everybody gets them . stop using bexsero and tell your doctor straight away if you notice any of the following serious side effects : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the site of injection , swelling of theskin at the area of injection site hardness at the place of injection injection site the following side effects have been reported with this vaccine : common : may affect up to 1 in every 10 people : fever , loss of appetite , and / or pain or tender
what bexsero contains - the active substances are recombinant neisseria meningitidis group b nhba fusion protein ( 1 , 2 , 3 , 50 micrograms ) and recombinant neuraminidase ( bnhba ). - the other ingredients are group b fungal ( e . coli ) and group b nasopharyngitis type 1 and 2 . each vial contains 3 g of reconstituted antigen ( nhbfhbp ). the vials are made up of : - outer membrane vials containing : - omv ( e._ coli ) - neiss
nytinone mdk contains the active substance nitisinone . this medicine is used to treat a rare disease called hereditary tyrosinemia ( hty ) in adults , adolescents and children aged 1 year and above . in this disease your body does not produce enough of the amino acid tyrosine ( amino acids are substances that are naturally present in the body ) as a result of the harmful substances in this medicine . by reducing the amount of tyrorosine in your body , it helps to lower the levels of some of the detrimental substances in the blood . your doctor has prescribed this medicine to reduce the amount
do not take nitisinone mdk - if you are allergic to any of the active substances in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . pregnancy , breast - feeding and fertility you must tell your doctor if you think you may be pregnant or are planning to have a baby . your doctor may ask you to have an eye examination while you are being treated . if you have been told by your doctor that you have eye problems due to inadequate dietary control ( see section 4 for more information ). during the treatment , your doctor will take blood samples
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment with this medicine will be started by a doctor who is experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended starting dose is 1 mg for every kg of body weight . this dose may be increased to 20 mg for this patient population . swallow the capsules whole with a small amount of water or formula diet . if you take more nitisinone mdk than you should if you accidentally take too many capsules , talk to a doctor or go to the nearest hospital
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). store in the original package in order to protect from light . from a microbiological point of view , the product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 2 hours at a temperature not above 25 .
what nitisinone mdk contains - the active substance is nisinone . each hard capsule contains either one or two active substances . - the other active substances are : ( see section 2 under ' information about some of the ingredients '). - the hard capsules come in different strengths ( e . g . 2 mg , 5 mg and 10 mg ). - the three active substances in each capsule also come in separate strengths ( i . e ., 3 mg , 10 mg and 20 mg ). the other ingredients are : - gelatin , titanium dioxide ( e171 ), black iron oxide ( e172 ) and shellac gl
docetaxel accord will be given to you by a doctor or nurse under the supervision of a doctor who is experienced in the use of anti - cancer medicines ( such as taxoids ). your doctor will decide on the most appropriate dose for you . the name of the medicine is debossed on the outer carton and the vial with the company symbol and the number of letters printed on the label and the carton in order to maintain a link between the tablets and the tablets . the type of breast cancer you have is defined as : - breast cancer , non - small cell lung cancer , prostate cancer , gastric
do not use docetaxel accord : - if you are allergic ( hypersensitive ) to any of the active substances ( listed in section 6 ) or to white blood cells if you have a severe liver disease . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . you may need to have blood tests to check that you have enough blood cells and that your liver is working properly . your doctor may decide to reduce or discontinue the use of this medicine if you think you may be suffering from any of these conditions . you should tell your doctor immediately if you experience : - white blood
docetaxel accord will be given to you by a doctor or nurse . the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m² ) and will determine the dose you should receive . method and route of administration dexamethasone accord is given as an infusion into one of your veins . the infusion will last approximately one hour . frequency of administration you will usually have your infusion once every 3 weeks . based on the results of your blood tests , your doctor may decide to change the dose or frequency of dosing , depending on the severity of your
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the following adverse reactions have been reported with docetaxel accord : decrease in the number of red blood cells and white blood cells ( alopecia ), nausea , vomiting , sores in the mouth , diarrhoea and tiredness . the frequency of adverse events listed below has not been estimated from the available data . if you have any of these , talk to your doctor , pharmacist or nurse before you are given this medicine . doc
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the container in the outer carton in order to protect from light . after dilution of the medicine , the infusion bag should be used within 6 hours ( up to 25 hours ) prior to infusion . the infusion solution should be stored in non - pvc bags for 48 hours ( 2 to 8 ). if not used immediately , in - use storage times and conditions prior
what docetaxel accord contains - the active substance is docepaxel . each ml of concentrate for solution for infusion contains 20 mg of docepel . one vial of 1 ml concentrate delivers 20 mg docephalon . the other ingredients are polysorbate 80 , ethanol anhydrous and water for injections ( see section 2 for further information on some of the ingredients of this medicine ). - the other ingredient in the concentrate is propylene glycol ( e1520 ). each 8 ml ampoule of concentrate contains 160 mg ( 1 . 5 mg ) docepalotec ( e1201
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the electrical activity of the brain ( electrical activity ). this medicine is used to treat impulsive , hyperactive adults , adolescents and children of all ages . your child ' s doctor has prescribed this medicine for ' attention deficit hyperactivity disorder ' ( adhd ) in combination with current stimulant medication . current medication is not controlling adhd symptoms . intuniv is used as part of a treatment programme consisting of psychological therapy , educational therapy and social therapy . it is used in adults and adolescents 38 years of age and older
do not take intuniv if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you have low or high blood pressure , heart problems , or heart problems . tell your doctor if you fainted or have recently had thoughts or feelings of suicide or any other psychiatric conditions such as withdrawal symptoms , increased heart rate ( especially if your heart is pumping too much ). if you suffer from any of these conditions , your doctor may want to monitor you more closely while you are taking intun
your treatment will be started by a doctor who is experienced in the treatment of adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor will work out the right dose for you based on your child ' s weight . the dose will depend on your response to your treatment and on how well your child responds to it . the usual starting dose is 1 tablet per day . this will be gradually increased over the course of 1 day . depending on how you respond to treatment , your doctor may
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , stop taking your medicine and seek medical advice straight away . serious side effects tell your doctor straight away if you notice any of the following side effects : feeling drowsy , feeling dizzy ( hypotension ), slow heart beat ( bradycardia ), feeling faint , loss of concentration ( syncope ), a serious withdrawal side effect from high blood pressure with symptoms such as headaches , feeling confused , nervousness , agitation and tremors ( hypertensive encephalopathy ). if any of these side effects occur , tell your
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister pack after exp . this medicine does not require any special temperature storage conditions . keep the tablets in the outer carton in order to protect from light . blister pack : do not throw away any medicines via wastewater . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what intuniv contains - the active substance is guanfacine hydrochloride . each prolonged - release tablet contains 1 mg of guanFacine ( see section 2 under ' important information about some of the ingredients '). - the other ingredients are : - in the long - release tablets : - for the first 2 weeks , guanedfacine ; - for each 3 week - long - term tablet : see section 3 under ' other ingredients ' ( see also section 3 of this leaflet for further information ). - in each 4 - year - long tablet : - guanfuce , hypromellose 220
ecalta contains the active substance anidulafungin . ecalta is used in adults , adolescents and children from the age of 18 years to treat adults with a type of fungal infection that affects the blood or other internal organs called invasive candidiasis . the infection is caused by fungal cells called candida ( echinocandins ). these medicines are used to treat serious fungal infections caused by problems with the fungal cell walls that can be life - threatening and can be fatal if they have not been properly protected by their own protection ( e . g ., they have no protection ). ecalt
do not use ecalta - if you are allergic to anidulafungin , other echinocandins , caspofungin acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using ecaltra . your doctor will check your liver function . if you have liver problems , your doctor may reduce your dose or stop your treatment with anaesthetics . if any of these apply to you ( or you are not sure ), your doctor or nurse will monitor your condition closely during and after treatment with ecalt
how much ecalta is given the treatment will be given to you by a doctor or nurse . the recommended dose is 200 mg or 100 mg given every 1 week . adults ( 18 years of age and older ) the usual dose is 3 . 0 mg , 200 mg , 1 . 5 mg and 100 mg . the doctor will work out the patient ' s weight based on their age and body surface area . your doctor will calculate the right dose for you based on your weight and your general condition . the dose you receive is given as a slow infusion ( a drip into a vein ) over a period of at least 1 .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : - potentially life - threatening allergic reactions , including difficulty breathing or wheezing or an existing rash . ecalta is not recommended for use in children and adolescents below the age of 18 years . if this happens to you , stop taking the medicine and seek medical help straight away . - if you experience any of these signs , stop using this medicine and contact your doctor immediately . - very common side effects ( may affect more than 1 in 10 people ): - low
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . this medicine does not require any special storage conditions . the reconstituted solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 8 unless dilution has taken place in controlled and validated aseptic conditions . in this case , the infusion solution may be stored at 25 for up to 48 hours
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 micrograms . - the other ingredients ( excipients ) are mannitol ( e421 ), polysorbate 80 , tartaric acid , sodium hydroxide , hydrochloric acid and 30 ml water for injections ( see section 2 ). what Ecalta looks like and contents of the pack ecaltfa is supplied as a box containing 1 vial containing 100 ml concentrate for solution for infusion . the powder is white to off - white .
adenovi contains the active substance rurioctocog alfa pegol , which is a copy of pegylated human coagulation factor viii ( hcviii ). how adynovi works recombinant dna technology ( rdna technology ) has been demonstrated for the treatment and prevention of bleeding in adults , adolescents and children 12 years of age and older . haemophilia a is an inherited bleeding disorder caused by lack of factor v iii .
do not use adynovi if you are allergic to rurioctocog alfa pegol or octocog aluminium or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor or pharmacist for advice . warnings and precautions talk to your doctor , pharmacist or nurse before using adnovi : if you have ever had an anaphylactic reaction ( a severe , sudden allergic reaction to any substance that is present in adsynovi ). allergic reactions may include rash , 95 hives , wheals , generalised itching , swelling of lips
treatment with adynovi will be started by a doctor who is experienced in the care of patients with haemophilia a . your doctor will decide on the most appropriate treatment for you . the duration of treatment depends on your condition and the type of bleeding that you are suffering from . if you are not sure , talk to your doctor , pharmacist or nurse before you are given adsynovi . if the replacement therapy is not suitable for you , your doctor may decide to give you a lower dose . if your condition is not well controlled , you may be given a life - long treatment . always use this medicine exactly as
like all medicines , this medicine can cause side effects , although not everybody gets them . if sudden allergic reactions ( anaphylactic ) occur , the injection must be stopped immediately . early symptoms of allergic reactions may include rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . if severe symptoms , such as difficulties in breathing or fainting , seek prompt emergency treatment . previous treatment with factor viii ( more than 150 days of treatment ) inhibitor antibodies ( see
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . the powder vial may be stored at room temperature ( up to 30 ) for a single period of up to 3 months . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 3 months at 2 - 8 unless dilution has
what adynovi contains - the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains nominally 250 , 500 , 1000 or 2000 iu ( iu / iu ) iu , iu or eu . - the other ingredients are : the solvent vial : 5 ml sterilised water for injections , mannitol ( e421 ), trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride diydrate , tris ( hydrox
rekovelle contains follitropin delta , a follicle stimulating hormone ( fsh ), which belongs to a group of hormones called gonadotropins . fsh is involved in the development of female fertility in women undergoing assisted reproduction programs ( i . e . in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection . it stimulates the ovaries to produce many egg sacs .
do not use this medicine if any of your fertility problems are serious or if you are allergic to follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ). if you have a tumour in your uterus , ovaries , breasts , pituitary gland or hypothalamus , enlarged ovaries or cysts on your ovaries ( polycystic ovarian disease ), bleeding from the vagina ( an early menopause ), malformations of the sexual organs ( pregnancy ), fibroids of the uterus ( see section " pregnancy and breast - feeding "). ovarian hyperstimulation syndrome gonadotropins
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose will be given to you by your doctor during your first treatment cycle . your doctor will prescribe a type of anti - müllerian hormone that stimulates your ovaries to produce stimulation with gonadotropins in your blood . your dose will depend on your body weight and on the results of a blood sample taken during the last 12 months of treatment . the dose may be adjusted depending on your general condition and on how you respond to treatment . dose the dose depends on your
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by hormones ( infertility ) this medicine may cause a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms include pain , discomfort , swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain and difficulty breathing . if you experience any of these symptoms , stop taking rekovelle and seek medical advice straight away . a side effect that may affect up to 1 in 10 people is headache . nausea is the most commonly reported symptom in women . in men it is more likely that ovarian
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . rekovelle may be stored at room temperature ( up to 25 ) for a single period of up to 3 months . after this period , the product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 3 months at 28 to 25 . during the treatment any unused solution should
what rekovelle contains - the active substance is follitropin delta . each multipack of each multidose cartridge contains 12 million units ( miu ), corresponding to one millilitre of solution . after dilution of 0 . 36 ml of solution , each ml contains 33 . 3 million units , corresponding to two millilitres of follitroin delta in each millilitere of solution ). - the other ingredients ( excipients ) are phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrates ,
the active substances of revinty ellipta are fluticasone furoate and vilanterol . each inhalation contains either one of the following active substances : - ellipta 92 micrograms ( 0 . 5 milligrams ) of the other two active substances ( e . g . flitasonefuroate in the morning and evening and in the evening ) and 184 microgram s ( 1 . 0 milligram ) of either of the active substances in the inhalation . 92 / 22 is used to treat chronic obstructive pulmonary disease ( copd ). asthma in adults and adolescents 12 years
do not take revinty ellipta - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking ellipta . ellipta has not been studied in patients with liver disease . it is not known whether ellipta causes side effects . if you have moderate or severe liver disease , your doctor may lower the dose to a maximum of 92 / 22 mg once a day . tell your doctor if : you have heart problems , high blood pressure , tuberculosis ( t
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much revinty ellipta to use asthma the recommended dose for asthma is two inhalations ( fluticasone furoate 22 mg and vilanterol ) once a day . if you have severe asthma , your doctor may prescribe the higher strength inhalation ( two doses each day ), such as a single inhalation (" fsh 22 mg ") and one tablet ( two tablets ( three tablets ( four tablets ) in the morning and evening , with or without food . for copd
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following symptoms while being treated with ellipta , stop using this medicine and contact your doctor immediately : skin rash , hives , redness swelling mainly of the face and mouth ( angioedema ), feeling very wheezy , coughing , difficulty in breathing , feeling weak or light headed , collapse or loss of consciousness immediate breathing difficulties stop using revinty ellipta and tell your doctor straight away if your
what revinty ellipta contains - the active substances are fluticasone furoate and vilanterol . each inhalation provides 92 micrograms of the two active substances . each delivered dose ( mbq ) corresponds to a maintenance dose ( maintenance dose ) for each nostril . - the other ingredients ( excipients ) are : - the dose for adults is as follows : - as maintenance dose for children of 92 years of age and older ( weighing 92 kg or more ) is asymptomatic . - as for adults , the maintenance dose depends on the child ' s body weight . -
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), emtricitabine , also known as a nucleosidermal necrolysis ( nrti ) and tenofovir , a nucleotide reverse transcriptase inhibitor . these active substances are used in combination with antiretroviral medicines to increase the number of copies of an enzyme ( reverse translase ) that the virus needs to reproduce itself . atripl
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken by mouth once a day . atripla should be taken on an empty stomach at least 1 hour before or 2 hours after food . some side effects may be more serious such as dizziness and drowsiness . if you take more tablets than you should if you accidentally take too many tablets , contact a doctor or go to the nearest hospital emergency department immediately . if possible , take the tablet pack with you so that you can easily describe what you have taken .
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . as with all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects lactic acidosis ( excess lactacid in the blood ) is rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following serious side effect , stop taking atripla and contact your doctor immediately
what atripla contains - the active substances are efavirenz ( as emtricitabine ) and tenofovir disoproxil . one tablet contains 600 mg of atrivirenz . each tablet contains 200 mg of emptricitubine ( as mesilate ) and 245 micrograms ( 5 milliliter ) of ten ofovir disproxil ( as fumarate ). - the other ingredients are croscarmellose sodium , hyprolose , magnesium stearate , microcrystalline cellulose , sodium laurilsulfate
orgalutran contains the active substance ganirelix . it belongs to a group of medicines known as anti - gonadotrophin . it is a synthetic version of the natural gonadonrophin releasing hormone ( gnrh ), which is produced by biotechnology in the laboratory . when the natural gnrh regulates the release of gonadsotrophins , follicle stimulating hormone ( fh ) is released and stimulates the growth and development of follicles in the ovaries . follicles are small round sacs that contain the egg cells and release the immature egg cells from the sacs . orgalut
do not use orgalutran if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be hypersensitive to gonadotrophin releasing hormone ( gnrh ) or to a gnrh analogue . if you have a moderate or severe kidney or liver disease . if any of these apply to you ( or you are not sure ), talk to your doctor or pharmacist before using this medicine . warnings and precautions if you develop signs of an active allergic condition , your doctor may recommend additional monitoring and treatment . allergic reactions allergic reactions are general
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . orgalutran will be given to you by a doctor or nurse who is experienced in the treatment of assisted reproduction techniques ( i . e . in vitro fertilisation ( ivf ), ovarian stimulation , follicle stimulating hormone ( corifollitropin ) on day 2 or day 3 of each cycle . your doctor will give you the injection under the skin ( subcutaneously ) over a period of 5 to 6 weeks . you will be monitored while you are being given the first dose of org
like all medicines , this medicine can cause side effects , although not everybody gets them . a side effect that may affect more than 1 in 10 people is local skin reactions ( e . g . redness and swelling ). the local reaction usually disappears after a few days . see section 4 for more information . uncommon ( may affect up to 1 in 100 people ) is headache , nausea , malaise ( rare ) ( frequency not known ( cannot be estimated from the available data ) is anaphylaxis ( hives and urticaria ) a pre - existing rash ( eczema ) has been reported after the first org
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . syringes should be stored in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . clear , solvent - free solutions should be used immediately .
what orgalutran contains - the active substance is ganirelix . each vial contains 0 . 5 ml of acetic acid . - the other ingredients are mannitol ( e421 ) and water for injections ( see section 2 ). - the ph is sodium hydroxide ( e524 ) which is used to adjust the dose and to increase the acidity of the solution after reconstitution . see section 4 under " how to use " for further information . - if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
what blitzima is blitzima contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a specific target in a certain type of white blood cell called " b - lymphocyte ". how blitzima works blitzima can be used in adults to treat : a ) non - hodgkin ' s lymphoma ( a disease of the lymph tissue that affects the immune system ) in adults . b ) an increase in the number of a - lymphocytes in the blood . blitzima may be used alone or in combination with other medicines called "
do not use blitzima - if you are allergic to rituximab , other proteins that are derived from the needles of yew trees , or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection with a weak immune system . if you suffer from severe heart failure or severe uncontrolled heart disease . warnings and precautions talk to your doctor , pharmacist or nurse before using blitzima if : you have ever had granulomatosis , polyangiitis , microscopic polyagiitis or pemphigus vulgaris ( see section " other medicines and blitz
your treatment with blitzima will be overseen by a doctor who is experienced in the use of this treatment . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you experience any side effects , stop using blitzima and contact your doctor straight away . blitzima is given as a drip ( intravenous infusion ). medicines given with each blitzima administration you will be given blitzima together with other medicines ( pre - medication ) to reduce the risk of side effects . your treatment will be repeated every three weeks . non - hodgkin ' s lymphoma
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion , fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of platelets
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the container in the outer carton in order to protect from light .
what blitzima contains - the active substance is rituximab . each ml of solution contains 10 mg or 100 mg . - the other ingredients are : powder for concentrate for solution for infusion ( 10 mg , 50 mg or 500 mg of ritukimab in 10 ml ), sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what blitzima looks like and contents of the pack blitzima is a clear , colourless solution for injection or infusion . it is available in packs of 2 , 50 and 1 vial . not all pack sizes may be marketed
roactemra contains the active substance toilizumab , a monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the body ). it blocks the activity of a protein called interleukin - 6 , which is involved in causing the inflammation in your body . when used in children and adolescents ( 12 years of age and older ), roactema is used to treat symptoms such as pain and swelling in your joints . roactemera reduces the damage to the cartilage and bone in the joints caused by the disease . if you have moderate to severe active rhe
do not use roactemra : if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active , severe infection . if any of these apply to you , tell your doctor before the infusion is started . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if you experience allergic reactions such as chest tightness , wheezing , severe dizziness , light - headedness , swelling of the lips or skin rash , stop the infusion and see your doctor straight away . infection if you get infections
always use roactemra exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the intravenous infusion will be given by a doctor or nurse who is experienced in the treatment of intravenous use . the usual dose is one 8 mg subcutaneous injection ( injection ) once a week for 4 weeks . your doctor may decide to increase your dose to two 30 mg per week for up to 8 weeks . if you have the impression that the effect is too strong or too weak , talk to your doctor . the recommended dose for adults is one 30 mg
like all medicines , roactemra can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects ( may affect up to 1 in 10 people ): allergic reactions such as difficulty with breathing , chest tightness , light - headedness , rash , itching , hives , swelling of the lips , tongue or face . serious infections such as fever and chills , mouth or skin blisters , stomach ache signs and symptoms of liver toxicity . common side effects (> 1 in 1000 people ): tiredness , abdominal pain , jaundice ( yellow discoloration
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and the vial label after exp . this medicine does not require any special storage conditions .
what roactemra contains - the active substance is tocilizumab . each ml of solution contains 4 mg of 80 mg of tociluzumab ( corresponding to 20 mg / ml ). each 10 ml vial contains 200 mg ( 25 mg ) of tocizumumab when reconstituted as 20 mg or 20 mg when diluted as 400 mg ( 20 mg ). - the other ingredients are sucrose , polysorbate 80 ( e433 ), disodium phosphate dodecahydrate , sodium dihydrogen phosphate dihydrate and water for injections ( see section 2 ). what ro
onbrez breezhaler contains the active substance indacaterol , which belongs to a group of medicines called bronchodilators . it works by relaxing the muscles in the walls of the small air passages in the lungs . this helps to open the airways more easily and allows air to get in and out of the lungs more easily . this medicine is used to treat breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). copd causes the muscles around the lungs to relax , which makes breathing difficult . your doctor has given you this medicine to relax these muscles in your lungs
do not use onbrez breezhaler : if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). if you have asthma . warnings and precautions talk to your doctor , pharmacist or nurse before using onbrezer if you : have heart problems . have epilepsy . have thyroid gland problems ( thyrotoxicosis ). have diabetes . if any of these apply to you , tell your doctor immediately . if you get tightness of the chest , coughing , wheezing or breathlessness immediately after using the medicine . have a condition called bronchospasm .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the usual dose is one 150 microgram capsule twice a day . your doctor may increase your dose to 300 micrograms once a day depending on how you respond to the treatment . use your inhaler at the same time each day for 24 hours . how to use onbrez breezhaler you will need an inhaler and capsules ( in blisters ) to inhale the medicine . the inhalation powder must be dissolved in water before inhalation . use the onbre
what onbrez breezhaler contains - the active substance is indacaterol . - the other ingredients are lactose and the capsule ( s ) contains gelatin . - after reconstitution with an inhaler , capsules are supplied in blisters . the capsules are coated with a white powder . - if you are not sure , talk to your doctor , pharmacist or nurse before you are given this medicine . - when you are giving this medicine , your doctor may decide to give you a higher or lower dose , such as a 150 mg dose or a 300 mg dose , depending on how you respond to indac
clopidogrel hcs is a medicine that belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping they reduce the chances of blood clots forming . this helps to prevent the formation of a rare , but potentially life - threatening , problem called thrombosis ( also known as " clots with thrombi "), which can occur when hardened blood vessels ( arteries ) become clogged ( atherothrombotic events , such as stroke , heart attack , or death ).
do not take clopidogrel hcs - if you are allergic to clopilogrel or any of the other ingredients of this medicine ( listed in section 6 ). - have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - have severe liver disease . if any of these apply to you , tell your doctor or pharmacist . warnings and precautions take special care when you are taking clopridogrel clcs : if you think you may be at an increased risk of bleeding , as this medicine can cause a risk of internal bleeding ( e . g .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may prescribe a lower or higher dose . the usual starting dose , which is 300 mg taken once daily , is two 75 mg tablets of cl
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
what clopidogrel hcs contains - the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopigrel ( as hydrochloride ). - the other ingredients ( excipients ) are : tablet core : ( see section 2 for important information about some of these ingredients ). tablet coating : ( e460 ), microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron
fetcroja contains the active substance cefiderocol . it is an antibiotic medicine that belongs to a group of antibiotics called cephalosporins . antibiotics are used to fight bacteria that cause infections . fetcroja is used to treat infections caused by bacteria that are resistant to other antibiotics .
do not use fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to other antibiotics , e . g . cephalosporins . if you have had a severe allergic reaction to certain antibiotics ( such as penicillins or carbapenems ) if you develop severe skin peeling and swelling of the hands , face , feet , lips , tongue or throat that may cause difficulty swallowing or breathing . warnings and precautions talk to your doctor , pharmacist or nurse before using any of these conditions :
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how fetcroja is given your doctor will give you an infusion ( a drip ) into your vein over a period of 3 to 2 hours . your doctor may change your dose , depending on how you respond to treatment and on the type of infection you have . if your infection does not go away or you feel any pain after the fetcroja infusion , it should be given into a vein . if you have kidney problems tell your doctor straight away if you get kidney problems . how much fetcro
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : - severe allergic reaction - sudden swelling of your lips , face , throat or tongue - a severe rash or other severe skin reactions - difficulty swallowing or breathing - signs of this reaction may include diarrhoea , stools , blood or mucus ( see section " warnings and precautions "). treatment with medicines that slow bowel movement can cause this reaction . other side effects include : common ( may affect up to 1 in 10 people
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg of ccfiderocol . - the other ingredients ( excipients ) are sucrose , sodium chloride and sodium hydroxide ( see section 2 for further information on some of the ingredients ). what fetcroJA looks like and contents of the pack fetcroja is a white to off - white powder for concentrate for solution for infusion . it is available in packs containing 10 vials .
depocyte is used for the treatment of lymphomatous meningitis in adults and children from one month of age . in adults , the condition is associated with a condition in which tumour cells accumulate in the membranes of the brain and spinal cord . depocyte works by blocking the activity of lymphoma tumour cell cells .
do not take depocyte if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). if you have a meningeal infection . warnings and precautions severe neurological side effects have been reported with depocyte . symptoms of the nervous system may include convulsions , pain , numbness , tingling , blindness and visual disturbances . if you experience any of these symptoms , stop taking any dexamethasone tablets and tell your doctor straight away . unwanted effects your doctor will monitor your side effects regularly to detect any new side effects . other medicines and depocyte tell your
treatment of cancer in the lumber sac will be overseen by a doctor who is experienced in the use of depocyte . depocyte will be prepared and given to you by a healthcare professional in a hospital or clinic under the supervision of a doctor with experience in the care of patients with advanced stage of cancer . your doctor will calculate the correct dose for you based on your weight and the type of cancer you have . each depocyte dose will be calculated according to the severity of any side effects you have experienced . the recommended dose for depocyte is based on body surface area ( temperature 22 to 30 ). after withdrawing depocyte from the v
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may occur during your treatment with depocyte : very common side effects ( affects more than 1 user in 10 ): common ( affects 1 to 10 users in 100 ): uncommon ( affects less than 1 users in 1 , 10 ) not known ( frequency cannot be estimated from the available data ): very common adverse events when depocyte is given in combination with other chemotherapeutic agents common side effect ( affects at least 1 user of 10 ) nausea , vomiting weakness , confusion fever headaches dizziness shaking uncommon side effects in combination of dep
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . depocyte may be stored at room temperature ( up to 25 ) for up to 4 weeks . depocytes must not be used if you notice that the solution is discoloured or shows signs of severe discolouration such as a changed appearance or a defective container . if depocyte is used in combination with cytarabine , it should be discarded .
what depocyte contains - the active substance is cytarabine . each ml of solution for injection contains 10 mg cytogrel ( equivalent to 5 mg / ml ). each vial of 50 ml contains 50 mg ( 3 mg ) or 300 mg ( 4 mg ). - the other ingredients are cholesterol , triolein ( e331 ), dioleoylphosphatidylcholine ( e339 ) ( e507 ), dipalmitoylophosphATidylglycerol ( e487 ), sodium chloride and water for injections . what depocyte looks like and contents of the pack depocyte is
the active substance of bemrist breezhaler is indacaterol , which belongs to a group of medicines called bronchodilators . it works by relaxing the muscles in the small airways in the lungs , making it easier for air to get in and out of the lungs . mometasone furoate is also used in combination with another medicine called corticosteroids , which are used to lower the amount of air in the smaller airways ( the airways that carry air ) in the larger airways . it is used to treat breathing problems in adults who have not previously used cortic
do not take bemrist breezhaler if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . if you have heart problems , such as an irregular or fast heartbeat , thyroid gland problems , diabetes , high blood sugar , seizures , low level of potassium in your blood , severe liver problems , tuberculosis ( tb ) of the lung , or any long - standing or untreated infections . if any of these apply to you , tell your doctor immediately .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . bemrist breezhaler capsules should be swallowed whole with water . swallow the capsules whole with a glass of water . you can take the medicine with or without food . do not chew or crush the capsules . if your asthma does not improve or your symptoms get worse , talk to your doctor straight away . how much to use the recommended dose is one inhaler twice a day . your doctor will tell you how many capsules to use and how often to use each . if you use more bem
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious . tell your doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives . these may be signs of allergic reaction ( see also section " warnings and precautions " and section " other side effects and bemrist breezhaler contains lactose and may affect up to 1 in 100 people ): swelling around the tongue and lips , face and throat
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special temperature storage conditions . the capsules should be kept in the original blister in order to protect from light .
what bemrist breezhaler contains - the active substances are indacaterol ( as acetate ) and mometasone furoate . each inhaler contains 125 micrograms ( 62 . 5 mg ) and 173 microlitres ( 3 . 0 mg ) of indaconaterol acetate . - the other ingredients ( excipients ) are : 150 microgram s ( 2 . 4 mg ) in each mouthpiece of the inhaler , corresponding to a total daily dose of 75 microgram ( 2 , 0 . 75 mg ) indacate and 80 microlitre ( 4 . 0
the active substance of zyllt is clopidogrel . it belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). zylltic is used to prevent blood clumps ( thrombi )forming in hardened blood vessels ( arteries ), a process known as atherothrombinosis , which can lead to atheroarthrombotic events ( such as stroke
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you ( or you are not sure ), talk to your doctor , pharmacist or nurse before taking zllt . warnings and precautions you should tell your doctor if you : - have an increased risk of bleeding , such as - a medicalcondition that puts you at risk of internal bleeding (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ) is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may lower your dose to 300 mg once a day . your doctor will tell you how long you should continue treatment . if your doctor tells you to take 75 mg of z
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the whites of the eyes ( jaundice ), bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an allergic reaction
what zyllt contains - the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopridogrel ( as hydrogen sulphate ). - the other ingredients are : tablet core : lactose ( see section 2 under ' zllt contains lactose '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core and hypromellose ( e464 ), titanium dioxide ( e171 ), red iron oxide ( e172 ), talc and propylene glycol in the film - coating . what
lamivudine teva contains the active substance lupus . it is a medicine that is used to treat long term ( chronic ) hepatitis b infection in adults , adolescents and children aged 12 years and older who weigh at least one kilogram ( kg ) and who have not previously been treated for hepatitis b . the hepatitis b virus belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis ). hepatitis b is a virus that infects the liver , and so is life - threatening . in patients who have been exposed to it for a long time it can lead to liver damage . lam
you must not be given lamivudine teva - if you are allergic , or if you think you may be allergic , if any of the above applies to you ( or you are not sure ), talk to your doctor or pharmacist before you are given this medicine . warnings and precautions 28 take special care while you are being treated , and while you ' re being treated by your doctor , it is important that you read the information in this leaflet carefully and follow the instructions for use , which are provided at the end of the leaflet ( see also section 28 " important information about some of the ingredients of lamiv
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor lamivudine teva is used to treat your hepatitis b infection . your doctor will work out the right dose for you depending on how you respond to your infection and on the severity of your illness . take the tablet at the same time each day . do not chew or break the tablet . you should swallow the tablet whole with a glass of water . if you cannot swallow the tablets whole , talk to your doctor . the recommended dose is one tablet once a day .
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects of lamivudine teva are related to other conditions linked to hepatitis b . the following side effects have been reported during therapy for ' hepatitis b ' in clinical trials : tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort , pain , nausea , vomiting , diarrhoea , increases in liver enzymes , and in the levels of enzymes in the muscles . allergic reaction ( rare , may affect up to 1 in 1 , 000 people ): swelling of eyelids , face or lips , difficulty swallowing or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . lamivudine teva should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamvudine . each film - coated tablet contains 100 mg of lamivUDine . - the other ingredients are : tablet core : microcrystalline cellulose , sodium starch glycolate , magnesium stearate . tablet film - coating : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( e172 ) and iron oxide red ( e 172 ). tablet film coating : shellac , talc ( e553b ), biconvex film - coat : 32 lamiv
nespo ( an anti - anaemic ) is used to treat your anaemia . anaemia occurs when your blood does not contain enough red blood cells . the symptoms include fatigue , weakness and shortness of breath . it is caused by the lack of the natural hormone erythropoietin ( a substance produced in the body by the kidneys ). your doctor has given you nespo to encourage your bone marrow to produce more redblood cells ( e . g . darbepoetin alfa ). chronic renal failure if you have symptomatic anaemia , you may have kidney failure . if kidney failure occurs
do not use nespo : if you have high blood pressure or are taking other medicines . if you think you may be allergic , ask your doctor or pharmacist for advice . warnings and precautions talk to your doctor , pharmacist or nurse before you are given neespo ( darbepoetin alfa ) or r - huepo . you should tell your doctor if any of the following applies to you . if your doctor has told you that you are at high risk of having a condition called sickle cell anaemia ( epileptic fits ( seizures ) or convulsions ( fits ). if you
your doctor will carry out blood tests before and during your treatment with nespo to check your haemoglobin level . the usual starting dose is 10 micrograms per kilogram of body weight . your doctor may increase your dose to a h5n1 / m2 ( equivalent to 10 mg / kg ) every 12 hours . the pre - filled syringe is intended for injection into a vein ( intravenous ). if you have chronic renal failure , your doctor will give you a single injection under the skin ( intravenously ). the dose may be increased or decreased depending on how well your anaemia is responding to nes
like all medicines , nespo can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) not known ( frequency cannot be estimated from the available data ) high blood pressure ( hypertension ) fluid retention ( oedema ) rare ( affecting 1 to 100 users in 10 , 000 ) serious allergic reactions sudden life - threatening allergic reactions ( anaphylaxis ) swelling of the face , lips , mouth , tongue or throat that may cause difficulty in swallowing or
keep out of the reach and sight of children . do not use nespo after the expiry date which is stated on the carton and on the syringe label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep your syringe in the outer carton in order to protect from light . after first opening : do not store above 30 and keep it at room temperature ( up to 7 ) for a single period of maximum seven days . keep the bottle tightly closed with the cap on the bottle , so that it can be easily removed from the bottle and thrown away if not used . do
what nespo contains - the active substance is darbepoetin alfa . each ml of a pre - filled syringe contains 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 iu . - the other ingredients are sodium phosphate monobasic , sodium phosphate dibasic ( e470b ), sodium chloride , polysorbate 80 and water for injections . the solvent is clear , colourless to slightly pearly liquid and not cloudy . 1 ml of solution for injection is available in packs of 4 pre -
macugen is a solution for the treatment of macular degeneration in adults . it contains the active substance pegaptanib . this medicine is used to prevent abnormal formation of new blood vessels in the eye . macugen is intended for use in adults , adolescents and children under the age of 18 years . the treatment is intended to be started by a doctor who has been trained in the use of this type of medicine in adult patients . in adults with macular dementia , the most common symptom of this disease is vision loss caused by damage to a part of the retina called the macula . macula is the eye ' s
do not use macugen : if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active or suspected infection in your eye . warnings and precautions talk to your doctor , pharmacist or nurse before using macugen . if you think you may have an infection or bleeding in the eye , stop macugen injection and contact your doctor immediately . you may experience the following symptoms : eye pain , increased discomfort , worsening eye redness , blurred or decreased vision , increased sensitivity to light , small particles in your vision , especially in the back of the eye .
mugen will be given to you by a doctor or nurse who is experienced in the use of injections of macugen . macugen is given as a single injection into your eye . it is given every 6 to 9 weeks . the injection will be injected into the vitreous part of your eye ( the front part of the eye ). macugen may be given in combination with antibiotic eye drops . your doctor will clean your eye and give you some local anaesthetic ( numbing medicine ) to relieve any pain you may have after the injection . if you think you may be allergic , ask your doctor for advice before you are given
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) angioedema of which symptoms include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting , rapid pulse , stomach cramps , nausea , vomiting and diarrhoea . the frequency of these side effects is not known ( frequency cannot be estimated from the available data ). an infection in the internal portion of the eye has been reported following macugen treatment . the symptoms are listed in section 2 under " warnings and precautions " and in section
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . store in the original package in order to protect from moisture . once opened , the medicine should be used immediately .
what macugen contains - the active substance in macugen is pegaptanib . each single dose pre - filled syringe contains 0 . 3 milligrams ( mg ) of pegaptenib in 90 ml of solution . - the other ingredients are : sodium chloride , monobasic sodium phosphate monohydrate , dibasicodium phosphate heptahydrate , sodium hydroxide , hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugen looks like and contents of the pack macugen solution for injection in a single dose pack is supplied in a pouch .
palifermin contains the active substance escherichia coli . palifermin is produced by biotechnology in the body by recombinant dna technology . it belongs to a group of proteins called epithelial cells . it is used in adults to treat oral mucositis ( soreness , dryness and inflammation of the mouth ) as an additional side effect to treatments for your blood cancer . if you have a problem with your bloodcancer , you may be treated with chemotherapy , radiotherapy or autologous hemopoietic stem cell transplantation ( a procedure in which blood cells are collected and given back to you
do not use kepivance - if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . children and adolescents do not give this medicine to children under 18 years of age because it has not been studied in this age group . other medicines and kepacivance tell your doctor or pharmacist if you take , have recently taken or might take any other medicines . this includes any medicines obtained without a prescription ( e . g . heparin
your doctor will decide how much kepivance you will receive and how often you will be given cancer treatment . your doctor will determine the dose you should receive . the usual starting dose is one 60 mg film - coated tablet ( 600 mg ). your doctor may decide to increase your dose to a maximum of one kilogram ( kg ) given as an intravenous injection into a vein . if you have any further questions on the use of this product , ask your doctor or pharmacist .
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ) side effects include skin rash , itching , redness , pruritus and erythaema ( an increase in the thickness in the mouth or tongue , change in colour of the face or tongue ), generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ), altered taste , raised levels of lipase and amylase levels in the blood , and decrease in the number of digestive enzymes in
what kepivance contains - the active substance is palifermin ( 6 . 25 mg / ml ). - the other ingredients ( excipients ) are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid ( see end of section 2 for further information on some of the ingredients of this medicine ). what kepvelance looks like and contents of the pack kepiverance is a white powder for concentrate for solution for injection in a vial . each carton contains 6 vials .
cinacalcet accordpharma contains the active ingredient tacrolimus , which increases the levels of calcium and phosphorous in the blood . it is used to treat problems with organs called parathyroid glands . parathyroids are four small glands in the neck ( the thyroid gland ) that help to control the amount of calcium in your blood ( hypercalcaemia ). it is also used in adult patients with secondary hyperparathyroidism ( if you have serious kidney disease or if you are on dialysis , or if waste products are not properly disposed of ). it can also reduce the amount calcium in the
you must not be given cinacalcet accordpharma - if you are allergic ( or to any of the other ingredients of this medicine ) or if you have low levels of calcium in your blood . your doctor will check your blood calcium levels regularly while you are being treated with this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have a history of seizures ( fits or convulsions ) you have ever had seizures you have liver problems you have heart failure you are not sure if any of these apply to you , but you should tell your doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of cinacalcet accordpharma is one tablet a day . your doctor will tell you how many tablets to take and how often you should take them . the tablets can be taken with or without food . regular blood samples will be taken during treatment . if you have secondary hyperparathyroidism , your doctor may prescribe a lower or lower dose than usual . the usual starting dose is one 30 mg tablet once a day ( two tablets a day ).
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - numbness or tingling around the mouth , muscle aches , cramps or seizures . these may be signs that your calcium levels are too low ( hypocalcaemia ). - swelling of the face , lips , mouth , tongue or throat that may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): - nausea and vomiting . if you notice any of these side effects seek medical advice immediately ( see section 2 ). common (
what cinacalcet accordpharma contains - each film - coated tablet contains either 30 mg , 60 mg or 90 mg ( in international units ). - the other ingredients ( excipients ) are : tablet core : hydrochloride , cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminum lake ( e132 ) and iron oxide yellow ( e172 ). see section 2 under ' important information about some of the ingredients ' for further information on the ingredients . what cin
jentadueto contains two different active substances called linagliptin and metformin . both of these active substances belong to a group of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) and have been shown to work together to reduce the amount of sugar in the blood after a meal ( called biguanides ). this medicine is used to lower blood sugar levels in adult patients with a type of diabetes called ' type 2 diabetes mellitus '. this medicine works by helping your body make better use of insulin . this medicine can be used alone or in combination with certain other
do not take jentadueto if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). if you have severely reduced kidney function ( uncontrolled diabetes with severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss , lactic acidosis ( see section " warnings and precautions "). if any of these apply to you ( or you are not sure ), talk to your doctor or pharmacist before taking this medicine . if you suffer from a condition called ' ketone bodies ' ( diabetic pre - coma
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jentadueto should only be prescribed by a doctor who is experienced in the treatment of patients who are currently taking metformin or who are unable to take individual tablets of linagliptin or metformatin . you should continue taking this medicine until your doctor tells you otherwise . if you have the impression that the effect of this medicine is too strong or too weak , talk to your doctor , pharmacist or nurse . you may experience an upset stomach . the recommended dose is 5 mg lin
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms may be serious and require immediate medical attention . stop taking jentadueto and see a doctor straight away if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ) trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change and confusion . if any of these apply to you , tell your doctor immediately . if you have any further questions on the use of this medicine , ask your doctor or pharmacist . very rare ( may affect up to 1 in 10 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special temperature storage conditions . keep the original package in the outer carton in order to protect from light and moisture . store in a refrigerator ( 2 - 8 ). do not freeze . jentadueto may be used if you notice that the pack is damaged or shows signs of tampering . the doctor or nurse will throw away any medicines you no longer use . these measures will help protect the environment .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . one tablet of either 2 . 5 mg or 850 mg film - coated tablets ( tablets ) contains two different active substances : linaglioptin and 850 mg met formin hydroxychloride , respectively . - the other ingredients are : tablet core : arginine , copovidone , magnesium stearate . tablet coating : maize starch , silica , colloidal anhydrous , hypromellose , titanium dioxide ( e171 ), talc , propylene glycol . what jent
edurant contains the active substance rilpivirine , which is used to treat human immunodeficiency virus ( hiv ) infection in adults . edurant belongs to a group of hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). it is used in adults to treat hiv in adults , adolescents and children 12 years of age and older who are infected with hiv . it is also used in children and adolescents who are not fully immunised against hiv and who have not been previously immunized with other types of medicines .
do not take edurant : - if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you start taking this medicine . if you think any of these apply to you , tell your doctor or pharmacist before you are given this medicine , or if you have been previously treated with any other of the following medicines : carbamazepine ( e . g . oxcarbazepine , phenobarbital , phenytoin ) medicines used to treat some bacterial infections ( such
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet once a day . children and adolescents edurant should not be used in children or adolescents under 18 years of age . your doctor will tell you how many tablets to take and how often to take them . the dose to take is based on your child ' s body weight and the type of bacterial infections that you are being treated with . if your child is taking rifabutin , your doctor may tell you to stop taking edur
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following : headache , nausea , difficulty falling asleep , insomnia , dizziness , changes in your routine liver tests ( transaminase ), increase in cholesterol and pancreatic amylase in your blood , abnormal dreams , rash , stomach pain , depression , tiredness , vomiting , drowsiness , decreased appetite , sleep disorders , stomach discomfort , depressed mood , dry mouth 36 low white blood cell and / or platelet count , decrease in haemoglobin in your bloodstream , triglycerides , lip
what edurant contains - the active substance is rilpivirine . each film - coated tablet contains rilpaline hydrochloride ( equivalent to 25 milligrams / tablet ). - the other ingredients are : tablet core : lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose ( e460 ) and magnesium stearate . tablet coating : the film - coating contains lactosemonohydrate , hypromellose 2910 , 6 mg titanium dioxide ( e171 ), macrogol 3000
avandamet tablets contain two different medicines called rosiglitazone and metformin . both of these two medicines help to control the level of sugar in your blood when you have type 2 diabetes . in some cases , your body does not make enough insulin to control your blood sugar levels . the insulin that your body makes does not work as well as it should , and your body may not be able to use the insulin it produces effectively . your doctor may prescribe a sulphonylurea to help control diabetes .
follow all your doctor ' s instructions carefully , even if they differ from the general information contained in this leaflet . check with your doctor or pharmacist if you are not sure . warnings and precautions talk to your doctor , pharmacist or nurse before taking avandamet if you : - are allergic ( hypersensitive ) to rosiglitazone , metformin or any of the other ingredients of avandamanet ( listed in section 6 ) - have had a heart attack or severe angina - have heart failure or have had heart failure in the past - have severe breathing difficulties - have liver disease - have
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended starting dose is 2 mg rosiglitazone ( equivalent to 1000 mg metformin ). this dose will be gradually increased by 1 mg every 8 hours . the maximum dose should be increased by 4 mg every 4 hours . your doctor will tell you the dose that you need to take . the dose may be adjusted by your doctor if your doctor determines that the right dose for you is not suitable for you . how long to take your daily dose is
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions ( see section 2 ). tell your doctor straight away if you notice any of the following : raised and itchy rash ( hives ) swelling mainly of the face or mouth ( angioedema ), which may cause difficulty in breathing collapse . these symptoms are usually mild to moderate and usually disappear within a few days . if any of these symptoms occur , contact your doctor . lactic acidosis ( a build - up of lacticacid ) has been reported in patients taking metformin . if you have severe kidney disease
your doctor , pharmacist or nurse knows how to store avandamet properly .
what avandamet contains - the active substances are rosiglitazone and metformin . each tablet contains either one or two of the following active substances ( see end of section 2 ). - both of these active substances can be prescribed by your doctor or pharmacist . - each of the three active substances is given as a single tablet . - the two strengths are : - one tablet each day ( monotherapy ) and the other tablet ( s ). - each tablet is made up of two different strengths , each corresponding to a total of two tablets each day (" monotherapy " and " s "). - each
clopidogrel mylan is a medicine that belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping they reduce the chances of blood clots forming . this helps to prevent the formation of a rare , but potentially life - threatening , problem called thrombosis . you have been prescribed clopidgin mylan because : you have a higher risk of clots ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombinosis ,
do not take clopidogrel mylan 31 if you think you may be allergic , or are planning to have a baby , ask your doctor for advice before taking this medicine . if you have a medical condition that is currently causing bleeding ( e . g . a stomach ulcer or bleeding within the brain ). if you suffer from severe liver disease . if any of these apply to you , or if you are in any doubt at all , consult your doctor before taking the medicine . warnings and precautions talk to your doctor , pharmacist or nurse before taking any of the following : if you currently have or have ever had bleeding
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may prescribe a lower or higher dose . the usual starting dose , which is 300 mg taken once daily , is two 75 mg tablets of cl
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
what clopidogrel mylan contains - the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopigrel ( as hydrochloride ). - the other ingredients are : tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 for further information on the ingredients ). tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide , yellow iron oxide ( e172 ), talc ( e553b ),
doptelet belongs to a group of medicines known as thrombopoietin receptor agonists . doptelet is used to treat chronic liver disease ( low platelet count ) in adults , adolescents and children ( 12 years of age and older ). it is used in a medical procedure to reduce the risk of bleeding . it works by reducing the number of platelets . platelets are a type of blood cells that are involved in the blood to clot and prevent bleeding .
do not use doptelet if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine : if you have ever had blood clots in your veins or arteries . if you think any of these apply to you , tell your doctor as soon as possible . if your doctor thinks you may be at an increased risk of bloodclots , ask your doctor for advice . children and adolescents do not give this medicine to children under the age of 23 years because the contraceptive birth control pill
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will calculate your dose based on the results of your procedure . the usual starting dose is one 5 mg tablet once a day for up to 8 weeks . if you take more doptelet than you should if you accidentally take too many tablets , talk to a doctor or go to a hospital straight away . you may need to take the tablets with or without food . swallow the tablets whole with a glass of water . do not chew , crush or split the tablets . you can take them with or
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with doptelet : very common ( may affect more than 1 in 10 people ): feeling tired uncommon ( might affect up to 1 in 100 people ): low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) upper abdominal pain swelling bone pain muscle aches fever reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaf
what doptelet contains - the active substance is avatrombopag . each film - coated tablet contains an active substance called avatrogopag maleate . each tablet contains 20 mg of avATrombapag . - the other ingredients are : tablet core : lactose monohydrate ( see section 2 ), microcrystalline cellulose , crospovidone type b [ e110 ], silica , colloidal anhydrous , magnesium stearate . tablet coating : vinyl alcohol , talc , macrogol 3350 , titanium dioxide ( e171 ), iron oxide yellow ( e172
rapiscan belongs to a group of medicines called ' coronary vasodilators '. these are used to monitor the heart arteries ( heart rate ) and the muscles of the heart . rapiscan is used in adults to perform a type of heart scan called ' myocardial perfusion imaging '. the scan uses a radioactive substance called a ' radiopharmaceutical '. these images are taken as part of a series of muscles in the heart using a treadmill to measure blood flow . a scan can be performed to measure the blood flow to and from the heart during catheterisation . this is done using imaging arteries of
do not take rapiscan if you have : slow heart rate , high degree heart block , sinus node disease , a pacemaker , chest pain ( unstable angina ), or treatment for low blood pressure ( hypotension ) or heart failure . if you are allergic to regadenoson or any of the other ingredients of this medicine ( listed in section 6 ). if you think any of these apply to you , tell your doctor before you take the tablet . warnings and precautions talk to your doctor , pharmacist or nurse before you are given the tablet if : you have a recent serious heart problem ( e . g . a
rapiscan will be given to you by a doctor or nurse who is experienced in the treatment of your heart . your doctor will work out your dose based on blood pressure . the recommended dose is 400 mg given as a 5 ml solution the injection may be given as either one 5 ml or two 10 ml injections depending on your weight , or as an injection of sodium chloride 9 mg ( 0 . 9 %) solution for injection ( 5 ml ) or as a radioactive substance ( radiopharmaceutical ). the dose of rapiscan you receive will depend on your heart rate and blood pressure , and may be adjusted by your
like all medicines , rapiscan can cause side effects , although not everybody gets them . the majority of the side effects are mild to moderate . however , some may be serious and need immediate medical attention . if you notice any of the following , stop taking your medicine and contact your doctor immediately : - sudden stopping of the heart which may be a sign of damage to the heart ( heart block ), a disorder of theheart ' s electrical signal , rapid heart beat low blood pressure , fainting , ministrokes , weakness of the face and inability to speak . - if you have had a stroke ( cerebrovascular
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , making it easier for you to get an erection when you are sexually stimulated . viagra is a treatment for adult men with erectile dysfunction or impotence . this is a condition where a man cannot get , keep or keep a hard , erect penis suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking viagra if : - you are taking medicines called nitrates , which could lead to a dangerous fall in your blood pressure . these medicines are used to treat angina pectoris ( also known as " chest pain "). - you have recently taken or might take any other medicines , including nitric oxide donors ( e . g . amyl nitrite ). - you may be taking medicines that could
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 50 mg tablet once a day . you can take viagra with or without food . viagra film - coated tablets are also available as viagra orodispersible tablets . if you take more viagra than you should if you accidentally take too many tablets , contact a doctor or the nearest hospital straight away . swallow the tablet whole with a glass of water . do not crush or chew the tablet . taking viagra at the same time each day will help you get an
like all medicines , this medicine can cause side effects , although not everybody gets them . some of the side effects may be serious and need immediate medical attention . stop taking viagra and see a doctor straight away if you notice any of the following serious side effects : - an allergic reaction ( may affect up to 1 in 100 people ). symptoms may include sudden wheeziness , difficulty in breathing , dizziness and swelling of the eyelids , face , lips or throat . - chest pains , especially if you are in a semi - sitting position . - nitrates may cause your chest pain . - prolonged and sometimes painful erections (
what viagra contains the active substance in viagra is sildenafil . each tablet contains 25 mg ( as the citrate salt ). the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate , hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( e132 ). what viagra looks like and contents of the pack viagra film - coated tablets have a rounded - diamond shape and are marked with " 25 " on one
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopamine receptors in the brain . stimulation of the dopamine receptors triggers nerve impulses in thebrain that help to control body movements . sifrol is used to treat the symptoms of primary parkinson ' s disease in adults . it is used in combination with levodopa ( another medicine for parkinson '. it is indicated for the treatment of the symptoms in adult patients with moderate to severe primary restless legs syndrome ).
do not take sifrol - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given sifol if you have any medical conditions , including symptoms of kidney disease . hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinations are temporary . dyskinesia ( abnormal , uncontrolled movements of the limbs ). in patients with advanced parkinson ' s disease , levodopa has been shown to increase the risk of developing this condition . if you develop dysk
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . sifrol should only be prescribed by a doctor experienced in the treatment of parkinson ' s disease . the recommended starting dose is 3 tablets per day . during the first week , your doctor will increase your dose to 1 tablet ( 0 . 088 mg ) of 0 . 264 mg once a day . thereafter , your dose will be gradually increased until the desired effect is achieved . this will be achieved gradually over a period of 1 to 3 weeks . your doctor may also increase the dose to 0 .
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common ( may affect more than 1 in 10 people ) common ( might affect up to 1 in 100 people ) uncommon ( likely to affect between 1 in 1 , 000 and 10 , 000 people ) not known ( frequency cannot be estimated from the available data ) if you have parkinson ' s disease , you may experience the following side effects : - dyskinesia ( abnormal , uncontrolled movements of the limbs ) - dizziness - nausea ( sickness ) - urge to behave in
what sifrol contains - the active substance is pramipexole . each tablet contains 0 . 088 mg , 0 . 18 mg or 0 . 35 mg , respectively ( 0 . 7 mg / ml ). - the other ingredients ( excipients ) are : tablet core : povidone k 25 , magnesium stearate ( e470b ). tablet coating : mannitol ( e421 ), maize starch , anhydrous colloidal silica ( e572 ), povidoone k25 , magnesium strearate in the tablet core and in the film - coating : shellac ( e9
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye in adults . it is used to prevent allergic conditions from occurring in the eye . the allergic reaction to emadine may be caused by the presence of some materials ( allergens ). allergic reactions may include itching , redness and swelling on the surface of your eye . if you notice any of these , tell your doctor straight away . you may feel worse .
do not use emadine : - if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine ). children and adolescents do not give this medicine to children or adolescents below the age of 3 years because benzalkonium chloride has been shown to be present in the blood in children and teenagers when emadide is used in combination with other eye drops ( see section 3 ). if you have kidney or liver problems , ask your doctor for advice . if you think any of these apply to
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose is 3 drops in your eye once a day . this medicine is for oral use . do not apply this medicine to your eyes unless your doctor tells you to . step 3 . step 1 step 2 step 1 take the emadine bottle out of the bottle and wash your hands . hold the bottle tightly closed with a finger . tilt your head back . pull down your eyelid with a clean finger until there is a ' pocket ' between the
like all medicines , this medicine can cause side effects , although not everybody gets them . stop using emadine and talk to your doctor or pharmacist immediately if you notice any of the effects listed below . common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye and eye redness . not known ( frequency cannot be estimated from the available data ): eye allergy , abnormal eye sensation , increased tear production , tired eyes , eye irritation , blurred vision , corneal staining and dry eye . general side effects : headache , difficulty sleeping , sinus headache , bad
keep this medicine out of the sight and reach of children . do not use emadine after the expiry date which is stated on the carton and blister after exp . store below 25 . store in the original package in order to protect from moisture and infections .
what emadine contains - the active substance is emadastine ( 0 . 5 mg / ml ). - the other ingredients are difumarate , benzalkonium chloride , trometamol , sodium chloride , hypromellose , purified water , hydrochloric acid , sodium hydroxide , acidity levels ( ph levels ) and water for injections ( see section 2 ). what emADine looks like and contents of the pack emademine is a liquid ( a solution ) supplied in a 5 ml or 10 ml plastic ( drop - bottle ) bottle with a screw cap . not all pack
levetiracetam is an antiepileptic medicine ( a medicine used to reduce the number of seizures in epilepsy ). it is used in adults , adolescents and children from 16 years of age with newly diagnosed epilepsy . epilepsy is a form of epilepsy where the patients have repeated fits ( seizures ). the epilepsy is defined as a condition in which the fits initially affect only one side of the brain , but may thereafter extend to larger areas on both sides of your brain ( partial onset seizure with or without secondary generalisation ) and may thereafter affect larger areas of your body ( e . g ., your whole body ). levet
you must not be given levetiracetam actavis - if you are allergic to any of the active substances in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if you : - have kidney problems . - have any slow down in the growth or puberty of your child . - are taking anti - epileptics ( see section 4 ). - have had thoughts of harming or killing themselves . tell your doctor or pharmacist if you have any symptoms of depression or suicidal ideation . if you think any of these apply to you , tell your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of levetiracetam actavis in the morning and one tablet in the evening . monotherapy dose the recommended starting dose for adults and adolescents 16 years of age and older is 1 , 000 mg once daily . your doctor may prescribe a lower or higher dose depending on your condition and on how you respond to the medicine . the dose may be increased or decreased by your doctor . the doctor will tell you how many tablets to take . the usual starting dose is 3 ,
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor or the nearest emergency department immediately if you experience : weakness , feel light - headed , dizzy or have difficulty breathing . these may be signs of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ). flu - like symptoms with a rash on the face and an extended rash with a high temperature . increased levels of liver enzymes seen in blood tests . decrease in a type of white blood cell 56 ( eosinophilia )
what levetiracetam actavis contains - the active substance is called lusicogrel . each film - coated tablet ( 250 mg ): one 250 mg tablet contains 250 mg of levetimacetam . one 500 mg tablet ( 500 mg ): two 500 mg tablets ( 1 , 000 mg ). - the other ingredient ( s ) are lactose ( lactose ) and water for injections ( see section 2 ). - each tablet ( 750 mg : one 300 mg tablet ) contains 750 mg levetomatam . - each 1, 000 mg tablet (" s "): one 600 mg tablet " contains 1 ,
what incruse ellipta is this medicine contains the active substance umeclidinium bromide , which belongs to a class of bronchodilators called " inhalation inhalation " ( inhaled using a syringe ) and is used for the treatment of chronic obstructive pulmonary disease ( copd ). copd is a long - term condition in which the airways in your lungs become blocked . this can lead to breathing difficulties . if you have difficulties in breathing , tightening of the muscles around your lungs . this medicine helps to stop tightening of these muscles , making it easier for air to get in and
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : - you have asthma . this medicine is not recommended for use in children and adolescents under the age of 27 . - you suffer from asthma or heart problems . you have an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ). you have severe liver problems . immediate breathing difficulties such
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should inhale this medicine every day for 24 hours at the same time each day . use incruse ellipta every day until your doctor tells you otherwise . do not use more than your prescribed dose . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are rare ( may affect up to 1 in 100 people ). if you experience any of the following symptoms while taking incruse ellipta , stop taking this medicine and tell your doctor straight away : itching skin rash , hives and redness 29 common side effects are : common cold infection of nose , throat cough , feeling of pressure , pain in the cheeks and forehead , inflammation of the sinuses ( sinusitis ), headache , constipation . uncommon side effects may be : uncommon side effect is : uncommon ( may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the inhaler after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the sealed tray in the outer carton in order to protect from light . after first opening of the vial , the seal may be removed for a single period of up to 6 months . once the seal has been removed , use the inhale within 30 . if not used immediately , in - use storage times and conditions prior to use are the responsibility of
what incruse ellipta contains - the active substance is umeclidinium bromide . each inhalation provides a delivered dose of 55 micrograms ( 0 . 5 millilitres ) umclidinicium . each delivered dose delivers a delivered delivered dose ( equivalent to 65 microgram s ) of ummclidinitium ( as monohydrate ). - the other ingredients ( excipients ) are lactose monohydrate ( see section 2 for further information on lactose '), magnesium stearate ( e470b ) and water for injections ( for inhalation use ). what incru
nucala contains the active substance mepolizumab , which is a monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the body ). it is used to treat severe asthma in adults , adolescents and children aged 6 years and older . severe asthma affects many eosinophils ( an important type of white blood cell that helps the airways to breathe ) and affects the functioning of the lungs . how nucala works and why it has been prescribed for you by your doctor to help control your asthma , your doctor has prescribed these medicines together with medicines called " oral
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine : if you have worsening asthma 58 if you experience asthma - related side effects , your doctor may decide to reduce your dose or temporarily stop your asthma . if you think any of these apply to you , tell your doctor or pharmacist straight away . if your doctor thinks that you may be allergic , ask your doctor for advice . injection site reactions medicines of this type ( monoclonal antibodies
nucala is given by injection under the skin ( subcutaneous injection ). adults and adolescents from 12 years of age and older : the recommended dose is 100 mg given once a week ( 1 injection in the pre - filled pen ). if you have any further questions on the use of nucala , ask your doctor , pharmacist or nurse . duration of treatment your doctor will tell you how long you should continue to receive the treatment . your doctor may decide to change your dose , or stop the treatment temporarily , depending on your asthma symptoms and on how you respond to injections . if you miss an appointment to receive nuc
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with nucala : allergic reactions allergic or allergic - like reactions may occur very commonly ( may affect more than 1 in 10 people ) after the injection . sometimes symptoms may include symptoms such as chest tightness , cough , difficulty breathing fainting , dizziness , feeling lightheaded ( due to a drop in blood pressure ), swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you experience a reaction similar reaction to any of the other side effects listed below .
keep this medicine out of the sight and reach of children . do not use nucala after the expiry date which is stated on the carton and on the pre - filled pen label after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the pen in the outer carton in order to protect from light . after first opening , the pen may be stored for a single period of up to 7 days at a temperature not above 25 . discard the pen if not used within 7 days .
what nucala contains - the active substance is mepolizumab . each ml of solution contains 1 mg or 100 mg of mepolzumab ( as besilate ). - the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate , polysorbate 80 , edta disodium dihydrate , and water for injections . what uucala looks like and contents of the pack nuucala 1 mg solution for injection is supplied as a pack containing 1 vial in a multipack . each pack contains 3 vials of 1 v
what ninlaro is and what it does it is a cancer medicine that contains the active substance ixazomib , a ' proteasome inhibitor '. what is it used for ? what is myeloma ? your doctor has prescribed this medicine for you because you have a cancer of the bone marrow called multiple sclerosis ( mds ) that has spread to other parts of the body . it is used in adults , adolescents and children ( 12 years of age and older ) who have had at least one other type of cancer before . how is it prescribed for you ? when your doctor prescribed a medicine to treat multiple myel
do not take ninlaro - if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . if you think any of these apply to you ( or you are not sure ), ask your doctor or pharmacist for advice before taking the medicine . do not take any more of the following if you have been told by your doctor that you are at an increased risk of bleeding : - persistent nausea , vomiting , diarrhoea - nerve problems such as tingling , numbness ,
do not take ninlaro if you have multiple myeloma . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will tell you how many capsules of this medicine to take . do not take more than the recommended dose of one capsule each day . if you take more of the active substance in this medicine than you should : lenalidomide and dexamethasone once a day for the first 4 weeks . you can take one of the other active substances in the medicine ( listed in section 6 ). lenalid
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ): low platelet counts ( thrombocytopenia ) nose bleeds that can easily bruise nausea , vomiting , diarrhoea numbness or tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs orfeet ( peripheral oedema ) skin rash ( itchy all over the body ). rare side effects may affect up to 1 in 1 , 000 people : severe skin rashes with red to purple bumps ( sweet
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 30 . store in the original package in order to protect from moisture . the capsule can be removed from the blister and left at room temperature ( up to 30 ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what ninlaro contains the active substance in each capsule is ixazomib . each capsule of 2 . 3 mg contains ixasomib citrate . the other ingredients are : capsule content : microcrystalline cellulose , magnesium stearate , talc . the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide ( e172 ). printing ink : shellac , propylene glycol , potassium hydroxide , black iron oxide [ e172 ]. the printing ink contains : - the capsule content is white to off - white , capsule shaped , with " nvr " deboss
do not use palforzia : if you are allergic to peanuts or arachis hypogaea . warnings and precautions talk to your doctor , pharmacist or nurse before using palfORzia . children and adolescents from 4 to 17 years of age should not receive treatment for peanut allergy because peanut ( desensitisation ) has not been studied in this age group . therefore , there is no information on the safety of this medicine in children below the age of 17 years .
do not take palforzia if you are allergic to peanut or soya or any of the other ingredients of this medicine ( listed in section 6 ). if you have severe asthma . if your asthma has become severe and you have a problem swallowing . if you suffer from long term problems with your digestive system such as a severe mast cell disorder or severe or life - threatening anaphylaxis . if any of these apply to you , tell your doctor , pharmacist , or nurse before you start treatment . warnings and precautions talk to your doctor or pharmacist before you are given this medicine , as the symptoms of peanut allergy
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . allergy if you have allergic reactions ( anaphylaxis ) to palforzia or any of the other ingredients of this medicine ( listed in section 6 ). your doctor will determine the dose you should take and will prescribe the dose that is right for you . the dose will depend on your condition and the type of allergy you are suffering from . the initial doseescalation and up - dosing steps will be given to you by your doctor . if you take more p
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with palforzia : severe allergic reactions tell your doctor straight away if you have any of the following symptoms while being treated with this medicine : signs of the reaction may include : trouble breathing , throat tightness , feeling offulness , trouble swallowing or speaking - changes in voice , dizziness or fainting severe stomach cramps , pain , vomiting , diarrhoea , severe flushing and itching of the skin polozia may cause problems with the stomach and digestive system ( eosin
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store below 25 . store in the original package in order to protect from light . this medicine must not be used if you notice any hard lumps of powder or if the liquid is discoloured .
what palforzia contains the active substances are : 0 . 5 mg , 1 mg , 10 mg and 20 mg . the other ingredients are : microcrystalline cellulose , colloidal anhydrous silica and magnesium stearate palforbzia 100 mg , oral powder in capsules with openingmicrocrystallose cellulose ( e460i ), colloidal Anhydroussilica ( e470b ) and magnesium unstearate ppalfborzia 300 mg , 2 mg , 3 mg , 4 mg , 5 mg tablets , single - dose blisters containing 1 ml of solution for injection
the active substance of zerene is benzodiazepine . it belongs to a group of medicinal products known as hypnotic actions . it is used to treat sleeping problems in adults . the duration of treatment is one month . if you have problems sleeping , talk to your doctor .
you should not be given zerene : if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if you are not sure . you should tell your doctor or pharmacist if you think you are ( or might become ) hypersensitive to any medicine or any medicine that may cause severe breathing or chest problems . children and adolescents do not give this medicine to children under 18 years of age because it has not been studied in this age group . zere
always take zerene exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 10 mg capsule per day to be taken orally with or without food . if you have difficulty falling asleep , you should take the capsule at least one hour before or one hour after food . for patients over 65 years of age with mild to moderate liver problems , the dose may be increased to two 5 mg capsules per day depending on how you respond to treatment . if the capsule is cloudy , you may be more likely to get an overdose . you may also feel increasingly drow
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) not known ( frequency cannot be estimated from the available data ) very rare ( affects less than 1 users in 1 , 000 ) very small number of patients have experienced the following side effects : very common : drowsiness memory difficulties sensations like tingling in the extremities ( para
what zerene contains - the active substance is zaleplon 5 mg . - the other ingredients are : tablet core : microcrystalline cellulose , pregelatinised starch , silicon dioxide , sodium lauryl sulphate , magnesium stearate . tablet coating : lactose monohydrate , indigo carmine ( e132 ), titanium dioxide ( e171 ). printing ink : shellac , lecithin , simethicone ( e1520 ) and yellow iron oxide ( e172 ). shellac shellac ( e904 ) and talc ( e553b ) printing ink: shellac
